TWI718257B - Uv-absorbing vinylic monomers and uses thereof - Google Patents

Uv-absorbing vinylic monomers and uses thereof Download PDF

Info

Publication number
TWI718257B
TWI718257B TW106105690A TW106105690A TWI718257B TW I718257 B TWI718257 B TW I718257B TW 106105690 A TW106105690 A TW 106105690A TW 106105690 A TW106105690 A TW 106105690A TW I718257 B TWI718257 B TW I718257B
Authority
TW
Taiwan
Prior art keywords
vinyl monomer
group
absorbing
patent application
lens
Prior art date
Application number
TW106105690A
Other languages
Chinese (zh)
Other versions
TW201736332A (en
Inventor
偉康 張
瑞恩 迪少撒
特洛伊 維農 荷蘭德
約翰 達拉斯 普魯特
傑瑞德 尼爾森
Original Assignee
瑞士商愛爾康公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 瑞士商愛爾康公司 filed Critical 瑞士商愛爾康公司
Publication of TW201736332A publication Critical patent/TW201736332A/en
Application granted granted Critical
Publication of TWI718257B publication Critical patent/TWI718257B/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52Amides or imides
    • C08F220/54Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F220/60Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide containing nitrogen in addition to the carbonamido nitrogen
    • C08F220/603Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide containing nitrogen in addition to the carbonamido nitrogen and containing oxygen in addition to the carbonamido oxygen and nitrogen
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29DPRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D11/00Producing optical elements, e.g. lenses or prisms
    • B29D11/00009Production of simple or compound lenses
    • B29D11/00038Production of contact lenses
    • B29D11/00125Auxiliary operations, e.g. removing oxygen from the mould, conveying moulds from a storage to the production line in an inert atmosphere
    • B29D11/00134Curing of the contact lens material
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/38Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18Benzotriazoles
    • C07D249/20Benzotriazoles with aryl radicals directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10Esters
    • C08F20/34Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
    • C08F20/36Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate containing oxygen in addition to the carboxy oxygen, e.g. 2-N-morpholinoethyl (meth)acrylate or 2-isocyanatoethyl (meth)acrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/62Monocarboxylic acids having ten or more carbon atoms; Derivatives thereof
    • C08F220/70Nitriles; Amides; Imides
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041Lenses
    • G02B1/043Contact lenses
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B5/00Optical elements other than lenses
    • G02B5/20Filters
    • G02B5/208Filters for use with infrared or ultraviolet radiation, e.g. for separating visible light from infrared and/or ultraviolet radiation
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B5/00Optical elements other than lenses
    • G02B5/20Filters
    • G02B5/22Absorbing filters
    • G02B5/223Absorbing filters containing organic substances, e.g. dyes, inks or pigments
    • GPHYSICS
    • G02OPTICS
    • G02CSPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00Optical parts
    • G02C7/02Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04Contact lenses for the eyes
    • G02C7/049Contact lenses having special fitting or structural features achieved by special materials or material structures
    • GPHYSICS
    • G02OPTICS
    • G02CSPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00Optical parts
    • G02C7/10Filters, e.g. for facilitating adaptation of the eyes to the dark; Sunglasses
    • G02C7/108Colouring materials
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/0002Condition, form or state of moulded material or of the material to be shaped monomers or prepolymers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Mechanical Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Eyeglasses (AREA)
  • Optical Filters (AREA)

Abstract

Described herein are water-soluble UV-absorbing vinylic monomers and their uses in preparing UV-absorbing contact lenses capable of blocking ultra-violet (“UV”) radiation and optionally (but preferably) violet radiation with wavelengths from 380 nm to 440 nm, thereby protecting eyes to some extent from damages caused by UV radiation and potentially from violet radiation. This invention also provides a UV-absorbing contact lens.

Description

UV吸收性乙烯基單體以及其用途UV-absorbing vinyl monomers and their uses

本發明涉及能夠吸收紫外線(UV)輻射和視情況高能紫光(HEVL)輻射的水溶性乙烯基單體以及其用於從水基水凝膠鏡片配製物生產能夠阻擋波長從380nm至440nm的紫外線(“UV”)輻射和視情況(但較佳的是)紫光輻射的水凝膠接觸鏡片之用途。 The present invention relates to a water-soluble vinyl monomer capable of absorbing ultraviolet (UV) radiation and optionally high-energy violet (HEVL) radiation and its use in the production of water-based hydrogel lens formulations capable of blocking ultraviolet rays with wavelengths from 380nm to 440nm ( The use of hydrogel contact lenses with "UV" radiation and optionally (but preferably) violet radiation.

大多數可商購的水凝膠接觸鏡片根據常規鑄造模製技術生產,該技術涉及使用一次性塑膠模具以及乙烯基單體和交聯劑的混合物。該常規鑄造模製技術存在幾個缺點。例如,傳統的鑄造模製製造方法經常包括鏡片萃取,其中必須藉由使用有機溶劑從鏡片中去除未聚合單體。使用有機溶劑可能是昂貴的並且不是環境友好的。此外,一次性塑膠模具固有地具有不可避免的尺寸變化,因為,在塑膠模具的注塑模製過程中,由於生產過程(溫度、壓力、材料特性)的波動可能發生模具尺寸的波動,並且還因為所產生的模具在注塑模製後可能經受不均勻的收縮。模具中的該等尺寸變化可能導致在有待產生的接觸鏡片的參數(峰值折射率、直徑、基本曲線、中心厚度等)的波動並且導致在複製複雜鏡片設計上的低保真度。 Most commercially available hydrogel contact lenses are produced according to conventional casting molding techniques, which involve the use of disposable plastic molds and a mixture of vinyl monomers and crosslinking agents. This conventional casting molding technique has several disadvantages. For example, traditional casting and molding manufacturing methods often include lens extraction, in which unpolymerized monomers must be removed from the lens by using an organic solvent. The use of organic solvents can be expensive and not environmentally friendly. In addition, disposable plastic molds inherently have unavoidable dimensional changes, because in the injection molding process of plastic molds, due to fluctuations in the production process (temperature, pressure, material characteristics), fluctuations in mold size may occur, and also because The resulting mold may experience uneven shrinkage after injection molding. Such dimensional changes in the mold may cause fluctuations in the parameters (peak refractive index, diameter, base curve, center thickness, etc.) of the contact lens to be produced and result in low fidelity in replicating complex lens designs.

在常規鑄造模製技術中遇到的上述缺點可藉由使用所謂的Lightstream TechnologyTM(視康(CIBA Vision))得以克服,其涉及(1)基 本上不含單體並且包含具有乙烯式不飽和基團的基本純化的水溶性預聚物的鏡片形成組成物,(2)以高精度生產的可重複使用的模具,和(3)在光化輻射(例如,UV)的空間限制下的固化,如在美國專利案號5,508,317、5,583,163、5,789,464、5,849,810、6,800,225、以及8,088,313中描述的。由於使用可重複使用的、高精度的模具,根據Lightstream TechnologyTM生產的鏡片可具有對初始鏡片設計的高一致性和高保真度。此外,具有高品質的接觸鏡片能夠以相對較低的成本(由於短的固化時間、高的生產率和沒有鏡片萃取)並且以環境友好的方式(因為使用水作為用於製備鏡片配製物的溶劑)生產。然而,Lightstream TechnologyTM尚未被應用於製造能夠吸收紫外(UV)光(在280nm與380nm之間)和視情況高能紫光(HEVL)(在380nm與440nm之間)的接觸鏡片,主要是因為可商購的可聚合的UV吸收性乙烯基單體和在美國專利案號4,612,358、4,528,311、4,716,234、7,803,359、8,153,703、8,232,326和8,585,938(以其全文藉由引用結合在此)中揭露的那些不是水溶性的並且不能在從水基鏡片配製物生產接觸鏡片中使用。 The above-mentioned shortcomings encountered in conventional casting and molding technology can be overcome by using the so-called Lightstream Technology TM (CIBA Vision), which involves (1) substantially no monomers and containing ethylenically unsaturated A lens forming composition of a substantially purified water-soluble prepolymer of the group, (2) a reusable mold produced with high precision, and (3) curing under the spatial limitation of actinic radiation (e.g., UV) , As described in U.S. Patent Nos. 5,508,317, 5,583,163, 5,789,464, 5,849,810, 6,800,225, and 8,088,313. Due to the use of reusable, high-precision molds, lenses produced according to Lightstream Technology TM can have high consistency and high fidelity to the original lens design. In addition, contact lenses with high quality can be used at relatively low cost (due to short curing time, high productivity and no lens extraction) and in an environmentally friendly manner (due to the use of water as a solvent for preparing lens formulations) produce. However, Lightstream Technology TM has not been used to make contact lenses capable of absorbing ultraviolet (UV) light (between 280nm and 380nm) and optionally high-energy violet (HEVL) (between 380nm and 440nm), mainly because of commercial availability. The commercially available polymerizable UV-absorbing vinyl monomers and those disclosed in U.S. Patent Nos. 4,612,358, 4,528,311, 4,716,234, 7,803,359, 8,153,703, 8,232,326, and 8,585,938 (incorporated herein by reference in their entirety) are not water-soluble And cannot be used in the production of contact lenses from water-based lens formulations.

因此,對於用於從水基鏡片配製物製造UV吸收性或UV/HEVL吸收性接觸鏡片的新的水溶性UV吸收性乙烯基單體或新的水溶性UV/HEVL吸收性乙烯基單體仍然存在需要。 Therefore, new water-soluble UV-absorbing vinyl monomers or new water-soluble UV/HEVL-absorbing vinyl monomers used to manufacture UV-absorbing or UV/HEVL-absorbing contact lenses from water-based lens formulations remain There is a need.

在一個方面,本發明提供了一種UV吸收性乙烯基單體,該UV吸收性乙烯基單體包含一個二苯甲酮或苯并三唑部分,一個或多個用於使該UV吸收性乙烯基單體係水溶性的親水性部分,以及(甲基)丙烯醯基。 In one aspect, the present invention provides a UV-absorbing vinyl monomer, the UV-absorbing vinyl monomer contains a benzophenone or benzotriazole moiety, one or more for making the UV-absorbing vinyl A single-system water-soluble hydrophilic part, and (meth)acrylic acid group.

在另一個方面,本發明提供了一種用於從包含至少一種本發 明的水溶性UV吸收性乙烯基單體的水性鏡片配製物生產UV吸收性接觸鏡片之方法。 In another aspect, the present invention provides a method for downloading from at least one of the present invention A method for producing UV-absorbing contact lenses with water-soluble lens formulations of water-soluble UV-absorbing vinyl monomers.

本發明在另外一個方面提供了包含本發明的UV吸收性乙烯基單體的單體單元的水凝膠接觸鏡片。 In another aspect, the present invention provides a hydrogel contact lens comprising monomer units of the UV-absorbing vinyl monomer of the present invention.

詳細描述 Detailed Description

除非另外定義,否則在此使用的所有技術和科學術語具有與由本發明所屬領域的普通技術人員通常所理解的相同的含義。總體上,在此使用的命名法和實驗室程序係本領域眾所周知的且常用的。常規的方法用於該等程序,如在本領域和各種通用參考文獻中提供的那些。當以單數提供術語時,諸位發明人也考慮了該術語的複數。在此使用的命名法和以下描述的實驗室程序係本領域中眾所周知的且常用的那些。 Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art to which the present invention belongs. In general, the nomenclature and laboratory procedures used herein are well-known and commonly used in the art. Conventional methods are used for these procedures, such as those provided in the art and various general references. When a term is provided in the singular, the inventors also considered the plural of the term. The nomenclature used here and the laboratory procedures described below are those well known and commonly used in the art.

如在此使用的“約”指的是被稱為“約”的數字包括所敘述的數加上或減去那個所敘述的數字的1%-10%。 As used herein, "about" refers to the number referred to as "about" including the stated number plus or minus 1%-10% of that stated number.

“視情況的”或“視情況”指的是隨後描述的事件或情況可能發生或可能不發生,並且指的是該描述包括其中該事件或情況發生的情形以及其中其不發生的情形。 "Depending on the situation" or "depending on the situation" means that the event or situation described later may or may not happen, and it means that the description includes the situation in which the event or situation occurs and the situation in which it does not occur.

“接觸鏡片”指的是可放置在佩帶者眼睛上或眼睛內的結構。接觸鏡片可以矯正、改進或改變使用者的視力,但不是必須如此。 "Contact lens" refers to a structure that can be placed on or in the eye of the wearer. Contact lenses can correct, improve or change the user's vision, but it doesn't have to be.

如在本申請中使用的,術語“水凝膠”或“水凝膠材料”指的是不可溶於水的,但當完全水合時能夠在其三維聚合物網路(即,聚合物基質)中容納至少10重量百分比的水的交聯的聚合物材料。 As used in this application, the term "hydrogel" or "hydrogel material" refers to water-insoluble, but capable of forming a three-dimensional polymer network (ie, polymer matrix) when fully hydrated A cross-linked polymer material that contains at least 10 weight percent of water.

“乙烯基單體”指的是具有一個唯一的乙烯式不飽和基團且可溶於溶劑中的化合物。 "Vinyl monomer" refers to a compound that has a single ethylenically unsaturated group and is soluble in a solvent.

關於化合物或材料在溶劑中的術語“可溶”意指化合物或材料在室溫(即,從約20℃至約30℃)下可溶於溶劑中以得到具有按重量計至少約0.1%的濃度的溶液。 The term "soluble" with respect to a compound or material in a solvent means that the compound or material is soluble in the solvent at room temperature (ie, from about 20°C to about 30°C) to obtain a compound or material having at least about 0.1% by weight Concentration of the solution.

關於化合物或材料在溶劑中的術語“不溶”意指化合物或材料在室溫(如上文所定義)下可溶於溶劑中以得到具有按重量計小於0.005%的濃度的溶液。 The term "insoluble" with respect to a compound or material in a solvent means that the compound or material is soluble in the solvent at room temperature (as defined above) to obtain a solution having a concentration of less than 0.005% by weight.

術語“乙烯式不飽和基團”在此在廣義上使用並且旨在涵蓋含有至少一個>C=C<基團的任何基團。示例性乙烯式不飽和基團包括但不限 於,(甲基)丙烯醯基(

Figure 106105690-A0202-12-0005-2
和/或
Figure 106105690-A0202-12-0005-3
)、烯丙基、乙烯基(-CH=CH2)、1-甲基乙烯基(
Figure 106105690-A0202-12-0005-4
)、苯乙烯基、或諸如此類。 The term "ethylenically unsaturated group" is used herein in a broad sense and is intended to encompass any group containing at least one >C=C< group. Exemplary ethylenically unsaturated groups include, but are not limited to, (meth)acryloyl (
Figure 106105690-A0202-12-0005-2
and / or
Figure 106105690-A0202-12-0005-3
), allyl, vinyl (-CH=CH 2 ), 1-methyl vinyl (
Figure 106105690-A0202-12-0005-4
), styryl, or the like.

術語“(甲基)丙烯醯胺基”指的是

Figure 106105690-A0202-12-0005-5
和/或
Figure 106105690-A0202-12-0005-6
的基團,其中Ro係氫或C1-C6烷基。 The term "(meth)acrylamido" refers to
Figure 106105690-A0202-12-0005-5
and / or
Figure 106105690-A0202-12-0005-6
The group where R o is hydrogen or C 1 -C 6 alkyl.

術語“(甲基)丙烯醯胺”指的是甲基丙烯醯胺和/或丙烯醯胺。 The term "(meth)acrylamide" refers to methacrylamide and/or acrylamide.

術語“(甲基)丙烯酸酯”指的是甲基丙烯酸酯和/或丙烯酸酯。 The term "(meth)acrylate" refers to methacrylate and/or acrylate.

如在此所用的,“親水性乙烯基單體”指的是能夠聚合以形成水溶性的或者可以吸收至少10重量百分比水的均聚物的乙烯基單體。 As used herein, "hydrophilic vinyl monomer" refers to a vinyl monomer that can be polymerized to form a homopolymer that is water-soluble or can absorb at least 10 weight percent water.

“疏水性乙烯基單體”指的是能夠聚合以形成不溶於水的並且可以吸收小於10重量百分比的水的均聚物的乙烯基單體。 "Hydrophobic vinyl monomer" refers to a vinyl monomer that can be polymerized to form a homopolymer that is insoluble in water and can absorb less than 10 weight percent of water.

“UVA”指的是在315與380奈米之間的波長下發生的輻射;“UVB”指的是在280與315奈米之間發生的輻射;“紫光”指的是在380與440奈米之間的波長下發生的輻射。 "UVA" refers to radiation that occurs at a wavelength between 315 and 380 nanometers; "UVB" refers to radiation that occurs between 280 and 315 nanometers; "violet light" refers to radiation between 380 and 440 nanometers Radiation that occurs at wavelengths between meters.

“UVA透射率”(或“UVA%T”)、“UVB透射率”或“UVB%T”和“紫光透射率”或“紫光%T”係藉由下式計算的

Figure 106105690-A0202-12-0006-7
"UVA transmittance" (or "UVA%T"), "UVB transmittance" or "UVB%T" and "violet transmittance" or "violet %T" are calculated by the following formula
Figure 106105690-A0202-12-0006-7

Figure 106105690-A0202-12-0006-8
Figure 106105690-A0202-12-0006-8

Figure 106105690-A0202-12-0006-9
Figure 106105690-A0202-12-0006-9

其中發光率%T係由該鏡片透射的光通量與入射光通量的比率(ISO 13666:1998)。 The luminosity %T is the ratio of the luminous flux transmitted by the lens to the incident luminous flux (ISO 13666: 1998).

如在本申請中使用的,術語“大分子單體”或“預聚物”指的是包含兩個或更多個乙烯式不飽和基團的中等和高分子量的化合物或聚合物。中等和高分子量典型地意思係大於700道耳頓的平均分子量。 As used in this application, the term "macromonomer" or "prepolymer" refers to medium and high molecular weight compounds or polymers containing two or more ethylenically unsaturated groups. Medium and high molecular weight typically mean an average molecular weight greater than 700 daltons.

如本申請使用的,術語“乙烯基交聯劑”指的是具有至少兩個乙烯式不飽和基團的化合物。“乙烯基交聯劑”指的是具有約700道耳頓或更小的分子量的乙烯基交聯劑。 As used in this application, the term "vinyl crosslinker" refers to a compound having at least two ethylenically unsaturated groups. "Vinyl crosslinking agent" refers to a vinyl crosslinking agent having a molecular weight of about 700 Daltons or less.

如在本申請中使用的,術語“聚合物”意指藉由將一種或多種單體或大分子單體或預聚物聚合/交聯形成的材料。 As used in this application, the term "polymer" means a material formed by polymerizing/crosslinking one or more monomers or macromers or prepolymers.

如在本申請中使用的,聚合物材料(包括單體材料或大分子單體材料)的術語“分子量”指的是重均分子量,除非另外確切地指出或除非測試條件另外指明。 As used in this application, the term "molecular weight" of polymer materials (including monomer materials or macromonomer materials) refers to the weight average molecular weight, unless specifically indicated otherwise or unless the test conditions indicate otherwise.

術語“烷基”指的是藉由從直鏈或支鏈烷烴化合物中去除氫原子獲得的單價基團。烷基(基團)與在有機化合物中的一個其他基團形成一個鍵。 The term "alkyl" refers to a monovalent group obtained by removing a hydrogen atom from a linear or branched alkane compound. The alkyl group (group) forms a bond with another group in an organic compound.

術語“伸烷基二價基團”或“伸烷基二基”或“烷基二基”可互換地指代藉由從烷基中去除一個氫原子而獲得的二價基團。伸烷基二價基團與有機化合物中的其他基團形成兩個鍵。 The term "alkylene divalent group" or "alkylene diyl group" or "alkyl diyl group" interchangeably refers to a divalent group obtained by removing a hydrogen atom from an alkyl group. The alkylene divalent group forms two bonds with other groups in the organic compound.

術語“烷基三基”指的是藉由從烷基中去除兩個氫原子獲得的三價基團。烷基三基與有機化合物中的其他基團形成三個鍵。 The term "alkyltriyl" refers to a trivalent group obtained by removing two hydrogen atoms from an alkyl group. The alkyl triyl group forms three bonds with other groups in the organic compound.

術語“烷氧基(alkoxy或alkoxyl)”指的是藉由從直鏈或分支烷基醇的羥基基團中去除氫原子而獲得的單價基團。烷氧基(基團)與有機化合物中的一個其他基團形成一個鍵。 The term "alkoxy (alkoxyl)" refers to a monovalent group obtained by removing a hydrogen atom from the hydroxyl group of a linear or branched alkyl alcohol. The alkoxy group (group) forms a bond with one of the other groups in the organic compound.

在本申請中,關於烷基二基或烷基基團的術語“取代”意指該烷基二基或該烷基基團包括至少一個取代基,該至少一個取代基替代該烷基二基或該烷基基團的一個氫原子,並且選自下組,該組由以下各項組成:羥基(-OH)、羧基(-COOH)、-NH2、巰基(-SH)、C1-C4烷基、C1-C4烷氧基、C1-C4烷硫基(烷基硫化物)、C1-C4醯基胺基、C1-C4烷基胺基、二-C1-C4烷基胺基、鹵素原子(Br或Cl)、以及其組合。 In this application, the term "substituted" with respect to an alkyldiyl group or an alkyl group means that the alkyldiyl group or the alkyl group includes at least one substituent, and the at least one substituent replaces the alkyldiyl group. Or one hydrogen atom of the alkyl group, and is selected from the group consisting of hydroxyl (-OH), carboxyl (-COOH), -NH 2 , mercapto (-SH), C 1- C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 alkylthio (alkyl sulfide), C 1 -C 4 acylamino, C 1 -C 4 alkylamino, two -C 1 -C 4 alkylamino group, halogen atom (Br or Cl), and combinations thereof.

“光引發劑”指的是藉由利用光引發自由基交聯/聚合反應的化學品。 "Photoinitiator" refers to a chemical that initiates a free radical crosslinking/polymerization reaction by using light.

在本申請中,“UV吸收性乙烯基單體”指的是包含乙烯式不飽和基團和能夠吸收或篩選出在從200nm至400nm範圍內的UV輻射的UV吸收性部分(二苯甲酮或苯并三唑部分)的乙烯基單體,如熟習該項技術者所理解的。 In this application, "UV-absorbing vinyl monomer" refers to a UV-absorbing moiety containing ethylenically unsaturated groups and capable of absorbing or screening out UV radiation in the range from 200nm to 400nm (benzophenone Or benzotriazole part) vinyl monomers, as understood by those familiar with the art.

“光化輻射的空間限制”指的是其中呈射線形式的能量輻射藉由例如掩模或屏障或其組合引導以便以空間受限制的方式撞擊到具有明確定義的週邊邊界的區域上的行為或過程。UV/可見光輻射的空間限制藉由使用掩模或屏障獲得,該掩模或屏障具有輻射(例如UV和/或可見光)可透過的區域、圍繞該輻射可透過區域的輻射(例如,UV和/或可見光)不可透過的區域、以及為該輻射不可透過的與輻射可透過的區域之間的邊界的投影輪廓,如在美國專利案號6,800,225(圖1-11)、和6,627,124(圖1-9)、7,384,590(圖1-6)、以及7,387,759(圖1-6)的附圖中示意性示出的,將所有該等專利以其全文藉由引用結合。掩模或屏障允許空間投射具有由該掩模或屏的投影輪廓所限定的橫截面輪廓的一束輻射(例如,UV輻射和/或可見輻射)。投射的輻射(例如,UV輻射和/或可見光輻射)束限制撞擊在位於從模具的該第一模製表面至該第二模製表面的投射束路徑中的鏡片配製物上的輻射。所產生的接觸鏡片包括由該第一模製表面限定的前表面、由該第二模製表面限定的相反的後表面、以及由該投射的UV和/或可見光束的截面輪廓限定的鏡片邊緣(即,輻射的空間限制)。用於該交聯的輻射係輻射能,尤其是UV輻射(和/或可見光輻射)、γ幅射、電子輻射或熱輻射,該輻射能較佳的是呈基本平行的束的形式,以便一方面實現好的限制並且另一方面有效利用該能量。 "Spatial limitation of actinic radiation" refers to the behavior or behavior in which energy radiation in the form of rays is guided by, for example, a mask or barrier or a combination thereof so as to impinge on an area with a well-defined peripheral boundary in a spatially limited manner. process. The spatial limitation of UV/visible light radiation is obtained by using a mask or barrier that has an area through which radiation (e.g., UV and/or visible light) is permeable, and the radiation (e.g., UV and/or visible light) surrounding the radiation permeable area. (Or visible light) impermeable area, and the projection profile of the boundary between the radiation impermeable and the radiation permeable area, as shown in U.S. Patent Nos. 6,800,225 (Figure 1-11) and 6,627,124 (Figure 1-9) ), 7,384,590 (Figures 1-6), and 7,387,759 (Figures 1-6) are shown schematically in the drawings, and all these patents are incorporated by reference in their entirety. The mask or barrier allows spatial projection of a beam of radiation (e.g., UV radiation and/or visible radiation) having a cross-sectional profile defined by the projection profile of the mask or screen. The beam of projected radiation (e.g., UV radiation and/or visible light radiation) limits radiation impinging on the lens formulation located in the path of the projected beam from the first molding surface to the second molding surface of the mold. The resulting contact lens includes a front surface defined by the first molded surface, an opposite back surface defined by the second molded surface, and a lens edge defined by the cross-sectional profile of the projected UV and/or visible light beam (That is, the space limitation of radiation). The radiation used for the crosslinking is radiation energy, especially UV radiation (and/or visible light radiation), gamma radiation, electron radiation or thermal radiation. The radiation energy is preferably in the form of substantially parallel beams, so as On the one hand, a good limit is achieved and on the other hand the energy is effectively used.

關於接觸鏡片或材料而言的術語“模量”或“彈性模量”意指作 為接觸鏡片或材料的剛度量度的拉伸模量或楊氏模量。該模量可以使用根據ANSI Z80.20標準的方法測量。熟習該項技術者熟知如何確定矽酮水凝膠材料或接觸鏡片的彈性模量。例如,所有的商業接觸鏡片具有報告的彈性模量的值。 The term "modulus" or "modulus of elasticity" in relation to contact lenses or materials means It is the tensile modulus or Young's modulus of the stiffness of the contact lens or material. The modulus can be measured using a method according to the ANSI Z80.20 standard. Those familiar with the technology know how to determine the elastic modulus of silicone hydrogel materials or contact lenses. For example, all commercial contact lenses have reported values for the modulus of elasticity.

總的來說,本發明針對一類UV吸收性乙烯基單體,該等單體由於一個或多個親水性部分的存在可溶於水,並且可以特別地根據Lightstream TechnologyTM在用於製造UV吸收性水凝膠接觸鏡片的水基水凝膠鏡片配製物中使用。任何未反應的UV吸收性乙烯基單體可以有效地藉由水或水性溶液作為萃取溶劑去除(如果必要的話)。 In general, the present invention is directed to a class of UV-absorbing vinyl monomers, which are soluble in water due to the presence of one or more hydrophilic moieties, and can be used in particular in the manufacture of UV-absorbing monomers according to Lightstream Technology TM Hydrogel contact lenses are used in water-based hydrogel lens formulations. Any unreacted UV-absorbing vinyl monomer can be effectively removed (if necessary) by using water or an aqueous solution as an extraction solvent.

在一個方面,本發明提供了一種具有式(I)至(VII)中任一個的UV吸收性乙烯基單體

Figure 106105690-A0202-12-0009-10
In one aspect, the present invention provides a UV-absorbing vinyl monomer having any one of formulas (I) to (VII)
Figure 106105690-A0202-12-0009-10

Figure 106105690-A0202-12-0009-11
Figure 106105690-A0202-12-0009-11

Figure 106105690-A0202-12-0009-12
Figure 106105690-A0202-12-0009-12

Figure 106105690-A0202-12-0009-13
Figure 106105690-A0202-12-0009-13

Figure 106105690-A0202-12-0009-14
Figure 106105690-A0202-12-0009-14

Figure 106105690-A0202-12-0010-16
Figure 106105690-A0202-12-0010-16

Figure 106105690-A0202-12-0010-17
Figure 106105690-A0202-12-0010-17

其中:Ro係H、CH3或C2H5;R1、R2和R2’彼此獨立的是H、CH3、CCl3、CF3、Cl、Br、OH、OCH3、或NR’R”,其中R’和R”彼此獨立的是H或C1-C4烷基;R1’彼此獨立的是H、CH3、CCl3、CF3、Cl、Br、OH、OCH3、SO3H、SO3Na、或NR’R”,其中R’和R”彼此獨立的是H或C1-C4烷基;R3和R4彼此獨立的是H或第一親水基團,該第一親水基團係*-CH2-(OC2H4)n1-OCH3、*-CH2-(OC2H4)n1-OH、

Figure 106105690-A0202-12-0010-18
Figure 106105690-A0202-12-0010-19
Figure 106105690-A0202-12-0010-20
Figure 106105690-A0202-12-0010-21
、或
Figure 106105690-A0202-12-0010-22
,條件係R3和R4中的至少一個係該第一親水基團;R5係H、*-COOH、*-CONH-C2H4-(OC2H4)n1-OCH3、或*-CONH-C2H4-(OC2H4)n1-OH;R6和R7之一係H或第二親水基團,該第二親水基團係 *-CH2-(OC2H4)n1-OCH3、*-CH2-(OC2H4)n1-OH、
Figure 106105690-A0202-12-0010-23
Figure 106105690-A0202-12-0011-24
Figure 106105690-A0202-12-0011-25
、或
Figure 106105690-A0202-12-0011-26
,而R6和R7中的另 一個係
Figure 106105690-A0202-12-0011-27
Figure 106105690-A0202-12-0011-28
Figure 106105690-A0202-12-0011-29
; R8係CH3、C2H5
Figure 106105690-A0202-12-0011-30
Figure 106105690-A0202-12-0011-31
、或
Figure 106105690-A0202-12-0011-32
; R9係SO3Na、
Figure 106105690-A0202-12-0011-33
Figure 106105690-A0202-12-0011-34
Figure 106105690-A0202-12-0011-35
Figure 106105690-A0202-12-0011-36
R9’係H、SO3Na、
Figure 106105690-A0202-12-0011-37
Figure 106105690-A0202-12-0011-38
Figure 106105690-A0202-12-0011-39
Figure 106105690-A0202-12-0011-40
R10係甲基或乙基;L1係
Figure 106105690-A0202-12-0011-41
Figure 106105690-A0202-12-0011-42
Figure 106105690-A0202-12-0011-43
Figure 106105690-A0202-12-0011-44
Figure 106105690-A0202-12-0011-45
、 或
Figure 106105690-A0202-12-0011-46
的直接鍵或鍵聯;L2係*-CH2-*、*-C2H4-*、*-C3H6-*、*-C3H6-S-C2H4-*、*-C3H6-S-C3H6-*、或
Figure 106105690-A0202-12-0011-47
的鍵聯;X1係O或NRo;並且Y1、Y2和Y3彼此獨立的是C2-C4伸烷基二價基團;Q1、Q2和Q3彼此獨立的是(甲基)丙烯醯胺基或(甲基)丙烯醯氧基;m1係零或1,條件係如果m1係零,那麼Q2係(甲基)丙烯醯胺基;並且 n1係2至20的整數(較佳的是3至15,更較佳的是4至10)。 Among them: R o is H, CH 3 or C 2 H 5 ; R 1 , R 2 and R 2 'are independent of each other are H, CH 3 , CCl 3 , CF 3 , Cl, Br, OH, OCH 3 , or NR 'R', where R'and R'are independent of each other are H or C 1 -C 4 alkyl; R 1 'are independent of each other are H, CH 3 , CCl 3 , CF 3 , Cl, Br, OH, OCH 3 , SO 3 H, SO 3 Na, or NR'R", where R'and R" independently of each other are H or C 1 -C 4 alkyl; R 3 and R 4 independently of each other are H or the first hydrophilic group Group, the first hydrophilic group is *-CH 2 -(OC 2 H 4 ) n1 -OCH 3 , *-CH 2 -(OC 2 H 4 ) n1 -OH,
Figure 106105690-A0202-12-0010-18
,
Figure 106105690-A0202-12-0010-19
,
Figure 106105690-A0202-12-0010-20
,
Figure 106105690-A0202-12-0010-21
,or
Figure 106105690-A0202-12-0010-22
, The condition is that at least one of R 3 and R 4 is the first hydrophilic group; R 5 is H, *-COOH, *-CONH-C 2 H 4 -(OC 2 H 4 ) n1 -OCH 3 , or *-CONH-C 2 H 4 -(OC 2 H 4 ) n1 -OH; one of R 6 and R 7 is H or a second hydrophilic group, and the second hydrophilic group is *-CH 2 -(OC 2 H 4 ) n1 -OCH 3 、*-CH 2 -(OC 2 H 4 ) n1 -OH,
Figure 106105690-A0202-12-0010-23
,
Figure 106105690-A0202-12-0011-24
,
Figure 106105690-A0202-12-0011-25
,or
Figure 106105690-A0202-12-0011-26
, And the other line of R 6 and R 7
Figure 106105690-A0202-12-0011-27
,
Figure 106105690-A0202-12-0011-28
or
Figure 106105690-A0202-12-0011-29
; R 8 is CH 3 , C 2 H 5 ,
Figure 106105690-A0202-12-0011-30
,
Figure 106105690-A0202-12-0011-31
,or
Figure 106105690-A0202-12-0011-32
; R 9 is SO 3 Na,
Figure 106105690-A0202-12-0011-33
,
Figure 106105690-A0202-12-0011-34
,
Figure 106105690-A0202-12-0011-35
,
Figure 106105690-A0202-12-0011-36
R 9 'based H, SO 3 Na,
Figure 106105690-A0202-12-0011-37
,
Figure 106105690-A0202-12-0011-38
,
Figure 106105690-A0202-12-0011-39
,
Figure 106105690-A0202-12-0011-40
R 10 is methyl or ethyl; L1 is
Figure 106105690-A0202-12-0011-41
,
Figure 106105690-A0202-12-0011-42
,
Figure 106105690-A0202-12-0011-43
,
Figure 106105690-A0202-12-0011-44
,
Figure 106105690-A0202-12-0011-45
, Or
Figure 106105690-A0202-12-0011-46
Direct bond or linkage; L2 series *-CH 2 -*, *-C 2 H 4 -*, *-C 3 H 6 -*, *-C 3 H 6 -SC 2 H 4 -*, *- C 3 H 6 -SC 3 H 6 -*, or
Figure 106105690-A0202-12-0011-47
The linkage of X1 is O or NR o ; and Y 1 , Y 2 and Y 3 are independently C 2 -C 4 alkylene divalent groups; Q1, Q2 and Q3 are independently (methyl) Acrylamido or (meth)acrylamido; m1 is zero or 1, provided that if m1 is zero, then Q 2 is a (meth)acrylamido; and n1 is an integer from 2 to 20 (more Preferably it is 3 to 15, more preferably 4 to 10).

具有式(I)之UV吸收性乙烯基單體的較佳的實例包括但不限於:

Figure 106105690-A0202-12-0012-48
Figure 106105690-A0202-12-0012-49
,以及
Figure 106105690-A0202-12-0012-50
Preferred examples of UV-absorbing vinyl monomers having formula (I) include, but are not limited to:
Figure 106105690-A0202-12-0012-48
Figure 106105690-A0202-12-0012-49
,as well as
Figure 106105690-A0202-12-0012-50

其中:Q1係(甲基)丙烯醯胺基或(甲基)丙烯醯氧基;Y1係伸乙基或伸丙基二價基團;R1和R2彼此獨立的是H、CH3、CCl3、CF3、Cl、Br、OH、OCH3、或NR’R”,其中R’和R”彼此獨立的是H、甲基或乙基。 Among them: Q 1 is a (meth)acrylamido or (meth)acrylamido group; Y 1 is an ethylene or propylene divalent group; R 1 and R 2 are independently H, CH 3 , CCl 3 , CF 3 , Cl, Br, OH, OCH 3 , or NR'R", where R'and R" are independently H, methyl or ethyl.

具有式(II)之UV吸收性乙烯基單體的較佳的實例包括但不限於:

Figure 106105690-A0202-12-0012-51
Figure 106105690-A0202-12-0013-52
Figure 106105690-A0202-12-0013-53
Figure 106105690-A0202-12-0013-54
Figure 106105690-A0202-12-0013-55
,以及
Figure 106105690-A0202-12-0013-56
Preferred examples of UV-absorbing vinyl monomers having formula (II) include, but are not limited to:
Figure 106105690-A0202-12-0012-51
Figure 106105690-A0202-12-0013-52
Figure 106105690-A0202-12-0013-53
,
Figure 106105690-A0202-12-0013-54
,
Figure 106105690-A0202-12-0013-55
,as well as
Figure 106105690-A0202-12-0013-56

其中:Q1係(甲基)丙烯醯胺基或(甲基)丙烯醯氧基;Y1係伸乙基或伸丙基二價基團;R1和R2彼此獨立的是CH3、CCl3、CF3、Cl、Br、NR’R”、OH、或OCH3;R’和R”彼此獨立的是H、甲基或乙基;R3和R4彼此獨立的是 *-CH2-(OC2H4)n1-OCH3、*-CH2-(OC2H4)n1-OH、

Figure 106105690-A0202-12-0013-57
Figure 106105690-A0202-12-0013-62
Figure 106105690-A0202-12-0013-59
Figure 106105690-A0202-12-0013-58
、或
Figure 106105690-A0202-12-0013-61
;R10係甲基或乙基。 Among them: Q 1 is a (meth)acrylamido or (meth)acryloxy; Y 1 is an ethylene or propylene divalent group; R 1 and R 2 are independently CH 3 , CCl 3 , CF 3 , Cl, Br, NR'R”, OH, or OCH 3 ; R'and R” independently of each other are H, methyl or ethyl; R 3 and R 4 independently of each other are *-CH 2 -(OC 2 H 4 ) n1 -OCH 3 、*-CH 2 -(OC 2 H 4 ) n1 -OH,
Figure 106105690-A0202-12-0013-57
,
Figure 106105690-A0202-12-0013-62
,
Figure 106105690-A0202-12-0013-59
,
Figure 106105690-A0202-12-0013-58
,or
Figure 106105690-A0202-12-0013-61
; R 10 is methyl or ethyl.

具有式(III)之UV吸收性乙烯基單體的較佳的實例包括但不限於:

Figure 106105690-A0202-12-0014-63
Figure 106105690-A0202-12-0015-64
Preferred examples of UV-absorbing vinyl monomers having formula (III) include, but are not limited to:
Figure 106105690-A0202-12-0014-63
Figure 106105690-A0202-12-0015-64

其中:Q1係(甲基)丙烯醯胺基或(甲基)丙烯醯氧基;Y1係伸乙基或伸丙基二價基團;R1和R2彼此獨立的是CH3、CCl3、CF3、Cl、Br、NR’R”、OH、或OCH3;其中R’和R”彼此獨立的是H或C1-C4烷基;R8係CH3、C2H5

Figure 106105690-A0202-12-0015-66
Figure 106105690-A0202-12-0015-67
、或
Figure 106105690-A0202-12-0015-68
;R10係甲基或乙基。 Among them: Q 1 is a (meth)acrylamido or (meth)acryloxy; Y 1 is an ethylene or propylene divalent group; R 1 and R 2 are independently CH 3 , CCl 3 , CF 3 , Cl, Br, NR'R", OH, or OCH 3 ; wherein R'and R" are independently H or C 1 -C 4 alkyl; R 8 is CH 3 , C 2 H 5 .
Figure 106105690-A0202-12-0015-66
,
Figure 106105690-A0202-12-0015-67
,or
Figure 106105690-A0202-12-0015-68
; R 10 is methyl or ethyl.

具有式(IV)或(V)之UV吸收性乙烯基單體的較佳的實例包括但不限於:

Figure 106105690-A0202-12-0015-65
Figure 106105690-A0202-12-0016-69
Preferred examples of UV-absorbing vinyl monomers having formula (IV) or (V) include, but are not limited to:
Figure 106105690-A0202-12-0015-65
Figure 106105690-A0202-12-0016-69

其中R1’係H、CH3、CCl3、CF3、Cl、Br、NR’R”,其中R’和R”彼此獨立的是H或C1-C4烷基、OH、或OCH3;Q2係(甲基)丙烯醯胺基或(甲基)丙烯醯氧基;Y2係伸乙基或伸丙基二價基團。 Wherein R 1 'is H, CH 3 , CCl 3 , CF 3 , Cl, Br, NR'R", where R'and R" are independently H or C 1 -C 4 alkyl, OH, or OCH 3 ; Q 2 is a (meth)acrylamido or (meth)acryloxy; Y 2 is an ethylene or propylene divalent group.

具有式(VI)或(VII)之UV吸收性乙烯基單體的較佳的實例包括但不限於:

Figure 106105690-A0202-12-0016-70
其中R1’係H、CH3、CCl3、CF3、Cl、Br、F、OH、或OCH3、NR’R”, 其中R’和R”彼此獨立的是H或C1-C4烷基,R8係CH3、C2H5
Figure 106105690-A0202-12-0016-71
Figure 106105690-A0202-12-0016-72
、或
Figure 106105690-A0202-12-0016-73
;R10係甲基或乙基;Q3係(甲基)丙烯醯胺基或(甲基)丙烯醯氧基;Y3係伸乙基或伸丙基二價基團。 Preferred examples of UV-absorbing vinyl monomers having formula (VI) or (VII) include, but are not limited to:
Figure 106105690-A0202-12-0016-70
Wherein R 1 'is H, CH 3 , CCl 3 , CF 3 , Cl, Br, F, OH, or OCH 3 , NR'R", where R'and R" are independent of each other are H or C 1 -C 4 Alkyl, R 8 is CH 3 , C 2 H 5 ,
Figure 106105690-A0202-12-0016-71
,
Figure 106105690-A0202-12-0016-72
,or
Figure 106105690-A0202-12-0016-73
; R 10 is methyl or ethyl; Q 3 is (meth)acrylamido or (meth)acryloxy; Y 3 is ethylene or propylene divalent group.

以上定義的具有式(I)之UV吸收性乙烯基單體可以根據在方案1中說明的程序製備:

Figure 106105690-A0202-12-0017-74
The UV-absorbing vinyl monomer of formula (I) defined above can be prepared according to the procedure described in Scheme 1:
Figure 106105690-A0202-12-0017-74

應理解的是在以上方案1或2的第二步驟中,H2N-Y1-Q1乙烯基單體(如以上定義的)可以被另一種HNRo-Y1-Q1乙烯基單體(如以上定義的)(其中Ro係CH3或C2H5)取代用於製造具有式(I)或(II)之其他UV吸收性乙烯基單體。HNRo-Y1-Q1的示例性乙烯基單體(如以上定義的)包括但不限於2-(甲基胺基)乙基(甲基)丙烯酸酯、2-(甲基胺基)乙基(甲基)丙烯醯胺、N-甲基-N-[2-(甲基胺基)乙基](甲基)丙烯醯胺、乙基胺基乙基(甲基)丙烯酸酯、乙基胺基乙基(甲基)丙烯醯胺、甲基胺基丙基(甲基)丙烯酸酯、甲基胺基丙基(甲基)丙烯醯胺、乙基胺基丙基(甲基)丙烯酸酯、和乙基胺基丙基(甲基)丙烯醯胺。 It should be understood that in the second step of Scheme 1 or 2 above, H 2 NY 1 -Q 1 vinyl monomer (as defined above) can be replaced by another HNR o -Y 1 -Q 1 vinyl monomer ( As defined above) (where Ro is CH 3 or C 2 H 5 ) substitution is used to make other UV-absorbing vinyl monomers of formula (I) or (II). Exemplary vinyl monomers of HNR o -Y 1 -Q 1 (as defined above) include, but are not limited to, 2-(methylamino)ethyl (meth)acrylate, 2-(methylamino) Ethyl (meth)acrylamide, N-methyl-N-[2-(methylamino)ethyl](meth)acrylamide, ethylaminoethyl (meth)acrylate, Ethylaminoethyl (meth)acrylamide, methylaminopropyl (meth)acrylate, methylaminopropyl (meth)acrylamide, ethylaminopropyl (methyl) ) Acrylate, and ethylaminopropyl (meth)acrylamide.

以上定義的具有式(II)之UV吸收性乙烯基單體可以根據在方案2中說明的程序製備:

Figure 106105690-A0202-12-0018-75
The UV-absorbing vinyl monomer with formula (II) defined above can be prepared according to the procedure described in Scheme 2:
Figure 106105690-A0202-12-0018-75

應理解的是在以上方案2的第二步驟中,H2N-Y1-Q1乙烯基單體(如以上定義的)可以被另一種HNRo-Y1-Q1乙烯基單體(如以上定義的)(其中Ro係CH3或C2H5)取代用於製造具有式(II)之其他UV吸收性乙烯基單體。還應理解的是可以改變方案2的第三步驟以在熟習該項技術者已知的條件下藉由使磷酸烷基伸烷基酯(例如,磷酸甲基伸乙基酯、磷酸乙基伸乙基酯、磷酸甲基伸丙基酯、或磷酸乙基伸丙基酯)代替1,3-丙磺酸內酯反應形成磷酸膽鹼基團(大分子化學快訊(Makromol.Chem.,Rapid Commun.)3,457-459(1982),以其全文藉由引用結合在此)。 It should be understood that in the second step of Scheme 2 above, H 2 NY 1 -Q 1 vinyl monomer (as defined above) can be replaced by another HNR o -Y 1 -Q 1 vinyl monomer (as above The defined) (where Ro is CH 3 or C 2 H 5 ) substitution is used to make other UV-absorbing vinyl monomers of formula (II). It should also be understood that the third step of Scheme 2 can be modified to make alkylene phosphate (e.g., methyl ethylene phosphate, ethyl ethylene phosphate, etc.) under conditions known to those skilled in the art. Phosphate, methyl propylene phosphate, or ethyl propylene phosphate) instead of 1,3-propane sultone to form a phosphocholine group (Makromol.Chem., Rapid Commun.) 3, 457-459 (1982), which is incorporated herein by reference in its entirety).

以上定義的具有式(III)之UV吸收性乙烯基單體可以根據在方案3中說明的程序製備:

Figure 106105690-A0202-12-0019-76
The UV-absorbing vinyl monomer with formula (III) defined above can be prepared according to the procedure described in Scheme 3:
Figure 106105690-A0202-12-0019-76

還應理解的是方案3可以藉由以下方式改變:藉由替換(CH3)2N-Y1-Q1乙烯基單體,其可以被另一種HNRo-Y1-Q1(其中Ro係CH3或C2H5)乙烯基單體替代,並且然後藉由增加一個以下步驟:在熟習該項技術者已知的條件下使第三步驟的產物與1,3-丙磺酸內酯或磷酸烷基伸烷基酯(例如,磷酸甲基伸乙基酯、磷酸乙基伸乙基酯、磷酸甲基伸丙基酯、或磷酸乙基伸丙基酯)反應以形成具有式(III)之UV吸收性乙烯基單體,其中R8係不同於甲基的基團。 It should also be understood that Scheme 3 can be changed in the following way: by replacing (CH 3 ) 2 NY 1 -Q 1 vinyl monomer, it can be replaced by another HNR o -Y 1 -Q 1 (where R o is CH 3 or C 2 H 5 ) vinyl monomers are replaced, and then by adding one of the following steps: the product of the third step is combined with 1,3-propane sultone under conditions known to those skilled in the art Or alkyl propylene phosphate (for example, methyl ethylene phosphate, ethyl ethylene phosphate, methyl propylene phosphate, or ethyl propylene phosphate) to form a formula (III) UV-absorbing vinyl monomer, where R 8 is a group different from methyl.

在任一個或兩個苯環上具有取代基的任何2-羥基-2’-羧基二苯甲酮可以在具有式(I)、(II)或(III)之UV吸收性乙烯基單體的製備中使用。人們知道如何從取代的或未取代的鄰苯二甲酸酐和取代的或未取代的苯酚製備具有取代基的2-羥基-2’-羧基二苯甲酮(參見例如US5925787,以其全文藉由引用結合在此)。 Any 2-hydroxy-2'-carboxybenzophenone having a substituent on any one or two benzene rings can be used in the preparation of UV-absorbing vinyl monomers of formula (I), (II) or (III) Used in. It is known how to prepare substituted or substituted 2-hydroxy-2'-carboxybenzophenone from substituted or unsubstituted phthalic anhydride and substituted or unsubstituted phenol (see, for example, US5925787, which is used in its entirety by Reference is incorporated here).

應理解的是在方案2的第二步驟中任何3-和4-取代的鄰苯二甲酸酐可用於與任何單-或二-取代的苯酚反應以獲得具有式(I)、(II)或(III)之UV吸收性乙烯基單體。各種3-和4-取代的鄰苯二甲酸酐係可商購的或可以根據在化學會會志(J.Chem.Soc.),Perkin Trans.(1977),1:2030-2036 (以其全文藉由引用結合在此)中描述的程序製備。 It should be understood that in the second step of Scheme 2 any 3- and 4-substituted phthalic anhydride can be used to react with any mono- or di-substituted phenol to obtain formula (I), (II) or (III) UV-absorbing vinyl monomer. Various 3- and 4-substituted phthalic anhydrides are commercially available or can be obtained according to J. Chem. Soc., Perkin Trans. (1977), 1: 2030-2036 (with its The entire text is prepared by reference to the procedures described in this).

以上定義的具有式(IV)或(V)之UV吸收性乙烯基單體可以根據在方案4至7中任一個中說明的程序製備:

Figure 106105690-A0202-12-0020-77
The above-defined UV-absorbing vinyl monomers of formula (IV) or (V) can be prepared according to the procedure described in any one of schemes 4 to 7:
Figure 106105690-A0202-12-0020-77

Figure 106105690-A0202-12-0020-78
Figure 106105690-A0202-12-0020-78

Figure 106105690-A0202-12-0020-79
Figure 106105690-A0202-12-0020-79

Figure 106105690-A0202-12-0021-80
Figure 106105690-A0202-12-0021-80

以上定義的具有式(VI)或(VII)之UV吸收性乙烯基單體可以根據在方案8或9中說明的程序製備:

Figure 106105690-A0202-12-0021-81
The above-defined UV-absorbing vinyl monomers of formula (VI) or (VII) can be prepared according to the procedure described in Scheme 8 or 9:
Figure 106105690-A0202-12-0021-81

Figure 106105690-A0202-12-0022-82
Figure 106105690-A0202-12-0022-82

任何具有取代基的苯并三唑可以在具有式(IV)至(VII)中任一個的乙烯基單體的製備中使用。人們知道如何根據已知的程序製備具有不同取代基的苯并三唑(參見例如US8262948,以其全文藉由引用結合在此)。 Any benzotriazole having a substituent may be used in the preparation of the vinyl monomer having any one of formulas (IV) to (VII). It is known how to prepare benzotriazoles with different substituents according to known procedures (see, for example, US8262948, which is incorporated herein by reference in its entirety).

以上描述的本發明的水溶性UV吸收性乙烯基單體可以在製造UV吸收性醫療裝置,較佳的是眼科裝置,更較佳的是眼內鏡片,甚至更較佳的是接觸鏡片中找到具體用途。 The water-soluble UV-absorbing vinyl monomer of the present invention described above can be found in the manufacture of UV-absorbing medical devices, preferably ophthalmic devices, more preferably intraocular lenses, and even more preferably contact lenses specific purpose.

在另一個方面,本發明提供了一種用於生產UV吸收性接觸鏡片的方法,該方法包括以下步驟:(1)獲得包含以下各項的鏡片配製物(a)(按重量計從約0.1%至約4%、較佳的是按重量計從約0.2%至約3.0%、更較 佳的是按重量計從約0.4%至約2%、甚至更較佳的是按重量計從約0.6%至約1.5%的)具有式(I)至(VII)中任一個的UV吸收性乙烯基單體(如以上定義的),(b)(按重量計從約0.1%至約2.0%、較佳的是按重量計從約0.25%至約1.75%、更較佳的是按重量計從約0.5%至約1.5%、甚至更較佳的是按重量計從約0.75%至約1.25%的)至少一種自由基引發劑,以及(c)至少一種選自下組的可聚合組分,該組由以下各項組成:親水性乙烯基單體、水溶性不含矽酮的預聚物、含矽酮的預聚物、非矽酮疏水性乙烯基單體、含矽氧烷的乙烯基單體、含矽氧烷的乙烯基大分子單體、乙烯基交聯劑、以及其組合;(2)將該鏡片配製物引入到用於製造軟質接觸鏡片的模具中,其中該模具具有第一半模和第二半模,該第一半模具有定義接觸鏡片的前表面的第一模製表面,該第二半模具有定義該接觸鏡片的後表面的第二模製表面,其中所述第一和第二半模被配置為接納彼此,使得在所述第一與第二模製表面之間形成型腔;以及(3)熱固化或光化固化在該模具中的該鏡片配製物以形成該UV吸收性接觸鏡片,其中該形成的UV吸收性接觸鏡片的特徵在於具有在280與315奈米之間的約10%或更小(較佳的是約5%或更小、更較佳的是約2.5%或更小、甚至更較佳的是約1%或更小)的UVB透射率和在315與380奈米之間的約30%或更小(較佳的是約20%或更小、更較佳的是約10%或更小、甚至更較佳的是約5%或更小)的UVA透射率以及視情況(但較佳的是)在380nm與440nm之間的約60%或更小、較佳的是約50%或更小、更較佳的是約40%或更小、甚至更較佳的是約30%或更小)的紫光透射率。 In another aspect, the present invention provides a method for producing UV-absorbing contact lenses, the method comprising the following steps: (1) obtaining a lens formulation comprising (a) (from about 0.1% by weight) To about 4%, preferably from about 0.2% to about 3.0% by weight, more Preferably from about 0.4% to about 2% by weight, and even more preferably from about 0.6% to about 1.5% by weight) having the UV absorbency of any one of formulas (I) to (VII) Vinyl monomer (as defined above), (b) (from about 0.1% to about 2.0% by weight, preferably from about 0.25% to about 1.75% by weight, more preferably by weight From about 0.5% to about 1.5%, even more preferably from about 0.75% to about 1.25% by weight) at least one free radical initiator, and (c) at least one polymerizable group selected from the group consisting of This group consists of the following items: hydrophilic vinyl monomers, water-soluble prepolymers without silicone, silicone-containing prepolymers, non-silicone hydrophobic vinyl monomers, silicone-containing (2) Introducing the lens formulation into a mold for manufacturing soft contact lenses, wherein the lens formulation is introduced into the mold for manufacturing soft contact lenses, wherein the vinyl monomers containing silicone, vinyl crosslinkers, and combinations thereof The mold has a first mold half and a second mold half, the first mold half has a first molding surface defining the front surface of the contact lens, and the second mold half has a second molding surface defining the back surface of the contact lens , Wherein the first and second mold halves are configured to receive each other, so that a cavity is formed between the first and second molding surfaces; and (3) thermally or actinically cured in the mold The lens is formulated to form the UV-absorbing contact lens, wherein the formed UV-absorbing contact lens is characterized by having between 280 and 315 nanometers of about 10% or less (preferably about 5% or Smaller, more preferably about 2.5% or less, even more preferably about 1% or less) UVB transmittance and about 30% or less between 315 and 380 nm (compared to Preferably, about 20% or less, more preferably about 10% or less, even more preferably about 5% or less) UVA transmittance and optionally (but preferably) in About 60% or less between 380nm and 440nm, preferably about 50% or less, more preferably about 40% or less, even more preferably about 30% or less) Violet transmittance.

根據本發明,自由基引發劑可以是自由基熱引發劑或自由基光引發劑。 According to the present invention, the free radical initiator may be a free radical thermal initiator or a free radical photoinitiator.

任何熱自由基引發劑可用於本發明中。合適的熱引發劑的實例包括但不限於2,2’-偶氮雙(2,4-二甲基戊腈)、2,2’-偶氮雙(2-甲基丙腈)、2,2’-偶氮雙(2-甲基丁腈)、過氧化物如過氧化苯甲醯等。較佳的是,該熱引發劑係2,2’-偶氮雙(異丁腈)(AIBN)。 Any thermal free radical initiator can be used in the present invention. Examples of suitable thermal initiators include, but are not limited to, 2,2'-azobis(2,4-dimethylvaleronitrile), 2,2'-azobis(2-methylpropionitrile), 2, 2'-Azobis(2-methylbutyronitrile), peroxides such as benzyl peroxide, etc. Preferably, the thermal initiator is 2,2'-azobis(isobutyronitrile) (AIBN).

可以吸收在從380nm至500nm範圍內的輻射的任何自由基光引發劑可用於本發明中。合適的光引發劑係安息香甲醚、二乙氧基苯乙酮、苯甲醯基氧化膦、1-羥基環己基苯基酮和Darocur和Irgacur型,較佳的是Darocur 1173®和Darocur 2959®,基於鍺的諾裡什(Norrish)I型光引發劑。苯甲醯基膦引發劑的實例包括苯基(2,4,6-三甲基苯甲醯基)次膦酸及其鹽、雙(2,4,6-三甲基苯甲醯基)次膦酸及其鹽、2,4,6-三甲基苯甲醯基二苯基氧化膦;雙-(2,6-二氯苯甲醯基)-4-N-丙苯基氧化膦;和雙-(2,6-二氯苯甲醯基)-4-N-丁苯基氧化膦。例如可以結合至大分子單體內或可用作特殊單體的反應性光引發劑也係合適的。反應性光引發劑的實例係在EP 632 329(藉由引用以其全文結合在此)中揭露的那些。最較佳的是,水溶性的基於鍺的諾裡什I型光引發劑,其在2015年6月2日提交的共同未決的美國專利申請號62/169,722(藉由引用以其全文結合在此)中揭露,可用於本發明中。然後該聚合可以由光化輻射,例如,合適波長的UV和/或可見光引發。因此如果適當的話,光譜要求可以藉由加入合適的光敏劑來控制。 Any radical photoinitiator that can absorb radiation in the range from 380 nm to 500 nm can be used in the present invention. Suitable photoinitiators are benzoin methyl ether, diethoxyacetophenone, benzyl phosphine oxide, 1-hydroxycyclohexyl phenyl ketone and Darocur and Irgacur types, preferably Darocur 1173® and Darocur 2959® , Norrish type I photoinitiator based on germanium. Examples of benzylphosphine initiators include phenyl(2,4,6-trimethylbenzyl)phosphinic acid and its salts, bis(2,4,6-trimethylbenzyl) Phosphinic acid and its salts, 2,4,6-trimethylbenzyl diphenyl phosphine oxide; bis-(2,6-dichlorobenzyl)-4-N-propylphenyl phosphine oxide ; And bis-(2,6-dichlorobenzyl)-4-N-butylphenylphosphine oxide. For example, reactive photoinitiators that can be incorporated into macromonomers or can be used as special monomers are also suitable. Examples of reactive photoinitiators are those disclosed in EP 632 329 (incorporated in its entirety by reference). Most preferably, the water-soluble germanium-based Norrish Type I photoinitiator, which was filed on June 2, 2015 in co-pending U.S. Patent Application No. 62/169,722 (incorporated in its entirety by reference) The disclosure in this) can be used in the present invention. The polymerization can then be initiated by actinic radiation, for example, UV and/or visible light of a suitable wavelength. Therefore, if appropriate, the spectral requirements can be controlled by adding appropriate photosensitizers.

幾乎任何親水性乙烯基單體可用於本發明中。合適的親水性乙烯基單體係,但這不是窮盡性列表,N,N-二甲基丙烯醯胺(DMA)、N,N-二甲基甲基丙烯醯胺(DMMA)、2-丙烯醯胺乙醇酸、N-羥基丙基丙烯醯胺、N-羥基乙基丙烯醯胺、N-[三(羥基甲基)甲基]-丙烯醯胺、N-乙烯基吡咯啶酮(NVP)、N-乙烯基甲醯胺、N-乙烯基乙醯胺、N-乙烯基異丙基醯胺、N- 乙烯基-N-甲基乙醯胺(VMA)、N-甲基-3-亞甲基-2-吡咯啶酮、1-甲基-5-亞甲基-2-吡咯啶酮、5-甲基-3-亞甲基-2-吡咯啶酮、2-羥基乙基甲基丙烯酸酯(HEMA)、2-羥基乙基丙烯酸酯(HEA)、羥基丙基丙烯酸酯、羥基丙基甲基丙烯酸酯、甲氧基乙基甲基丙烯酸酯(即,乙二醇甲醚甲基丙烯酸酯,EGMA)、三甲基銨2-羥基丙基甲基丙烯酸酯鹽酸鹽、胺基丙基甲基丙烯酸酯鹽酸鹽、甲基丙烯酸二甲基胺基乙酯(DMAEMA)、甲基丙烯酸甘油酯(GMA)、具有最高達1500的重均分子量的C1-C4-烷氧基聚乙二醇(甲基)丙烯酸酯、具有最高達1500的重均分子量的聚乙二醇(甲基)丙烯酸酯、甲基丙烯酸、丙烯酸、及其混合物。 Almost any hydrophilic vinyl monomer can be used in the present invention. Suitable hydrophilic vinyl single system, but this is not an exhaustive list, N,N-dimethylacrylamide (DMA), N,N-dimethylmethacrylamide (DMMA), 2-propylene Glycolic acid, N-hydroxypropyl acrylamide, N-hydroxyethyl acrylamide, N -[tris(hydroxymethyl)methyl]-acrylamide, N-vinylpyrrolidone (NVP) , N-vinylformamide, N-vinylacetamide, N-vinylisopropylamide, N-vinyl-N-methylacetamide (VMA), N-methyl-3- Methylene-2-pyrrolidone, 1-methyl-5-methylene-2-pyrrolidone, 5-methyl-3-methylene-2-pyrrolidone, 2-hydroxyethyl methyl Base acrylate (HEMA), 2-hydroxyethyl acrylate (HEA), hydroxypropyl acrylate, hydroxypropyl methacrylate, methoxyethyl methacrylate (ie, ethylene glycol methyl ether methyl Acrylate, EGMA), trimethylammonium 2-hydroxypropyl methacrylate hydrochloride, aminopropyl methacrylate hydrochloride, dimethylaminoethyl methacrylate (DMAEMA), Glyceryl methacrylate (GMA), C 1 -C 4 -alkoxy polyethylene glycol (meth)acrylate with a weight average molecular weight of up to 1500, polyethylene glycol with a weight average molecular weight of up to 1500 Alcohol (meth)acrylate, methacrylic acid, acrylic acid, and mixtures thereof.

不含矽酮的水溶性預聚物的實例包括但不限於:在美國專利案號5583163和6303687中描述的水溶性可交聯聚(乙烯醇)預聚物;在美國專利案號6995192中描述的水溶性乙烯基封端的聚胺甲酸酯預聚物;在美國專利案號5849841中揭露的聚乙烯基醇、聚乙烯亞胺或聚乙烯基胺的衍生物;在美國專利案號6479587和7977430中描述的水溶性可交聯聚脲預聚物;可交聯聚丙烯醯胺;在美國專利案號5712356中揭露的乙烯基內醯胺、MMA和共聚單體的可交聯統計共聚物,在美國專利案號5665840中揭露的乙烯基內醯胺、乙烯基乙酸酯和乙烯基醇的可交聯共聚物;在美國專利案號6492478中揭露的具有可交聯側鏈的聚醚-聚酯共聚物;在美國專利案號6165408中揭露的支鏈聚伸烷基二醇-尿烷預聚物;在美國專利案號6221303中揭露的聚伸烷基二醇-四(甲基)丙烯酸酯預聚物;在美國專利案號6472489中揭露的可交聯的聚烯丙胺葡萄糖酸內酯預聚物;將所有該等美國專利藉由引用以其全文結合在此。 Examples of water-soluble prepolymers that do not contain silicone include, but are not limited to: the water-soluble crosslinkable poly(vinyl alcohol) prepolymers described in U.S. Patent Nos. 5583163 and 6,303,687; described in U.S. Patent No. 6,995,192 The water-soluble vinyl-terminated polyurethane prepolymer; the derivatives of polyvinyl alcohol, polyethyleneimine or polyvinylamine disclosed in U.S. Patent No. 5,849,841; In U.S. Patent No. 6,479,587 and The water-soluble crosslinkable polyurea prepolymer described in 7977430; the crosslinkable polypropylene amide; the crosslinkable statistical copolymer of vinyl lactam, MMA and comonomer disclosed in U.S. Patent No. 5712356 , The crosslinkable copolymer of vinyl lactam, vinyl acetate and vinyl alcohol disclosed in U.S. Patent No. 5665840; polyether with crosslinkable side chains disclosed in U.S. Patent No. 6492478 -Polyester copolymer; branched polyalkylene glycol-urethane prepolymer disclosed in U.S. Patent No. 6165408; polyalkylene glycol-tetra(methyl) disclosed in U.S. Patent No. 6,221,303 ) Acrylate prepolymer; the crosslinkable polyallylamine gluconolactone prepolymer disclosed in US Patent No. 6,472,489; all these US patents are incorporated herein by reference in their entirety.

任何合適的具有親水性區段和疏水性區段的含矽酮的預聚 物可以用於本發明中。此類含矽酮的預聚物的實例包括在共同擁有的美國專利案號6,039,913、7,091,283、7,268,189和7,238,750、7,521,519;共同擁有的美國專利申請公開案號US 2008-0015315 A1、US 2008-0143958 A1、US 2008-0143003 A1、US 2008-0234457 A1、US 2008-0231798 A1、US 2010-0296049 A1和US 2010-0298446 A1中描述的那些;將所有該等美國專利藉由引用以其全文結合在此。 Any suitable silicone-containing prepolymer with a hydrophilic section and a hydrophobic section Materials can be used in the present invention. Examples of such silicone-containing prepolymers include the commonly-owned U.S. Patent Nos. 6,039,913, 7,091,283, 7,268,189 and 7,238,750, 7,521,519; the commonly-owned U.S. Patent Application Publication Nos. US 2008-0015315 A1, US 2008-0143958 A1 , US 2008-0143003 A1, US 2008-0234457 A1, US 2008-0231798 A1, US 2010-0296049 A1, and US 2010-0298446 A1; all such US patents are incorporated herein by reference in their entirety .

本發明的鏡片配製物還可以包含非矽酮疏水性單體(即,不含矽酮)。藉由將一定量的非矽酮疏水性乙烯基單體結合至鏡片配製物中,可以改進所得聚合物的機械特性(例如,彈性模量)。幾乎任何非矽酮疏水性乙烯基單體可以用於製備具有側官能團或末端官能團的中間共聚物的可光化聚合的組成物中。較佳的非矽酮疏水性乙烯基單體的實例包括甲基丙烯酸酯、乙基丙烯酸酯、丙基丙烯酸酯、異丙基丙烯酸酯、環己基丙烯酸酯、2-乙基己基丙烯酸酯、甲基甲基丙烯酸酯、乙基甲基丙烯酸酯、丙基甲基丙烯酸酯、乙酸乙烯酯、丙酸乙烯酯、丁酸乙烯酯、戊酸乙烯酯、苯乙烯、氯丁二烯、氯乙烯、偏二氯乙烯、丙烯腈、1-丁烯、丁二烯、甲基丙烯腈、乙烯基甲苯、乙烯基乙醚、全氟己基乙基-硫代-羰基-胺基乙基-甲基丙烯酸酯、異冰片基(isobornyl)甲基丙烯酸酯、三氟乙基甲基丙烯酸酯、六氟-異丙基甲基丙烯酸酯、六氟丁基甲基丙烯酸酯。 The lens formulations of the present invention may also include non-silicone hydrophobic monomers (ie, free of silicone). By incorporating a certain amount of non-silicone hydrophobic vinyl monomer into the lens formulation, the mechanical properties (e.g., modulus of elasticity) of the resulting polymer can be improved. Almost any non-silicone hydrophobic vinyl monomer can be used in the actinically polymerizable composition of the intermediate copolymer with pendant functional groups or terminal functional groups. Examples of preferred non-silicone hydrophobic vinyl monomers include methacrylate, ethyl acrylate, propyl acrylate, isopropyl acrylate, cyclohexyl acrylate, 2-ethylhexyl acrylate, methyl acrylate Methyl methacrylate, ethyl methacrylate, propyl methacrylate, vinyl acetate, vinyl propionate, vinyl butyrate, vinyl valerate, styrene, chloroprene, vinyl chloride, Vinylidene chloride, acrylonitrile, 1-butene, butadiene, methacrylonitrile, vinyl toluene, vinyl ethyl ether, perfluorohexylethyl-thio-carbonyl-aminoethyl-methacrylate , Isobornyl methacrylate, trifluoroethyl methacrylate, hexafluoro-isopropyl methacrylate, hexafluorobutyl methacrylate.

在本發明中可以使用任何合適的含矽氧烷的乙烯基單體。較佳的含矽氧烷的乙烯基單體的實例包括而不限於N-[三(三甲基矽烷氧基)矽基丙基]-(甲基)丙烯醯胺、N-[三(二甲基丙基矽烷氧基)-矽基丙基]-(甲基)丙烯醯胺、N-三(二甲基苯基矽烷氧基)丙基](甲基)丙烯醯胺、N-[三(二甲基乙基矽烷氧基)矽基丙基](甲基)丙烯醯胺、N-(2-羥基-3-(3-(雙(三甲基矽基氧 基)-甲基矽基)丙氧基)丙基)-2-甲基丙烯醯胺;N-(2-羥基-3-(3-(雙(三甲基矽烷氧基)-甲基矽基)丙氧基)丙基)丙烯醯胺;N,N-雙[2-羥基-3-(3-(雙(三甲基矽烷氧基)-甲基矽基)丙氧基)丙基]-2-甲基丙烯醯胺;N,N-雙[2-羥基-3-(3-(雙(三甲基矽烷氧基)-甲基矽基)丙氧基)丙基]丙烯醯胺;N-(2-羥基-3-(3-(三(三甲基矽烷氧基)矽基)-丙氧基)丙基)-2-甲基丙烯醯胺;N-(2-羥基-3-(3-(三(三甲基矽烷氧基)矽基)丙氧基)-丙基)丙烯醯胺;N,N-雙[2-羥基-3-(3-(三(三甲基矽烷氧基)矽基)丙氧基)丙基]-2-甲基丙烯醯胺;N,N-雙[2-羥基-3-(3-(三(三甲基矽烷氧基)矽基)丙氧基)丙基]丙烯醯胺;N-[2-羥基-3-(3-(三級丁基二甲基矽基)丙氧基)丙基]-2-甲基丙烯醯胺;N-[2-羥基-3-(3-(三級丁基二甲基矽基)丙氧基)丙基]丙烯醯胺;N,N-雙[2-羥基-3-(3-(三級丁基二甲基矽基)-丙氧基)丙基]-2-甲基丙烯醯胺;N,N-雙[2-羥基-3-(3-(三級丁基二甲基矽基)丙氧基)-丙基]丙烯醯胺;3-甲基丙烯醯氧基丙基五甲基二矽氧烷、三(三甲基矽烷氧基)矽基丙基甲基丙烯酸酯(TRIS)、(3-甲基丙烯醯氧基-2-羥基丙氧基)丙基二(三甲基矽烷氧基)-甲基矽烷)、(3-甲基丙烯醯氧基-2-羥基丙氧基)丙基三(三甲基矽烷氧基)矽烷、3-甲基丙烯醯氧基-2-(2-羥基乙氧基)-丙氧基)丙基二(三甲基矽烷氧基)甲基矽烷、N-2-甲基丙烯醯氧基乙基-O-(甲基-雙-三甲基矽烷氧基-3-丙基)矽基胺基甲酸酯、3-(三甲基矽基)-丙基乙烯基碳酸酯、3-(乙烯氧基羰基硫代)丙基-三(三甲基-矽烷氧基)矽烷、3-[三(三甲基-矽烷氧基)矽基]丙基乙烯基胺基甲酸酯、3-[三(三甲基矽烷氧基)矽基]丙基烯丙基胺基甲酸酯、3-[三(三甲基矽烷氧基)矽基]丙基乙烯基碳酸酯、三級丁基二甲基-矽烷氧基乙基乙烯基碳酸酯;三甲基矽基乙基乙烯基碳酸酯、以及三甲基矽基甲基乙烯基碳酸酯);各種分子量的單甲基丙烯酸酯化或單丙烯酸酯化的聚二甲基矽氧烷(例如單-3-甲基丙烯醯氧基丙基封端、單-丁基封端的聚二甲基矽氧烷或單-(3-甲基丙烯醯氧基-2-羥基丙氧基)丙基封端、單-丁基 封端的聚二甲基矽氧烷);單乙烯基碳酸酯封端的聚二甲基矽氧烷;單乙烯基胺基甲酸酯封端的聚二甲基矽氧烷;單-甲基丙烯醯胺封端的聚二甲基矽氧烷;單-丙烯醯胺封端的聚二甲基矽氧烷;揭露於美國專利案號7915323和8420711、美國專利申請公開案號2012/244088和2012/245249(藉由引用以其全文結合在此)中的碳矽氧烷乙烯基單體;其組合。 Any suitable silicone-containing vinyl monomer can be used in the present invention. Examples of preferred silicone-containing vinyl monomers include, but are not limited to, N-[tris(trimethylsilyloxy)silylpropyl]-(meth)acrylamide, N-[tris(di (Methylpropylsilyloxy)-silylpropyl]-(meth)acrylamide, N-tris(dimethylphenylsiloxy)propyl](meth)acrylamide, N-[ Tris(dimethylethylsilyloxy)silylpropyl)(meth)acrylamide, N-(2-hydroxy-3-(3-(bis(trimethylsilyloxy) (Yl)-methylsilyl)propoxy)propyl)-2-methacrylamide; N-(2-hydroxy-3-(3-(bis(trimethylsilyloxy)-methylsilyl) Yl)propoxy)propyl)acrylamide; N,N-bis[2-hydroxy-3-(3-(bis(trimethylsilyloxy)-methylsilyl)propoxy)propyl ]-2-methacrylamide; N,N-bis[2-hydroxy-3-(3-(bis(trimethylsilyloxy)-methylsilyl)propoxy)propyl]acrylamide Amine; N-(2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)-propoxy)propyl)-2-methacrylamide; N-(2-hydroxy -3-(3-(tris(trimethylsilyloxy)silyl)propoxy)-propyl)propenamide; N,N-bis[2-hydroxy-3-(3-(tris(tris) Methylsilyloxy)silyl)propoxy)propyl]-2-methacrylamide; N,N-bis[2-hydroxy-3-(3-(tris(trimethylsilyloxy)) Silyl)propoxy)propyl]propenamide; N-[2-hydroxy-3-(3-(tertiary butyldimethylsilyl)propoxy)propyl]-2-methylpropene Amide; N-[2-hydroxy-3-(3-(tertiarybutyldimethylsilyl)propoxy)propyl]acrylamide; N,N-bis[2-hydroxy-3-( 3-(tertiary butyldimethylsilyl)-propoxy)propyl]-2-methacrylamide; N,N-bis[2-hydroxy-3-(3-(tertiary butyl) (Dimethylsilyl)propoxy)-propyl]acrylamide; 3-methacryloxypropylpentamethyldisiloxane, tris(trimethylsilyloxy)silylpropylmethyl Acrylate (TRIS), (3-methacryloxy-2-hydroxypropoxy) propyl bis(trimethylsilyloxy)-methylsilane), (3-methacryloxy -2-Hydroxypropoxy) propyl tris (trimethylsilyloxy) silane, 3-methacryloxy-2-(2-hydroxyethoxy)-propoxy) propyl bis(trimethyl) Methylsilyloxy)methylsilane, N-2-methacryloxyethyl-O-(methyl-bis-trimethylsilyloxy-3-propyl)silyl carbamate , 3-(trimethylsilyl)-propyl vinyl carbonate, 3-(vinyloxycarbonylthio)propyl-tris(trimethyl-silanoxy) silane, 3-[tris(trimethyl) -Silyloxy)silyl]propyl vinyl carbamate, 3-[tris(trimethylsilyloxy)silyl]propyl allyl carbamate, 3-[tris( Trimethylsilyloxy)silyl]propyl vinyl carbonate, tertiary butyldimethyl-silyloxyethyl vinyl carbonate; trimethylsilylethyl vinyl carbonate, and trimethyl Silyl methyl vinyl carbonate); various molecular weights of monomethacrylate or monoacrylate polydimethylsiloxane (for example, mono-3-methacryloxypropyl end-capped, Mono-butyl terminated polydimethylsiloxane or mono-(3-methacryloxy-2-hydroxypropoxy) propyl terminated, mono-butyl End-capped polydimethylsiloxane); monovinyl carbonate end-capped polydimethylsiloxane; monovinyl carbamate end-capped polydimethylsiloxane; mono-methacrylic acid Amine-terminated polydimethylsiloxane; mono-acrylamide-terminated polydimethylsiloxane; disclosed in U.S. Patent Nos. 7915323 and 8420711, U.S. Patent Application Publication Nos. 2012/244088 and 2012/245249 ( The carbosiloxane vinyl monomer in its entirety is incorporated herein by reference; its combination.

任何合適的含矽氧烷的乙烯基大分子單體(即,交聯劑)可用於本發明中。較佳的含矽氧烷的乙烯基大分子單體(交聯劑)的實例係各種分子量的二甲基丙烯酸酯化或二丙烯酸酯化的聚二甲基矽氧烷;二乙烯基碳酸酯封端的聚二甲基矽氧烷;二乙烯基胺基甲酸酯封端的聚二甲基矽氧烷;二甲基丙烯醯胺封端的聚二甲基矽氧烷;二丙烯醯胺封端的聚二甲基矽氧烷;雙-3-甲基丙烯醯氧基-2-羥基丙氧基丙基聚二甲基矽氧烷;N,N,N',N'-四(3-甲基丙烯醯氧基-2-羥基丙基)-α,ω-雙-3-胺基丙基-聚二甲基矽氧烷;聚矽氧烷基烷基(甲基)丙烯酸單體;選自由US 5,760,100(藉由引用以其全文結合在此)中所述的大分子單體A、大分子單體B、大分子單體C和大分子單體D組成的組的含矽氧烷的大分子單體;揭露於US 201008843 A1和US 20120088844 A1(藉由引用以其全文結合在此)中的鏈延伸的聚矽氧烷乙烯基交聯劑;甲基丙烯酸縮水甘油酯與胺基官能的聚二甲基矽氧烷的反應產物;羥基官能化的含矽氧烷的乙烯基單體或大分子單體;美國專利案號4,136,250、4,153,641、4,182,822、4,189,546、4,343,927、4,254,248、4,355,147、4,276,402、4,327,203、4,341,889、4,486,577、4,543,398、4,605,712、4,661,575、4,684,538、4,703,097、4,833,218、4,837,289、4,954,586、4,954,587、5,010,141、5,034,461、5,070,170、5,079,319、5039,761、5,346,946、5,358,995、5,387,632、5,416,132、5,451,617、5,486,579、5,962,548、5,981,675、6,039,913和6,762,264(藉由引用以其全文結合在此)中揭露的含聚矽氧烷的大分子 單體;美國專利案號4,259,467、4,260,725和4,261,875(藉由引用以其全文結合在此)中揭露的含聚矽氧烷的大分子單體。 Any suitable silicone-containing vinyl macromer (ie, crosslinking agent) can be used in the present invention. Examples of preferred silicone-containing vinyl macromonomers (crosslinkers) are dimethacrylated or diacrylated polydimethylsiloxanes of various molecular weights; divinyl carbonate End-capped polydimethylsiloxane; Divinyl carbamate-terminated polydimethylsiloxane; Dimethacrylamide-terminated polydimethylsiloxane; Diacrylamide-terminated polydimethylsiloxane; Diacrylamide-terminated polydimethylsiloxane Polydimethylsiloxane; Bis-3-methacryloxy-2-hydroxypropoxypropyl polydimethylsiloxane; N,N,N',N'-tetra(3-methyl) (2-hydroxypropyl)-α,ω-bis-3-aminopropyl-polydimethylsiloxane; polysiloxane alkyl (meth) acrylic monomer; optional Free from the group consisting of macromonomer A, macromonomer B, macromonomer C and macromonomer D described in US 5,760,100 (incorporated in its entirety by reference) containing silicone Macromonomer; chain-extended polysiloxane vinyl crosslinker disclosed in US 201008843 A1 and US 20120088844 A1 (incorporated in its entirety by reference); glycidyl methacrylate and amine functional The reaction product of polydimethylsiloxane; hydroxyl-functionalized siloxane-containing vinyl monomer or macromonomer; U.S. Patent Nos. 4,136,250, 4,153,641, 4,182,822, 4,189,546, 4,343,927, 4,254,248, 4,355,147, 4,276,402 , 4,327,203, 4,341,889, 4,486,577, 4,543,398, 4,605,712, 4,661,575, 4,684,538, 4,703,097, 4,833,218, 4,837,289, 4,954,586, 4,954,587, 5,010,141, 5,034,461,5,010,141, 5,034,461,5,070,5,358,5,034,461,5,5,070,5,034,461,5,5,617,5,034,461,132 Polysiloxane-containing macromolecules disclosed in, 5,981,675, 6,039,913 and 6,762,264 (incorporated in its entirety by reference) Monomers; U.S. Patent Nos. 4,259,467, 4,260,725 and 4,261,875 (incorporated in its entirety by reference) disclosed polysiloxane-containing macromonomers.

較佳的乙烯基交聯劑的實例包括而不限於四乙二醇二丙烯酸酯、三乙二醇二丙烯酸酯、二乙二醇二丙烯酸酯、乙二醇二丙烯酸酯、四乙二醇二甲基丙烯酸酯、三乙二醇二甲基丙烯酸酯、二乙二醇二甲基丙烯酸酯、乙二醇二甲基丙烯酸酯、四乙二醇二乙烯基醚、三乙二醇二乙烯基醚、二乙二醇二乙烯基醚、乙二醇二乙烯基醚、三羥甲基丙烷三甲基丙烯酸酯、季戊四醇四甲基丙烯酸酯、雙酚A二甲基丙烯酸酯、乙烯基甲基丙烯酸酯、乙二胺二甲基丙烯醯胺、乙二胺二丙烯醯胺、二甲基丙烯酸甘油酯、三烯丙基異氰尿酸酯、三烯丙基氰尿酸酯、烯丙基甲基丙烯酸酯、烯丙基丙烯酸酯、N-烯丙基-甲基丙烯醯胺、N-烯丙基-丙烯醯胺、1,3-雙(甲基丙烯醯胺丙基)-1,1,3,3-四(三甲基-矽烷氧基)二矽氧烷、N,N’-亞甲基雙丙烯醯胺、N,N’-亞甲基雙甲基丙烯醯胺、N,N’-乙烯雙丙烯醯胺、N,N’-乙烯雙甲基丙烯醯胺、1,3-雙(N-甲基丙烯醯胺丙基)-1,1,3,3-四-(三甲基矽烷氧基)二矽氧烷、1,3-雙(甲基丙烯醯胺丁基)-1,1,3,3-四(三甲基矽烷氧基)-二矽氧烷、1,3-雙(丙烯醯胺丙基)-1,1,3,3-四(三甲基矽烷氧基)二矽氧烷、1,3-雙(甲基丙烯醯氧基乙基脲基丙基)-1,1,3,3-四(三甲基矽烷氧基)二矽氧烷、及其組合。較佳的交聯劑係四(乙二醇)二丙烯酸酯、三(乙二醇)二丙烯酸酯、乙二醇二丙烯酸酯、二(乙二醇)二丙烯酸酯、亞甲基雙丙烯醯胺、三烯丙基異氰脲酸酯或三烯丙基氰脲酸酯。所用的交聯劑的量以相對於總聚合物的重量含量表示並且較佳的是在從約0.05%至約3%(更較佳的是從約0.1%至約2%)的範圍內。 Examples of preferred vinyl crosslinkers include, but are not limited to, tetraethylene glycol diacrylate, triethylene glycol diacrylate, diethylene glycol diacrylate, ethylene glycol diacrylate, tetraethylene glycol diacrylate, Methacrylate, triethylene glycol dimethacrylate, diethylene glycol dimethacrylate, ethylene glycol dimethacrylate, tetraethylene glycol divinyl ether, triethylene glycol divinyl Ether, diethylene glycol divinyl ether, ethylene glycol divinyl ether, trimethylolpropane trimethacrylate, pentaerythritol tetramethacrylate, bisphenol A dimethacrylate, vinyl methyl Acrylate, ethylene diamine dimethyl acrylamide, ethylene diamine diacryl amide, glycerol dimethacrylate, triallyl isocyanurate, triallyl cyanurate, allyl Methacrylate, allyl acrylate, N-allyl-methacrylamide, N-allyl-acrylamide, 1,3-bis(methacrylamide propyl)-1, 1,3,3-Tetra(trimethyl-silanoxy)disiloxane, N,N'-methylenebisacrylamide, N,N'-methylenebismethacrylamide, N ,N'-ethylene bisacrylamide, N,N'-ethylene bismethacrylamide, 1,3-bis(N-methacrylamide propyl)-1,1,3,3-tetra- (Trimethylsilyloxy)disiloxane, 1,3-bis(methacrylamide butyl)-1,1,3,3-tetra(trimethylsilyloxy)-disiloxane , 1,3-bis(acrylamidopropyl)-1,1,3,3-tetra(trimethylsilyloxy)disiloxane, 1,3-bis(methacryloxyethyl) Ureapropyl)-1,1,3,3-tetra(trimethylsilyloxy)disiloxane, and combinations thereof. The preferred crosslinking agents are tetra(ethylene glycol) diacrylate, tri(ethylene glycol) diacrylate, ethylene glycol diacrylate, di(ethylene glycol) diacrylate, methylene diacrylate Amine, triallyl isocyanurate or triallyl cyanurate. The amount of crosslinking agent used is expressed in terms of weight content relative to the total polymer and is preferably in the range of from about 0.05% to about 3% (more preferably from about 0.1% to about 2%).

本發明的鏡片配製物可以進一步包含可視性著色劑(例如, D&C藍6號、D&C綠6號、D&C紫2號、咔唑紫、某些銅錯合物、某些鉻氧化物、各種鐵氧化物、酞菁綠、酞菁藍、二氧化鈦、或其混合物)、抗微生物劑(例如,銀奈米粒子)、生物活性劑(例如,藥物、胺基酸、多肽、蛋白質、核酸、2-吡咯啶酮-5-羧酸(PCA)、α羥基酸、亞油酸和γ亞油酸、維生素、或其任何組合)、可浸出的潤滑劑(例如,具有從5,000至500,000、較佳的是從10,000至300,000、更較佳的是從20,000至100,000道耳頓的平均分子量的不可交聯的親水性聚合物)、可浸出的眼淚穩定劑(例如,磷脂、甘油單酯、甘油二酯、甘油三酯、糖脂、甘油糖脂、鞘脂、神經鞘糖脂、具有8至36個碳原子的脂肪酸、具有8至36個碳原子的脂肪醇、或其混合物)、以及類似物,如熟習該項技術者已知的。 The lens formulation of the present invention may further include a visibility colorant (e.g., D&C Blue No. 6, D&C Green No. 6, D&C Violet No. 2, Carbazole Violet, certain copper complexes, certain chromium oxides, various iron oxides, phthalocyanine green, phthalocyanine blue, titanium dioxide, or mixtures thereof ), antimicrobial agents (for example, silver nanoparticles), bioactive agents (for example, drugs, amino acids, polypeptides, proteins, nucleic acids, 2-pyrrolidone-5-carboxylic acid (PCA), alpha hydroxy acids, Linoleic acid and gamma linoleic acid, vitamins, or any combination thereof), leachable lubricants (for example, having from 5,000 to 500,000, preferably from 10,000 to 300,000, more preferably from 20,000 to 100,000 Non-crosslinkable hydrophilic polymers with average molecular weight of earton), leachable tear stabilizers (for example, phospholipids, monoglycerides, diglycerides, triglycerides, glycolipids, glyceroglycolipids, sphingolipids, nerves Glycosphingolipids, fatty acids having 8 to 36 carbon atoms, fatty alcohols having 8 to 36 carbon atoms, or mixtures thereof), and the like are known to those skilled in the art.

在較佳的實施方式中,該鏡片配製物係包含一種或多種水溶性的可光化交聯的聚(乙烯醇)預聚物的水基鏡片配製物。較佳的是,水溶性 的可光化交聯的聚乙烯醇預聚物包含乙烯醇(即,

Figure 106105690-A0202-12-0030-83
)的重複單元和具有式(VIII)之重複單元
Figure 106105690-A0202-12-0030-84
In a preferred embodiment, the lens formulation is a water-based lens formulation containing one or more water-soluble actinically crosslinkable poly(vinyl alcohol) prepolymers. Preferably, the water-soluble actinically crosslinkable polyvinyl alcohol prepolymer contains vinyl alcohol (ie,
Figure 106105690-A0202-12-0030-83
) And the repeating unit of formula (VIII)
Figure 106105690-A0202-12-0030-84

其中:R11係氫或C1-C6烷基(較佳的是氫或C1-C4烷基、更較佳的是氫或甲基或乙基、甚至更較佳的是氫或甲基); R12

Figure 106105690-A0202-12-0030-85
Figure 106105690-A0202-12-0030-86
乙烯式不飽和基團 其中q1和q2彼此獨立的是零或一,並且R16和R17彼此獨立的是C2-C8伸烷基二價基團,R18係C2-C8烯基;R13可以是氫或C1-C6烷基(較佳的是氫);並且R14係C1-C6伸烷基二價基團(較佳的是C1-C4伸烷基二價基團、更較佳的是亞甲基或伸丁基二價基團、甚至更較佳的是亞甲基二價基團)。 Among them: R 11 is hydrogen or C 1 -C 6 alkyl (preferably hydrogen or C 1 -C 4 alkyl, more preferably hydrogen or methyl or ethyl, even more preferably hydrogen or Methyl); R 12 series
Figure 106105690-A0202-12-0030-85
or
Figure 106105690-A0202-12-0030-86
An ethylenically unsaturated group where q1 and q2 are independent of each other are zero or one, and R 16 and R 17 are independent of each other are a C 2 -C 8 alkylene divalent group, and R 18 is a C 2 -C 8 alkene R 13 can be hydrogen or C 1 -C 6 alkyl (preferably hydrogen); and R 14 is a C 1 -C 6 alkylene divalent group (preferably C 1 -C 4 extension An alkyl divalent group, more preferably a methylene or butylene divalent group, even more preferably a methylene divalent group).

在另一個較佳的實施方式中,鏡片配製物包含水溶性的含矽酮的預聚物。水溶性的含矽酮的預聚物的實例包括但不限於在US 9,187,601中揭露的那些(藉由引用以其全文結合在此)。 In another preferred embodiment, the lens formulation contains a water-soluble silicone-containing prepolymer. Examples of water-soluble silicone-containing prepolymers include, but are not limited to, those disclosed in US 9,187,601 (incorporated in its entirety by reference).

“水基鏡片配製物”指的是包含水作為溶劑或溶劑混合物的可聚合組成物,該可聚合組成物包含相對於該溶劑混合物和可聚合/可交聯組分的總量按重量計至少約60%(較佳的是至少約80%、更較佳的是至少約90%、甚至更較佳的是至少約95%、最較佳的是至少約98%)的水,並且該可聚合組成物可以被熱固化或光化固化(即,聚合和/或交聯)以獲得交聯的/聚合的聚合物材料。 "Water-based lens formulation" refers to a polymerizable composition containing water as a solvent or solvent mixture, the polymerizable composition containing at least by weight relative to the total amount of the solvent mixture and the polymerizable/crosslinkable component About 60% (preferably at least about 80%, more preferably at least about 90%, even more preferably at least about 95%, most preferably at least about 98%) water, and The polymer composition may be thermally cured or actinically cured (ie, polymerized and/or crosslinked) to obtain a crosslinked/polymerized polymer material.

應理解的是在該鏡片配製物中存在的UV吸收性乙烯基單體的量足以給予所得接觸鏡片(其係從該鏡片配製物的固化獲得的)阻擋或吸收(即,透射率的倒數)照射到鏡片上的至少90%(較佳的是至少約95%、更較佳的是至少約97.5%、甚至更較佳的是至少約99%)的UVB(在280與315奈米之間),至少70%(較佳的是至少約80%、更較佳的是至少約90%、甚至更較佳的是至少約95%)的UVA透射率(在315與380奈米之間),和視情況(但較佳的是)至少30%(較佳的是至少約40%、更較佳的是至少約50%、甚至更較佳的是至少約60%)的在380nm與440nm之間的紫光的能力。 It should be understood that the amount of UV-absorbing vinyl monomer present in the lens formulation is sufficient to impart blocking or absorption (ie, the inverse of the transmittance) to the resulting contact lens (which is obtained from curing of the lens formulation) At least 90% (preferably at least about 95%, more preferably at least about 97.5%, even more preferably at least about 99%) of UVB (between 280 and 315 nanometers) irradiated on the lens ), at least 70% (preferably at least about 80%, more preferably at least about 90%, even more preferably at least about 95%) UVA transmittance (between 315 and 380 nm) , And optionally (but preferably) at least 30% (preferably at least about 40%, more preferably at least about 50%, even more preferably at least about 60%) at 380nm and 440nm The ability of purple light among.

根據本發明,鏡片配製物可以是水基鏡片配製物、有機溶劑基鏡片配製物、或無溶劑的配製物。 According to the present invention, the lens formulation may be a water-based lens formulation, an organic solvent-based lens formulation, or a solvent-free formulation.

鏡片配製物可以藉由將所有希望的組分溶解在水、水和有機溶劑的混合物、有機溶劑、或兩種或更多種有機溶劑的混合物中,或藉由在沒有任何溶劑的情況下共混所有可聚合組分來製備,如熟習該項技術者已知的。 Lens formulations can be achieved by dissolving all the desired components in water, a mixture of water and organic solvents, an organic solvent, or a mixture of two or more organic solvents, or by co-existence without any solvents. It is prepared by mixing all polymerizable components, as known to those skilled in the art.

在另一個較佳的實施方式中,該鏡片配製物包含具有式(I)至(VII)中任一個的UV吸收性乙烯基單體,其中Q1、Q2和Q3係(甲基)丙烯醯胺基(較佳的是丙烯醯胺基)。藉由具有(甲基)丙烯醯胺基(較佳的是丙烯醯胺基),可以實現相對短的固化時間(例如,小於100秒、較佳的是小於75秒、更較佳的是小於50秒、甚至更較佳的是約30秒或更短)。 In another preferred embodiment, the lens formulation comprises a UV-absorbing vinyl monomer having any one of formulas (I) to (VII), wherein Q1, Q2 and Q3 are (meth)acrylamides Group (preferably an acrylamido group). By having a (meth)acrylamido group (preferably an acrylamido group), a relatively short curing time (for example, less than 100 seconds, preferably less than 75 seconds, more preferably less than 50 seconds, even more preferably about 30 seconds or less).

用於製備接觸鏡片的鏡片模具對於熟習該項技術者係眾所周知的。製造用於鑄塑模製接觸鏡片的模具區域的方法總體上對於熟習該項技術者來說是眾所周知的。本發明的方法不局限於任何特定的形成模具之方法。事實上,任何的模具成型法均可用於本發明。該第一和第二半模可以藉由各種技術(如注射模製或車床加工)形成。用於形成該等半模的適合方法的實例揭露於Schad的美國專利案號4,444,711;Boehm等人的4,460,534;Morrill的5,843,346;以及Boneberger等人的5,894,002中,該等專利也藉由引用結合在此。幾乎本領域已知的所有用於製造模具的材料都可以用於製造用於製備接觸鏡片的模具。例如,可以使用聚合物材料,如聚乙烯、聚丙烯、聚苯乙烯、PMMA、Topas® COC級8007-S10(來自德國法蘭克福市和美國新澤西州薩米特(Frankfurt,Germany and Summit,New Jersey)的泰科納公司(Ticona GmbH)的乙烯與降冰片烯的清澈無定形的 共聚物)等。可以使用允許紫外線透射的其他材料,如石英玻璃和藍寶石。 The lens molds used to prepare contact lenses are well known to those skilled in the art. The method of manufacturing the mold area for casting and molding contact lenses is generally well known to those skilled in the art. The method of the present invention is not limited to any specific method of forming a mold. In fact, any mold forming method can be used in the present invention. The first and second mold halves can be formed by various techniques such as injection molding or lathe processing. Examples of suitable methods for forming the mold halves are disclosed in Schad's U.S. Patent No. 4,444,711; Boehm et al. 4,460,534; Morrill et al. 5,843,346; and Boneberger et al. 5,894,002, which patents are also incorporated herein by reference . Almost all materials known in the art for making molds can be used for making molds for making contact lenses. For example, polymer materials such as polyethylene, polypropylene, polystyrene, PMMA, Topas® COC grade 8007-S10 (from Frankfurt, Germany and Summit, New Jersey) can be used. Ticona GmbH (Ticona GmbH) ethylene and norbornene clear amorphous Copolymer) and so on. Other materials that allow ultraviolet transmission, such as quartz glass and sapphire, can be used.

較佳的是,在本發明中使用適合於輻射的空間限制的可重複使用的模具,投射的輻射束(例如,來自包括在360nm至550nm範圍內的光的光源的輻射)限制撞擊在位於從該可重複使用的模具的第一模製表面至第二模製表面的投射束路徑中的鏡片形成材料的混合物上的輻射(例如,UV輻射)。所得接觸鏡片包括由第一模製表面限定的前表面、由第二模製表面限定的相反的後表面、以及由投射的輻射束的截面輪廓(即,輻射的空間限制)限定的鏡片邊緣(具有銳利邊緣和高品質)。適合用於輻射的空間限制的可重複使用的模具的實例包括但不限於在美國專利案號6,627,124、6,800,225、7,384,590和7,387,759中揭露的那些,該等專利藉由引用以其全文結合。 Preferably, a reusable mold suitable for the space limitation of radiation is used in the present invention, and the projected radiation beam (for example, radiation from a light source including light in the range of 360 nm to 550 nm) is restricted from impacting at a location from Radiation (for example, UV radiation) on the mixture of lens forming materials in the projected beam path from the first molding surface to the second molding surface of the reusable mold. The resulting contact lens includes a front surface defined by a first molded surface, an opposite back surface defined by a second molded surface, and a lens edge defined by the cross-sectional profile of the projected radiation beam (ie, the spatial limitation of radiation) ( With sharp edges and high quality). Examples of reusable molds suitable for space confinement of radiation include, but are not limited to, those disclosed in U.S. Patent Nos. 6,627,124, 6,800,225, 7,384,590, and 7,387,759, which are incorporated by reference in their entirety.

例如,較佳的可重複使用的模具包括具有第一模製表面的第一半模和具有第二模製表面的第二半模。較佳的可重複使用的模具的這兩個半模不相互接觸,而是存在安排在這兩個半模之間的具有環形設計的細間隙。該間隙與在第一模製表面與第二模製表面之間形成的模具型腔相連,以使過量混合物可流入該間隙內。應當理解,在本發明中可以使用具有任何設計的間隙。 For example, a preferred reusable mold includes a first mold half having a first molding surface and a second mold half having a second molding surface. The two mold halves of the preferred reusable mold do not contact each other, but there is a fine gap of annular design arranged between the two mold halves. The gap is connected to the mold cavity formed between the first molding surface and the second molding surface so that excess mixture can flow into the gap. It should be understood that gaps of any design can be used in the present invention.

在較佳的實施方式中,該第一模製表面和第二模製表面中的至少一者對交聯輻射係可透過的。更較佳的是,該第一模製表面和第二模製表面之一對交聯輻射係可透過的,而另一個模製錶面對交聯輻射係較差地可透過的。 In a preferred embodiment, at least one of the first molding surface and the second molding surface is transparent to cross-linking radiation. More preferably, one of the first molding surface and the second molding surface is transparent to cross-linking radiation, and the other molding surface is poorly transparent to cross-linking radiation.

該可重複使用的模具包括掩模,該掩模被固定、構造或安排在具有輻射可透過的模製表面的半模中、處或上。該掩模係不可透過的或 至少具有與輻射可透過的模製表面的透過率相比較差的透過率。該掩模一直向內延伸至模具型腔並包圍模具型腔以遮蔽除模具型腔外的該掩模後的所有區域。 The reusable mold includes a mask that is fixed, structured, or arranged in, at, or on a mold half having a radiation-permeable molding surface. The mask is impermeable or At least it has a transmittance that is inferior to that of a radiation-permeable molding surface. The mask extends inward to the mold cavity and surrounds the mold cavity to cover all areas behind the mask except the mold cavity.

該掩模可較佳的是薄鉻層,其可根據如照相平版印刷術和紫外平版印刷術中已知的方法製成。其他金屬或金屬氧化物也可以是合適的掩模材料。如果用於模具或半模的材料係石英,該掩模也可以塗覆有保護層(例如二氧化矽)。 The mask may preferably be a thin chromium layer, which may be made according to methods such as known in photolithography and ultraviolet lithography. Other metals or metal oxides may also be suitable mask materials. If the material used for the mold or mold half is quartz, the mask can also be coated with a protective layer (such as silicon dioxide).

可替代地,該掩模可以如美國專利案號7,387,759(藉由引用以其全文結合)中所述的,係由包含UV/可見光-吸收劑的材料製成的掩模環並且基本上阻擋穿過其中的固化能量。在這個較佳的實施方式中,具有該掩模的該半模包含總體上圓盤形的透射部分和具有被適配為適合與該透射部分緊密接合的內徑的掩模環,其中所述透射部分係由光學透明的材料製成並允許固化能量穿過其中,並且其中該掩模環由包含光-阻隔劑的材料製成並基本上阻擋固化能量穿過其中,其中該掩模環總體上類似於墊圈或麵包圈,具有用於接納該透射部分的中心孔,其中將該透射部分壓入該掩模環的中心開口中並將該掩模環安裝在套管內。 Alternatively, the mask may be a mask ring made of a material containing UV/visible light-absorbent as described in U.S. Patent No. 7,387,759 (incorporated in its entirety by reference) and substantially block penetration. Through the curing energy. In this preferred embodiment, the mold half with the mask includes a generally disc-shaped transmissive part and a mask ring having an inner diameter adapted to be tightly engaged with the transmissive part, wherein The transmissive part is made of an optically transparent material and allows curing energy to pass therethrough, and wherein the mask ring is made of a material containing a light-blocking agent and substantially blocks curing energy from passing therethrough, and the mask ring as a whole The upper is similar to a gasket or a donut, with a central hole for receiving the transmission part, wherein the transmission part is pressed into the central opening of the mask ring and the mask ring is installed in the sleeve.

可重複使用的模具可由石英、玻璃、藍寶石、CaF2、環烯烴共聚物(例如像來自德國法蘭克福市和新澤西州薩米特的泰科納公司的Topas® COC級8007-S10(乙烯和降冰片烯的透明無定形共聚物),來自肯塔基州路易斯維爾的瑞翁化學公司(Zeon Chemicals LP,Louisville,KY)的Zeonex®和Zeonor®)、聚甲基丙烯酸甲酯(PMMA)、來自杜邦(DuPont)的聚甲醛(Delrin)、來自G.E.塑膠(G.E.Plastics)的Ultem®(聚醚醯亞胺)、PrimoSpire®等製成。因為半模的再使用性,在它們的生產時可能消耗較高 的費用以獲得具有極高精度和再現性的模具。由於半模在待生產的鏡片的區域中(即型腔或實際模製表面)不互相接觸,因此消除了由接觸引起的損害。這確保了高的模具使用壽命,這尤其還確保了有待生產的接觸鏡片的高的再現性和鏡片設計的高保真度。 Reusable molds can be made of quartz, glass, sapphire, CaF 2 , cycloolefin copolymers (such as Topas ® COC grade 8007-S10 (ethylene and norbornyl) from Ticona of Frankfurt, Germany and Summit, New Jersey Transparent amorphous copolymer of olefin), Zeonex® and Zeonor® from Zeon Chemicals LP, Louisville, KY), polymethylmethacrylate (PMMA), from DuPont ) Polyoxymethylene (Delrin), Ultem® (polyether imide) from GE Plastics (GE Plastics), PrimoSpire®, etc. Because of the reusability of the mold halves, higher costs may be consumed in their production to obtain molds with extremely high precision and reproducibility. Since the mold halves are not in contact with each other in the area of the lens to be produced (ie, the cavity or the actual molding surface), damage caused by contact is eliminated. This ensures a high mold life, which in particular also ensures high reproducibility of the contact lenses to be produced and high fidelity of the lens design.

根據本發明,可根據任何已知的方法將該鏡片配製物引入(分配)至由模具形成的型腔內。 According to the present invention, the lens formulation can be introduced (dispensed) into the cavity formed by the mold according to any known method.

在該鏡片配製物被分配到模具中之後,將其聚合以產生接觸鏡片。交聯可以用熱的方法或在暴露於包括在380nm至500nm之間的範圍內的光的光源時,較佳的是在光化輻射的空間限制下引發,以交聯混合物中的可聚合組分。 After the lens formulation is dispensed into the mold, it is polymerized to produce a contact lens. The cross-linking can be thermally or when exposed to a light source including light in the range of 380nm to 500nm, preferably initiated under the spatial limitation of actinic radiation, to crosslink the polymerizable group in the mixture. Minute.

根據本發明,光源可以是足以活化基於鍺烷的諾裡什I型光引發劑的發射在380-500nm範圍內的光的任何光源。藍色光源係可商購的並且包括:Palatray CU藍光單元(從加利福尼亞州爾灣賀利氏古莎公司(Heraeus Kulzer,Inc.,Irvine,Calif.)可獲得)、Fusion F450藍光系統(從德克薩斯州理查森TEAMCO(TEAMCO,Richardson,Tex.)可獲得)、Dymax Blue Wave 200、來自Opsytec的LED光源(385nm、395nm、405nm、435nm、445nm、460nm)、來自Hamamatsu的LED光源(385nm)以及GE 24”藍色螢光燈(從美國通用電氣公司(General Electric Company,U.S.)可獲得)。較佳的藍色光源係來自Opsytec的UV LED(以上描述的那些)。 According to the present invention, the light source may be any light source sufficient to activate the germane-based Norrish Type I photoinitiator to emit light in the range of 380-500 nm. The blue light source is commercially available and includes: Palatray CU blue light unit (available from Heraeus Kulzer, Inc., Irvine, Calif.), Fusion F450 blue light system (from Germany) TEAMCO (available from TEAMCO, Richardson, Tex.), Dymax Blue Wave 200, LED light source from Opsytec (385nm, 395nm, 405nm, 435nm, 445nm, 460nm), LED light source from Hamamatsu (385nm) And a GE 24" blue fluorescent lamp (available from General Electric Company, US). The preferred blue light source is UV LED from Opsytec (those described above).

光源的強度較佳的是從約2至約40mW/cm2,較佳的是在400nm至550nm範圍內從約4至約20mW/cm2係更較佳的。該等強度值係藉由使用光引發劑主光譜對燈輸出進行加權確定的。 The intensity of the light source is preferably from about 2 to about 40mW / cm 2, preferably within the range of 400nm to 550nm from about 4 to about 20mW / cm 2 is more preferred system. These intensity values are determined by weighting the lamp output using the main spectrum of the photoinitiator.

根據本發明的光致交聯可以在非常短的時間內實現,例如在

Figure 106105690-A0202-12-0036-244
約120秒內、較佳的是在
Figure 106105690-A0202-12-0036-245
約80秒內、更較佳的是在
Figure 106105690-A0202-12-0036-247
約50秒內、甚至更較佳的是在
Figure 106105690-A0202-12-0036-248
約30秒內、並且最較佳的是在4至30秒內。 The photocrosslinking according to the present invention can be achieved in a very short time, for example in
Figure 106105690-A0202-12-0036-244
In about 120 seconds, preferably in
Figure 106105690-A0202-12-0036-245
In about 80 seconds, more preferably in
Figure 106105690-A0202-12-0036-247
In about 50 seconds, or even better
Figure 106105690-A0202-12-0036-248
Within about 30 seconds, and most preferably within 4 to 30 seconds.

使得可以從該模具中移除該模製的鏡片的模具打開可以按本身已知的方式發生。 The opening of the mold so that the molded lens can be removed from the mold can occur in a manner known per se.

模製的接觸鏡片可以經受鏡片萃取以去除未聚合的乙烯基單體和大分子單體。萃取溶劑較佳的是水或水性溶液。在萃取之後,鏡片可以在水或潤濕劑(例如,親水性聚合物)的水溶液中水合;包裝在具有包裝溶液的鏡片包裝中,該包裝溶液可含有按重量計約0.005%至約5%的潤濕劑(例如,親水性聚合物)、黏度增強劑(例如,甲基纖維素(MC)、乙基纖維素、羥甲基纖維素、羥乙基纖維素(HEC)、羥丙基纖維素(HPC)、羥丙基甲基纖維素(HPMC)或其混合物);消毒,如在從118℃至124℃下高壓滅菌持續至少約30分鐘;等等。 Molded contact lenses can be subjected to lens extraction to remove unpolymerized vinyl monomers and macromers. The extraction solvent is preferably water or an aqueous solution. After extraction, the lens can be hydrated in water or an aqueous solution of a wetting agent (for example, a hydrophilic polymer); packaged in a lens package with a packaging solution, the packaging solution may contain from about 0.005% to about 5% by weight Wetting agents (for example, hydrophilic polymers), viscosity enhancers (for example, methyl cellulose (MC), ethyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose (HEC), hydroxypropyl Cellulose (HPC), hydroxypropyl methyl cellulose (HPMC) or mixtures thereof); sterilization, such as autoclaving from 118°C to 124°C for at least about 30 minutes; and so on.

在另一個方面,本發明提供了一種包含交聯的聚合物材料的水凝膠接觸鏡片,該聚合物材料包含具有式(I)至(VII)中任一個的UV吸收性乙烯基單體的重複單元。 In another aspect, the present invention provides a hydrogel contact lens comprising a cross-linked polymer material, the polymer material comprising a UV-absorbing vinyl monomer having any one of formulas (I) to (VII) Repeating unit.

本發明的接觸鏡片的特徵在於具有在280與315奈米之間的約10%或更小(較佳的是約5%或更小、更較佳的是約2.5%或更小、甚至更較佳的是約1%或更小)的UVB透射率和在315與380奈米之間的約30%或更小(較佳的是約20%或更小、更較佳的是約10%或更小、甚至更較佳的是約5%或更小)的UVA透射率以及視情況(但較佳的是)在380nm與440nm之間的約60%或更小、較佳的是約50%或更小、更較佳的是約40%或更小、甚至更較佳的是約30%或更小)的紫光透射率。 The contact lens of the present invention is characterized by having about 10% or less between 280 and 315 nanometers (preferably about 5% or less, more preferably about 2.5% or less, even more Preferably about 1% or less) UVB transmittance and about 30% or less between 315 and 380 nm (preferably about 20% or less, more preferably about 10 % Or less, even more preferably about 5% or less) and optionally (but preferably) between 380nm and 440nm of about 60% or less, preferably About 50% or less, more preferably about 40% or less, even more preferably about 30% or less) violet light transmittance.

本發明的接觸鏡片當完全水合時進一步具有按重量計較佳的是從約15%至約80%、更較佳的是從約30%至約70%的含水量(在室溫,約22℃至28℃下)。 The contact lens of the present invention, when fully hydrated, further has a water content by weight, preferably from about 15% to about 80%, more preferably from about 30% to about 70% (at room temperature, about 22°C). To 28°C).

儘管已經使用特定的術語、裝置和方法描述了本發明的各種實施方式,但此類描述僅用於說明目的。所使用的詞語係描述性而不是限制性的詞語。應當理解,可以由熟習該項技術者在不偏離在以下申請專利範圍中闡述的本發明的精神或範圍下作出改變和變化。此外,應理解,各個實施方式的多個方面可以整體地或部分地互換或者可以按照任何方式組合和/或一起使用,如下文所說明的: Although various embodiments of the present invention have been described using specific terms, devices, and methods, such descriptions are for illustrative purposes only. The words used are descriptive rather than restrictive words. It should be understood that changes and changes can be made by those skilled in the art without departing from the spirit or scope of the present invention set forth in the scope of the following patent applications. In addition, it should be understood that various aspects of the various embodiments can be interchanged in whole or in part or can be combined and/or used together in any manner, as explained below:

1.一種具有式(I)至(VII)中任一個的UV吸收性乙烯基單體

Figure 106105690-A0202-12-0037-87
1. A UV-absorbing vinyl monomer having any one of formula (I) to (VII)
Figure 106105690-A0202-12-0037-87

Figure 106105690-A0202-12-0037-88
Figure 106105690-A0202-12-0037-88

Figure 106105690-A0202-12-0037-89
Figure 106105690-A0202-12-0037-89

Figure 106105690-A0202-12-0037-90
Figure 106105690-A0202-12-0037-90

Figure 106105690-A0202-12-0037-91
Figure 106105690-A0202-12-0037-91

Figure 106105690-A0202-12-0038-92
Figure 106105690-A0202-12-0038-92

Figure 106105690-A0202-12-0038-93
Figure 106105690-A0202-12-0038-93

其中:Ro係H或CH3;R1、R2和R2’彼此獨立的是H、CH3、CCl3、CF3、Cl、Br、OH、OCH3、或NR’R”,其中R’和R”彼此獨立的是H或C1-C4烷基;R1’彼此獨立的是H、CH3、CCl3、CF3、Cl、Br、OH、OCH3、SO3H、SO3Na、或NR’R”,其中R’和R”彼此獨立的是H或C1-C4烷基;R3和R4彼此獨立的是H或第一親水基團,該第一親水基團係*-CH2-(OC2H4)n1-OCH3、*-CH2-(OC2H4)n1-OH、

Figure 106105690-A0202-12-0038-94
Figure 106105690-A0202-12-0038-97
Figure 106105690-A0202-12-0038-96
Figure 106105690-A0202-12-0038-95
、或
Figure 106105690-A0202-12-0038-98
,條件係R3和R4中的至少一個係該第一親水基團;R5係H、*-COOH、*-CONH-C2H4-(OC2H4)n1-OCH3、或*-CONH-C2H4-(OC2H4)n1-OH;R6和R7之一係H或第二親水基團,該第二親水基團係 *-CH2-(OC2H4)n1-OCH3、*-CH2-(OC2H4)n1-OH、
Figure 106105690-A0202-12-0038-99
Figure 106105690-A0202-12-0039-100
Figure 106105690-A0202-12-0039-101
、或
Figure 106105690-A0202-12-0039-102
,而R6和R7中的另 一個係
Figure 106105690-A0202-12-0039-103
Figure 106105690-A0202-12-0039-104
Figure 106105690-A0202-12-0039-105
;R8係CH3、C2H5
Figure 106105690-A0202-12-0039-106
Figure 106105690-A0202-12-0039-107
、或
Figure 106105690-A0202-12-0039-108
;R9係SO3Na、
Figure 106105690-A0202-12-0039-109
Figure 106105690-A0202-12-0039-110
Figure 106105690-A0202-12-0039-111
Figure 106105690-A0202-12-0039-112
R9’係H、SO3Na、
Figure 106105690-A0202-12-0039-113
Figure 106105690-A0202-12-0039-114
Figure 106105690-A0202-12-0039-115
Figure 106105690-A0202-12-0039-117
R10係甲基或乙基;L1係
Figure 106105690-A0202-12-0039-118
Figure 106105690-A0202-12-0039-119
Figure 106105690-A0202-12-0039-120
Figure 106105690-A0202-12-0039-121
Figure 106105690-A0202-12-0039-122
、 或
Figure 106105690-A0202-12-0039-123
的直接鍵或鍵聯;L2係*-CH2-*、*-C2H4-*、*-C3H6-*、*-C3H6-S-C2H4-*、*-C3H6-S-C3H6-*、或
Figure 106105690-A0202-12-0039-124
的鍵聯;X1係O或NRo;並且Y1、Y2和Y3彼此獨立的是C2-C4伸烷基二價基團;Q1、Q2和Q3彼此獨立的是(甲基)丙烯醯胺基或(甲基)丙烯醯氧基;m1係零或1,條件係如果m1係零,那麼Q2係(甲基)丙烯醯胺基;並且 n1係2至20的整數(較佳的是3至15,更較佳的是4至10)。 Wherein: R o is H or CH 3 ; R 1 , R 2 and R 2 'are independent of each other are H, CH 3 , CCl 3 , CF 3 , Cl, Br, OH, OCH 3 , or NR'R", where R'and R" independently of each other are H or C 1 -C 4 alkyl; R 1 'independently of each other are H, CH 3 , CCl 3 , CF 3 , Cl, Br, OH, OCH 3 , SO 3 H, SO 3 Na, or NR'R", where R'and R" are independent of each other are H or C 1 -C 4 alkyl; R 3 and R 4 are independent of each other are H or the first hydrophilic group, the first Hydrophilic groups *-CH 2 -(OC 2 H 4 ) n1 -OCH 3 、*-CH 2 -(OC 2 H 4 ) n1 -OH,
Figure 106105690-A0202-12-0038-94
,
Figure 106105690-A0202-12-0038-97
,
Figure 106105690-A0202-12-0038-96
,
Figure 106105690-A0202-12-0038-95
,or
Figure 106105690-A0202-12-0038-98
, The condition is that at least one of R 3 and R 4 is the first hydrophilic group; R 5 is H, *-COOH, *-CONH-C 2 H 4 -(OC 2 H 4 ) n1 -OCH 3 , or *-CONH-C 2 H 4 -(OC 2 H 4 ) n1 -OH; one of R 6 and R 7 is H or a second hydrophilic group, and the second hydrophilic group is *-CH 2 -(OC 2 H 4 ) n1 -OCH 3 、*-CH 2 -(OC 2 H 4 ) n1 -OH,
Figure 106105690-A0202-12-0038-99
,
Figure 106105690-A0202-12-0039-100
,
Figure 106105690-A0202-12-0039-101
,or
Figure 106105690-A0202-12-0039-102
, And the other line of R 6 and R 7
Figure 106105690-A0202-12-0039-103
,
Figure 106105690-A0202-12-0039-104
or
Figure 106105690-A0202-12-0039-105
; R 8 is CH 3 , C 2 H 5 ,
Figure 106105690-A0202-12-0039-106
,
Figure 106105690-A0202-12-0039-107
,or
Figure 106105690-A0202-12-0039-108
; R 9 is SO 3 Na,
Figure 106105690-A0202-12-0039-109
,
Figure 106105690-A0202-12-0039-110
,
Figure 106105690-A0202-12-0039-111
,
Figure 106105690-A0202-12-0039-112
R 9 'based H, SO 3 Na,
Figure 106105690-A0202-12-0039-113
,
Figure 106105690-A0202-12-0039-114
,
Figure 106105690-A0202-12-0039-115
,
Figure 106105690-A0202-12-0039-117
R 10 is methyl or ethyl; L1 is
Figure 106105690-A0202-12-0039-118
,
Figure 106105690-A0202-12-0039-119
,
Figure 106105690-A0202-12-0039-120
,
Figure 106105690-A0202-12-0039-121
,
Figure 106105690-A0202-12-0039-122
, Or
Figure 106105690-A0202-12-0039-123
Direct bond or linkage; L2 series *-CH 2 -*, *-C 2 H 4 -*, *-C 3 H 6 -*, *-C 3 H 6 -SC 2 H 4 -*, *- C 3 H 6 -SC 3 H 6 -*, or
Figure 106105690-A0202-12-0039-124
The linkage of X1 is O or NR o ; and Y 1 , Y 2 and Y 3 are independently C 2 -C 4 alkylene divalent groups; Q1, Q2 and Q3 are independently (methyl) Acrylamido or (meth)acrylamido; m1 is zero or 1, provided that if m1 is zero, then Q 2 is a (meth)acrylamido; and n1 is an integer from 2 to 20 (more Preferably it is 3 to 15, more preferably 4 to 10).

2.如發明1所述之UV吸收性乙烯基單體,係具有式(I)之乙烯基單體。 2. The UV-absorbing vinyl monomer according to Invention 1 is a vinyl monomer having formula (I).

3.如發明2所述之UV吸收性乙烯基單體,係選自具有下式中任一個的乙烯基單體:

Figure 106105690-A0202-12-0040-125
Figure 106105690-A0202-12-0040-126
,以及
Figure 106105690-A0202-12-0040-127
3. The UV-absorbing vinyl monomer according to invention 2 is selected from vinyl monomers having any of the following formulas:
Figure 106105690-A0202-12-0040-125
Figure 106105690-A0202-12-0040-126
,as well as
Figure 106105690-A0202-12-0040-127

其中:Q1係(甲基)丙烯醯胺基或(甲基)丙烯醯氧基;Y1係伸乙基或伸丙基二價基團;R1和R2彼此獨立的是H、CH3、CCl3、CF3、Cl、Br、OH、OCH3、或NR’R”,其中R’和R”彼此獨立的是H、甲基或乙基。 Among them: Q 1 is a (meth)acrylamido or (meth)acrylamido group; Y 1 is an ethylene or propylene divalent group; R 1 and R 2 are independently H, CH 3 , CCl 3 , CF 3 , Cl, Br, OH, OCH 3 , or NR'R", where R'and R" are independently H, methyl or ethyl.

4.如發明1所述之UV吸收性乙烯基單體,係具有式(II)之乙烯基單體。 4. The UV-absorbing vinyl monomer according to Invention 1 is a vinyl monomer having formula (II).

5.如發明4所述之UV吸收性乙烯基單體,係選自具有下式中任一個的乙烯基單體:

Figure 106105690-A0202-12-0040-128
Figure 106105690-A0202-12-0041-129
Figure 106105690-A0202-12-0041-130
Figure 106105690-A0202-12-0041-131
Figure 106105690-A0202-12-0041-132
,以及
Figure 106105690-A0202-12-0041-133
5. The UV-absorbing vinyl monomer according to Invention 4 is selected from vinyl monomers having any one of the following formulas:
Figure 106105690-A0202-12-0040-128
Figure 106105690-A0202-12-0041-129
Figure 106105690-A0202-12-0041-130
,
Figure 106105690-A0202-12-0041-131
,
Figure 106105690-A0202-12-0041-132
,as well as
Figure 106105690-A0202-12-0041-133

其中:Q1係(甲基)丙烯醯胺基或(甲基)丙烯醯氧基;Y1係伸乙基或伸丙基二價基團;R1和R2彼此獨立的是CH3、CCl3、CF3、Cl、Br、NR’R”、OH、或OCH3;R’和R”彼此獨立的是H、甲基或乙基;R3和R4彼此獨立的是 *-CH2-(OC2H4)n1-OCH3、*-CH2-(OC2H4)n1-OH、

Figure 106105690-A0202-12-0041-134
Figure 106105690-A0202-12-0041-135
Figure 106105690-A0202-12-0041-136
Figure 106105690-A0202-12-0041-137
、或
Figure 106105690-A0202-12-0041-138
;R10係甲基或乙基。 Among them: Q 1 is a (meth)acrylamido or (meth)acryloxy; Y 1 is an ethylene or propylene divalent group; R 1 and R 2 are independently CH 3 , CCl 3 , CF 3 , Cl, Br, NR'R”, OH, or OCH 3 ; R'and R” independently of each other are H, methyl or ethyl; R 3 and R 4 independently of each other are *-CH 2 -(OC 2 H 4 ) n1 -OCH 3 、*-CH 2 -(OC 2 H 4 ) n1 -OH,
Figure 106105690-A0202-12-0041-134
,
Figure 106105690-A0202-12-0041-135
,
Figure 106105690-A0202-12-0041-136
,
Figure 106105690-A0202-12-0041-137
,or
Figure 106105690-A0202-12-0041-138
; R 10 is methyl or ethyl.

6.如發明1所述之UV吸收性乙烯基單體,係具有式(III)之乙烯基單體。 6. The UV-absorbing vinyl monomer according to Invention 1 is a vinyl monomer having formula (III).

7.如發明6所述之UV吸收性乙烯基單體,係選自具有下式中任一個的乙烯基單體:

Figure 106105690-A0202-12-0042-139
Figure 106105690-A0202-12-0043-141
7. The UV-absorbing vinyl monomer according to invention 6 is selected from vinyl monomers having any one of the following formulas:
Figure 106105690-A0202-12-0042-139
Figure 106105690-A0202-12-0043-141

其中:Q1係(甲基)丙烯醯胺基或(甲基)丙烯醯氧基;Y1係伸乙基或伸丙基二價基團;R1和R2彼此獨立的是CH3、CCl3、CF3、Cl、Br、NR’R”、OH、或OCH3;其中R’和R”彼此獨立的是H或C1-C4烷基;R8係CH3、C2H5

Figure 106105690-A0202-12-0043-142
Figure 106105690-A0202-12-0043-143
、或
Figure 106105690-A0202-12-0043-144
;R10係甲基或乙基。 Among them: Q 1 is a (meth)acrylamido or (meth)acryloxy; Y 1 is an ethylene or propylene divalent group; R 1 and R 2 are independently CH 3 , CCl 3 , CF 3 , Cl, Br, NR'R", OH, or OCH 3 ; wherein R'and R" are independently H or C 1 -C 4 alkyl; R 8 is CH 3 , C 2 H 5 .
Figure 106105690-A0202-12-0043-142
,
Figure 106105690-A0202-12-0043-143
,or
Figure 106105690-A0202-12-0043-144
; R 10 is methyl or ethyl.

8.如發明1所述之UV吸收性乙烯基單體,係具有式(IV)或(V)之乙烯基單體。 8. The UV-absorbing vinyl monomer according to invention 1 is a vinyl monomer having formula (IV) or (V).

9.如發明8所述之UV吸收性乙烯基單體,係選自具有下式中任一個的乙烯基單體:

Figure 106105690-A0202-12-0044-145
9. The UV-absorbing vinyl monomer according to Invention 8, which is selected from vinyl monomers having any one of the following formulas:
Figure 106105690-A0202-12-0044-145

其中R1’係H、CH3、CCl3、CF3、Cl、Br、NR’R”,其中R’和R”彼此獨立的是H或C1-C4烷基、OH、或OCH3;Q2係(甲基)丙烯醯胺基或(甲基)丙烯醯氧基;Y2係伸乙基或伸丙基二價基團。 Wherein R 1 'is H, CH 3 , CCl 3 , CF 3 , Cl, Br, NR'R", where R'and R" are independently H or C 1 -C 4 alkyl, OH, or OCH 3 ; Q 2 is a (meth)acrylamido or (meth)acryloxy; Y 2 is an ethylene or propylene divalent group.

10.如發明1所述之UV吸收性乙烯基單體,係具有式(VI)或(VII)之乙烯基單體。 10. The UV-absorbing vinyl monomer according to Invention 1, which is a vinyl monomer having formula (VI) or (VII).

11.如發明10所述之UV吸收性乙烯基單體,係選自具有下式中任一個的乙烯基單體:

Figure 106105690-A0202-12-0044-146
其中R1’係H、CH3、CCl3、CF3、Cl、Br、OH、或OCH3、NR’R”,其 中R’和R”彼此獨立的是H或C1-C4烷基,R8係CH3、C2H5
Figure 106105690-A0202-12-0045-147
Figure 106105690-A0202-12-0045-148
、或
Figure 106105690-A0202-12-0045-149
;R10係甲基或乙基;Q3係(甲基)丙烯醯胺基或(甲基)丙烯醯氧基;Y3係伸乙基或伸丙基二價基團。 11. The UV-absorbing vinyl monomer according to Invention 10 is selected from vinyl monomers having any one of the following formulas:
Figure 106105690-A0202-12-0044-146
Wherein R 1 'is H, CH 3 , CCl 3 , CF 3 , Cl, Br, OH, or OCH 3 , NR'R", wherein R'and R" are independently H or C 1 -C 4 alkyl , R 8 is CH 3 , C 2 H 5 ,
Figure 106105690-A0202-12-0045-147
,
Figure 106105690-A0202-12-0045-148
,or
Figure 106105690-A0202-12-0045-149
; R 10 is methyl or ethyl; Q 3 is (meth)acrylamido or (meth)acryloxy; Y 3 is ethylene or propylene divalent group.

12.一種水凝膠接觸鏡片,包含交聯的聚合物材料,該交聯的聚合物材料包含如發明1至11中任一項所述的UV吸收性乙烯基單體的重複單元,其中該水凝膠接觸鏡片具有:在280與315奈米之間的約10%或更小的UVB透射率(指定為UVB%T);在315與380奈米之間的約30%或更小的UVA透射率(指定為UVA%T);以及當完全水合時按重量計從約15%至約80%的水含量(在室溫,約22℃至28℃下)。 12. A hydrogel contact lens comprising a cross-linked polymer material, the cross-linked polymer material comprising the repeating unit of the UV-absorbing vinyl monomer according to any one of the inventions 1 to 11, wherein the Hydrogel contact lenses have: a UVB transmittance of about 10% or less between 280 and 315nm (designated as UVB%T); about 30% or less between 315 and 380nm UVA transmittance (designated UVA%T); and water content from about 15% to about 80% by weight when fully hydrated (at room temperature, about 22°C to 28°C).

13.如發明12所述之水凝膠接觸鏡片,其中該水凝膠接觸鏡片具有在280與315奈米之間的約5%或更小(較佳的是約2.5%或更小,更較佳的是約1%或更小)的UVB%T。 13. The hydrogel contact lens according to Invention 12, wherein the hydrogel contact lens has between 280 and 315 nanometers of about 5% or less (preferably about 2.5% or less, more Preferably, about 1% or less) UVB%T.

14.如發明12或13所述之水凝膠接觸鏡片,其中該水凝膠接觸鏡片具有在315與380奈米之間的約20%或更小(較佳的是約10%或更小,更較佳的是約5%或更小)的UVA%T。 14. The hydrogel contact lens according to Invention 12 or 13, wherein the hydrogel contact lens has between 315 and 380 nanometers of about 20% or less (preferably about 10% or less , More preferably about 5% or less) UVA%T.

15.如發明12至14中任一項所述之水凝膠接觸鏡片,其中該水凝膠接觸鏡片進一步具有在380nm與440nm之間的約60%或更小(較佳的是約50%或更小、更較佳的是約40%或更小、甚至更較佳的是約30%或更小)的紫光透射率(指定為紫光%T)。 15. The hydrogel contact lens according to any one of Inventions 12 to 14, wherein the hydrogel contact lens further has about 60% or less (preferably about 50%) between 380nm and 440nm Or less, more preferably about 40% or less, even more preferably about 30% or less) violet light transmittance (designated as violet %T).

16.如發明12至15中任一項所述之水凝膠接觸鏡片,其中該水凝膠接觸鏡片當完全水合時具有按重量計從約30%至約75%的水含量(在 室溫,約22℃至28℃下)。 16. The hydrogel contact lens according to any one of Inventions 12 to 15, wherein the hydrogel contact lens when fully hydrated has a water content of from about 30% to about 75% by weight (in Room temperature, about 22°C to 28°C).

17.如發明12至16中任一項所述之水凝膠接觸鏡片,其中該水凝膠接觸鏡片係矽酮水凝膠接觸鏡片,其中該交聯的聚合物材料包含至少一種親水性乙烯基單體的重複單元和至少一種含矽氧烷的乙烯基單體和/或大分子單體的重複單元。 17. The hydrogel contact lens according to any one of Inventions 12 to 16, wherein the hydrogel contact lens is a silicone hydrogel contact lens, wherein the cross-linked polymer material comprises at least one hydrophilic vinyl The repeating unit of the base monomer and the repeating unit of at least one siloxane-containing vinyl monomer and/or macromonomer.

18.如發明12至16中任一項所述之水凝膠接觸鏡片,其中該交聯的聚合物材料包含可光化交聯的聚乙烯醇預聚物的重複單元。 18. The hydrogel contact lens according to any one of Inventions 12 to 16, wherein the cross-linked polymer material comprises repeating units of actinically cross-linkable polyvinyl alcohol prepolymer.

19.如發明18所述之水凝膠接觸鏡片,其中該可光化交聯的 聚乙烯醇預聚物包含乙烯醇(即,

Figure 106105690-A0202-12-0046-150
)的重複單元和具有式(VIII)之重複單元
Figure 106105690-A0202-12-0046-151
19. The hydrogel contact lens according to Invention 18, wherein the actinically crosslinkable polyvinyl alcohol prepolymer comprises vinyl alcohol (ie,
Figure 106105690-A0202-12-0046-150
) And the repeating unit of formula (VIII)
Figure 106105690-A0202-12-0046-151

其中:R11係氫或C1-C6烷基;R12

Figure 106105690-A0202-12-0046-152
Figure 106105690-A0202-12-0046-153
乙烯式不飽和基團 Among them: R 11 is hydrogen or C 1 -C 6 alkyl; R 12 is
Figure 106105690-A0202-12-0046-152
or
Figure 106105690-A0202-12-0046-153
Ethylenically unsaturated group

其中q1和q2彼此獨立的是零或一,並且R16和R17彼此獨立的是C2-C8伸烷基二價基團,R18係C2-C8烯基;R13可以是氫或C1-C6烷基;並且R14係C1-C6伸烷基二價基團。 Where q1 and q2 are zero or one independently of each other, and R 16 and R 17 are independently C 2 -C 8 alkylene divalent groups, R 18 is a C 2 -C 8 alkenyl group; R 13 may be Hydrogen or C 1 -C 6 alkyl; and R 14 is a C 1 -C 6 alkylene divalent group.

20.如發明19所述之水凝膠接觸鏡片,其中在式(VIII)中R11係氫或C1-C4烷基(較佳的是氫或甲基或乙基,更較佳的是氫或甲基)。 20. The hydrogel contact lens according to Invention 19, wherein in formula (VIII), R 11 is hydrogen or C 1 -C 4 alkyl (preferably hydrogen or methyl or ethyl, more preferably Is hydrogen or methyl).

21.如發明19或20所述之水凝膠接觸鏡片,其中在式(VIII)中R13係氫。 21. The hydrogel contact lens according to Invention 19 or 20, wherein in formula (VIII), R 13 is hydrogen.

22.如發明19至21中任一項所述之水凝膠接觸鏡片,其中在式(VIII)中R14係C1-C4伸烷基二價基團(較佳的是亞甲基或伸丁基二價基團,更較佳的是亞甲基二價基團)。 22. The hydrogel contact lens according to any one of Inventions 19 to 21, wherein in formula (VIII), R 14 is a C 1 -C 4 alkylene divalent group (preferably methylene Or a butylene divalent group, more preferably a methylene divalent group).

23.一種用於生產UV吸收性接觸鏡片之方法,該方法包括以下步驟:(1)獲得包含以下各項的鏡片配製物(a)如發明1至11中任一項所述之UV吸收性乙烯基單體,(b)至少一種自由基引發劑,以及(c)至少一種選自下組的可聚合組分,該組由以下各項組成:親水性乙烯基單體、水溶性不含矽酮的預聚物、含矽酮的預聚物、非矽酮疏水性乙烯基單體、含矽氧烷的乙烯基單體、含矽氧烷的乙烯基大分子單體、乙烯基交聯劑、以及其組合;(2)將該鏡片配製物引入到用於製造軟性接觸鏡片的模具中,其中該模具具有第一半模和第二半模,該第一半模具有限定接觸鏡片的前表面的第一模製表面,該第二半模具有限定該接觸鏡片的後表面的第二模製表面,其中所述第一和第二半模被配置為接納彼此,使得在所述第一與第二模製表面之間形成型腔;並且 (3)熱固化或光化固化在該模具中的該鏡片配製物以形成該UV吸收性接觸鏡片,其中該形成的UV吸收性接觸鏡片的特徵在於具有在280與315奈米之間的約10%或更小的UVB%T和在315與380奈米之間的約30%或更小的UVA%T。 23. A method for producing UV-absorbing contact lenses, the method comprising the following steps: (1) obtaining a lens formulation comprising (a) the UV-absorbing properties according to any one of Inventions 1 to 11 Vinyl monomer, (b) at least one free radical initiator, and (c) at least one polymerizable component selected from the group consisting of: hydrophilic vinyl monomer, water-soluble and non-free Silicone prepolymers, silicone-containing prepolymers, non-silicone hydrophobic vinyl monomers, silicone-containing vinyl monomers, silicone-containing vinyl macromonomers, vinyl cross-linked Coupling agents, and combinations thereof; (2) Introducing the lens formulation into a mold for manufacturing soft contact lenses, wherein the mold has a first mold half and a second mold half, and the first mold half has a defined contact lens The front surface of the first molding surface, the second mold half has a second molding surface that defines the back surface of the contact lens, wherein the first and second mold halves are configured to receive each other so that the A cavity is formed between the first and second molding surfaces; and (3) The lens formulation in the mold is cured thermally or photochemically to form the UV-absorbing contact lens, wherein the formed UV-absorbing contact lens is characterized by having an approximate value of between 280 and 315 nanometers. 10% or less UVB%T and about 30% or less UVA%T between 315 and 380 nanometers.

24.如發明23所述之方法,其中該鏡片配製物包含按重量計從約0.1%至約4%、較佳的是按重量計從約0.2%至約3.0%、更較佳的是按重量計從約0.4%至約2%、甚至更較佳的是按重量計從約0.6%至約1.5%的如發明1至11中任一項所述的UV吸收性乙烯基單體。 24. The method of Invention 23, wherein the lens formulation comprises from about 0.1% to about 4% by weight, preferably from about 0.2% to about 3.0% by weight, more preferably From about 0.4% to about 2% by weight, even more preferably from about 0.6% to about 1.5% by weight of the UV-absorbing vinyl monomer according to any one of Inventions 1 to 11.

25.如發明23或24所述之方法,其中該鏡片配製物包含按重量計從約0.1%至約2.0%、較佳的是按重量計從約0.25%至約1.75%、更較佳的是按重量計從約0.5%至約1.5%、甚至更較佳的是按重量計從約0.75%至約1.25%的至少一種自由基引發劑。 25. The method of Invention 23 or 24, wherein the lens formulation comprises from about 0.1% to about 2.0% by weight, preferably from about 0.25% to about 1.75% by weight, more preferably It is from about 0.5% to about 1.5% by weight, even more preferably from about 0.75% to about 1.25% by weight of at least one free radical initiator.

26.如發明23至25中任一項所述之方法,其中該自由基引發劑係熱引發劑,其中用熱的方法進行該固化步驟。 26. The method according to any one of Inventions 23 to 25, wherein the free radical initiator is a thermal initiator, and the curing step is performed by a thermal method.

27.如發明23至25中任一項所述之方法,其中該自由基引發劑係光引發劑,其中該固化步驟係藉由用具有在從380nm至500nm範圍內的波長的光照射而進行的。 27. The method according to any one of Inventions 23 to 25, wherein the free radical initiator is a photoinitiator, and wherein the curing step is performed by irradiating with light having a wavelength in the range from 380nm to 500nm of.

28.如發明27所述之方法,其中該光引發劑係苯甲醯基氧化膦。 28. The method according to Invention 27, wherein the photoinitiator is benzyl phosphine oxide.

29.如發明27所述之方法,其中該光引發劑係基於鍺的諾裡什I型光引發劑。 29. The method according to Invention 27, wherein the photoinitiator is a Norish type I photoinitiator based on germanium.

30.如發明23至27中任一項所述之方法,其中該鏡片配製物 包含至少一種親水性乙烯基單體、至少一種含矽氧烷的乙烯基單體、至少一種含矽氧烷的乙烯基大分子單體。 30. The method according to any one of Inventions 23 to 27, wherein the lens formulation It contains at least one hydrophilic vinyl monomer, at least one silicone-containing vinyl monomer, and at least one silicone-containing vinyl macromonomer.

31.如發明27至30中任一項所述之方法,其中該模具係可重複使用的模具,其中該固化步驟係藉由使用光化輻射的空間限制進行的。 31. The method according to any one of Inventions 27 to 30, wherein the mold is a reusable mold, and wherein the curing step is performed by using the space limitation of actinic radiation.

32.如發明27至31中任一項所述之方法,其中該固化步驟持續約120秒或更短(較佳的是約80秒或更短、更較佳的是約50秒或更短、甚至更較佳的是約30秒或更短、最較佳的是從約5至約30秒)的時間段。 32. The method according to any one of Inventions 27 to 31, wherein the curing step lasts for about 120 seconds or less (preferably about 80 seconds or less, more preferably about 50 seconds or less , Even more preferred is a time period of about 30 seconds or less, most preferably from about 5 to about 30 seconds.

33.如發明23至32中任一項所述之方法,其中該鏡片配製物係包含至少一種可光化交聯的聚乙烯醇預聚物的水基鏡片配製物,其中該 可光化交聯的聚乙烯醇預聚物包含乙烯醇(即,

Figure 106105690-A0202-12-0049-154
)的重複單元和具有式(VIII)之重複單元
Figure 106105690-A0202-12-0049-155
33. The method of any one of Inventions 23 to 32, wherein the lens formulation is a water-based lens formulation comprising at least one actinically crosslinkable polyvinyl alcohol prepolymer, wherein the actinically crosslinkable The linked polyvinyl alcohol prepolymer contains vinyl alcohol (ie,
Figure 106105690-A0202-12-0049-154
) And the repeating unit of formula (VIII)
Figure 106105690-A0202-12-0049-155

其中:R11係氫或C1-C6烷基;R12

Figure 106105690-A0202-12-0049-156
Figure 106105690-A0202-12-0049-157
乙烯式不飽和基團 Among them: R 11 is hydrogen or C 1 -C 6 alkyl; R 12 is
Figure 106105690-A0202-12-0049-156
or
Figure 106105690-A0202-12-0049-157
Ethylenically unsaturated group

其中q1和q2彼此獨立的是零或一,並且R16和R17彼此獨立的是C2-C8伸烷基二價基團,R18係C2-C8烯基;R13可以是氫或C1-C6烷基;並且 R14係C1-C6伸烷基二價基團。 Where q1 and q2 are zero or one independently of each other, and R 16 and R 17 are independently C 2 -C 8 alkylene divalent groups, R 18 is a C 2 -C 8 alkenyl group; R 13 may be Hydrogen or C 1 -C 6 alkyl; and R 14 is a C 1 -C 6 alkylene divalent group.

34.如發明33所述之方法,其中在式(VIII)中R11係氫或C1-C4烷基(較佳的是氫或甲基或乙基,更較佳的是氫或甲基)。 34. The method according to Invention 33, wherein in formula (VIII), R 11 is hydrogen or C 1 -C 4 alkyl (preferably hydrogen or methyl or ethyl, more preferably hydrogen or methyl base).

35.如發明33或34所述之方法,其中在式(VIII)中R13係氫。 35. The method according to Invention 33 or 34, wherein in formula (VIII), R 13 is hydrogen.

36.如發明33至35中任一項所述之方法,其中在式(VIII)中R14係C1-C4伸烷基二價基團(較佳的是亞甲基或伸丁基二價基團,更較佳的是亞甲基二價基團)。 36. The method according to any one of Inventions 33 to 35, wherein in formula (VIII), R 14 is a C 1 -C 4 alkylene divalent group (preferably methylene or butylene A divalent group, more preferably a methylene divalent group).

37.如發明33至36中任一項所述之方法,其中在式(VIII)中R11係氫或甲基,R13係氫,並且R14係亞甲基二價基團。 37. The method according to any one of Inventions 33 to 36, wherein in formula (VIII), R 11 is hydrogen or methyl, R 13 is hydrogen, and R 14 is a methylene divalent group.

38.如發明23至37中任一項所述之方法,其中該形成的UV吸收性接觸鏡片具有在280與315奈米之間的約5%或更小(較佳的是約2.5%或更小,更較佳的是約1%或更小)的UVB%T。 38. The method according to any one of Inventions 23 to 37, wherein the formed UV-absorbing contact lens has between 280 and 315 nanometers of about 5% or less (preferably about 2.5% or Less, more preferably about 1% or less) UVB%T.

39.如發明23至38中任一項所述之水凝膠接觸鏡片,其中該形成的UV吸收性接觸鏡片具有在315與380奈米之間的約20%或更小(較佳的是約10%或更小,更較佳的是約5%或更小)的UVA%T。 39. The hydrogel contact lens according to any one of Inventions 23 to 38, wherein the formed UV-absorbing contact lens has about 20% or less between 315 and 380 nm (preferably About 10% or less, more preferably about 5% or less) UVA%T.

40.如發明23至39中任一項所述之水凝膠接觸鏡片,其中該水凝膠接觸鏡片進一步具有在380nm與440nm之間的約60%或更小(較佳的是約50%或更小、更較佳的是約40%或更小、甚至更較佳的是約30%或更小)的紫光%T。 40. The hydrogel contact lens according to any one of Inventions 23 to 39, wherein the hydrogel contact lens further has about 60% or less (preferably about 50%) between 380nm and 440nm Or less, more preferably about 40% or less, even more preferably about 30% or less) purple light %T.

上述揭露內容將使熟習該項技術者能夠實踐本發明。可以對在此描述的各個實施方式作出各種修改、變化和組合。為了使讀者能夠更好地理解其具體實施方式及優點,建議參考以下實例。所旨在的是本說明 書和實例被認為係示例性的。 The above disclosure will enable those familiar with the technology to practice the present invention. Various modifications, changes, and combinations can be made to the various embodiments described herein. In order to enable readers to better understand its specific implementation and advantages, it is recommended to refer to the following examples. The purpose is this description The books and examples are considered exemplary.

圖1示出了呈受保護的形式(曲線1)和未保護的形式(曲線2)的本發明的較佳的水溶性UV吸收性乙烯基單體的UV可見吸收光譜。 Figure 1 shows the UV visible absorption spectra of the preferred water-soluble UV-absorbing vinyl monomers of the present invention in a protected form (curve 1) and an unprotected form (curve 2).

圖2示出了以下接觸鏡片的UV可見透射率光譜:0wt%-從具有0wt%的任何UV吸收性乙烯基單體的鏡片配製物製備的對照接觸鏡片;和0.7wt%-根據較佳的實施方式從包含約0.7wt%的本發明的UV吸收性乙烯基單體的鏡片配製物製備的接觸鏡片。 Figure 2 shows the UV visible transmittance spectrum of the following contact lenses: 0wt%-a control contact lens prepared from a lens formulation with 0wt% of any UV-absorbing vinyl monomer; and 0.7wt%-according to the preferred Embodiments Contact lenses are prepared from lens formulations containing about 0.7 wt% of the UV-absorbing vinyl monomers of the present invention.

圖3示出了以下接觸鏡片的UV可見透射率光譜:0wt%-從具有0wt%的任何UV吸收性乙烯基單體的鏡片配製物製備的對照接觸鏡片;和1.5wt%-根據較佳的實施方式從包含約1.5wt%的本發明的UV吸收性乙烯基單體的鏡片配製物製備的接觸鏡片。 Figure 3 shows the UV visible transmittance spectrum of the following contact lenses: 0wt%-a control contact lens prepared from a lens formulation with 0wt% of any UV-absorbing vinyl monomer; and 1.5wt%-according to the preferred Embodiments Contact lenses are prepared from lens formulations containing about 1.5 wt% of the UV-absorbing vinyl monomers of the present invention.

圖4示出了呈受保護的形式(曲線1)和未保護的形式(曲線2)的本發明的較佳的水溶性UV吸收性乙烯基單體的UV可見吸收光譜。 Figure 4 shows the UV visible absorption spectra of the preferred water-soluble UV-absorbing vinyl monomers of the present invention in protected form (curve 1) and unprotected form (curve 2).

圖5示出了以下接觸鏡片的UV可見透射率光譜:0wt%-從具有0wt%的任何UV吸收性乙烯基單體的鏡片配製物製備的對照接觸鏡片;和0.9wt%-根據較佳的實施方式從包含約0.9wt%的本發明的UV吸收性乙烯基單體的鏡片配製物製備的接觸鏡片。 Figure 5 shows the UV visible transmittance spectrum of the following contact lenses: 0wt%-a control contact lens prepared from a lens formulation with 0wt% of any UV-absorbing vinyl monomer; and 0.9wt%-according to the preferred Embodiments Contact lenses are prepared from lens formulations containing about 0.9 wt% of the UV-absorbing vinyl monomers of the present invention.

圖6示出了以下接觸鏡片的UV可見透射率光譜:0wt%-從 具有0wt%的任何UV吸收性乙烯基單體的鏡片配製物製備的對照接觸鏡片;和1.4wt%-根據較佳的實施方式從包含約1.4wt%的本發明的UV吸收性乙烯基單體的鏡片配製物製備的接觸鏡片。 Figure 6 shows the UV visible transmittance spectrum of the following contact lenses: 0wt%-from A control contact lens prepared from a lens formulation having 0 wt% of any UV-absorbing vinyl monomer; and 1.4 wt%-according to a preferred embodiment from containing about 1.4 wt% of the UV-absorbing vinyl monomer of the present invention Contact lenses prepared with lens formulations.

實例1Example 1

透射率.將接觸鏡片手動地放置在特別製造的樣品固持器或類似物中,該樣品固持器或類似物可以保持鏡片的形狀,就像放置在眼睛上時一樣。然後將該固持器浸沒到含有磷酸鹽緩衝鹽水(PBS,pH約7.0-7.4)的1cm路徑長度的石英池中作為參考。UV/可見光分光光度計,例如,具有LabSphere DRA-CA-302分束器或類似物的Varian Cary 3E UV-可見光分光光度計,可以在該測量中使用。在250-800nm的波長範圍處收集百分比透射光譜,其中以0.5nm間隔收集%T值。將該數據轉換到Excel電子數據表上並用於確定鏡片係否符合1級UV吸光度。透射率使用以下等式計算:

Figure 106105690-A0202-12-0051-158
Transmittance. The contact lens is manually placed in a specially manufactured sample holder or the like that can maintain the shape of the lens, just as when placed on the eye. Then the holder was immersed in a quartz cell with a path length of 1 cm containing phosphate buffered saline (PBS, pH about 7.0-7.4) as a reference. A UV/visible spectrophotometer, for example, a Varian Cary 3E UV-visible spectrophotometer with a LabSphere DRA-CA-302 beam splitter or the like, can be used in this measurement. The percentage transmission spectra are collected at the wavelength range of 250-800nm, where the %T value is collected at 0.5nm intervals. This data is converted to an Excel spreadsheet and used to determine whether the lens meets the level 1 UV absorbance. The transmittance is calculated using the following equation:
Figure 106105690-A0202-12-0051-158

Figure 106105690-A0202-12-0051-159
Figure 106105690-A0202-12-0051-159

Figure 106105690-A0202-12-0051-160
Figure 106105690-A0202-12-0051-160

其中發光率%T係在380與780之間的平均%透射率。 The luminosity %T is the average% transmittance between 380 and 780.

光流變:光流變實驗測量在固化期間隨時間變化的彈性(G’)和黏性模量(G”)。該實驗係藉由使用適當的光源(視情況截止濾波器以選擇感興趣的波長)和流變儀進行的。該光源係適當波長(即385、405、435、445或460nm)的LED,或者Hamamatsu光源中的汞燈泡。光源的強度藉由調節光源輸出或擋板開口來設置以獲得由輻射計測量的適當強度。將樣品放置在允許UV光藉由的石英板與流變儀之間。當彈性模量(G’)達到穩定 態(plateau)時確定固化時間。 Optical rheology : The optical rheology experiment measures the elasticity (G') and viscous modulus (G") that change with time during curing. This experiment uses an appropriate light source (optionally cut-off filters to select interesting The wavelength of the light source) and the rheometer. The light source is an LED of the appropriate wavelength (ie 385, 405, 435, 445 or 460nm), or a mercury bulb in the Hamamatsu light source. The intensity of the light source can be adjusted by adjusting the light source output or the baffle opening Set to obtain the appropriate intensity measured by the radiometer. Place the sample between the quartz plate that allows UV light to pass through and the rheometer. Determine the curing time when the elastic modulus (G') reaches a plateau.

實例2Example 2

這個實例示出了如何根據在以下方案中示出的程序製備本發明的較佳的UV吸收性乙烯基單體。 This example shows how to prepare the preferred UV-absorbing vinyl monomer of the present invention according to the procedure shown in the following scheme.

Figure 106105690-A0202-12-0052-161
Figure 106105690-A0202-12-0052-161

步驟1-2-乙醯氧基-4-甲氧基-4’-甲基-二苯甲酮的合成 Step 1-2-Acetyloxy-4-methoxy-4'-methyl-benzophenone synthesis

在配備有攪拌棒並用乾燥氮氣(dN2)吹掃的圓底(rb)燒瓶中,取80g無水四氫呋喃(THF,來自奧德里奇公司(Aldrich))、10g(41.29mmol/1.0當量)的2-羥基-4-甲氧基-4’-甲基二苯甲酮(HO-MeO-Me-Bzp)(來自阿法埃莎公司(Alfa Aesar))(化合物I)和0.25g的N,N-二甲基胺基吡啶(DMAP)(相對於[wrt]來自阿法埃莎公司的化合物I為5mol%)。使用約5mL乾燥的THF沖洗DMAP小瓶並且然後將其加入反應燒瓶中。將混合物在室溫(RT)下攪拌以在15分鐘內溶解。然後,藉由注射器加入26g(6當量)三乙胺(TEA,來自奧德里奇公司)。將溶液在室溫下攪拌15分鐘。然後,將13.17g(3.1當量)乙酸酐(Ac2O)在5分鐘內緩慢加入到反應混合物中。將15mL無水THF加入到燒瓶中。將該反應溶液在氮氣(N2)下在室溫下攪拌過夜並且然後減壓濃縮以除去約80%的揮發物。加入THF以製備具有相對 於起始二苯甲酮約30wt%的濃度的總溶液質量。將溶液在室溫下攪拌5分鐘。將產物藉由在攪拌下緩慢加入150g 1:1的冰:水混合物(5倍的按重量計(wt)的反應溶液)來沈澱。將燒瓶放置在冰水浴中並攪拌3小時。3小時後,溶液相的pH測量為3.86(pH計),並將混合物藉由Whatman#4(25μm)濾紙在940毫巴的真空下過濾。將沈澱物用約1500g冰冷的水洗滌直到洗滌液係澄清無色的,並且濾液的電導率係<10μS/cm並且pH為中性的。將沈澱物收集並懸浮在100mL冷DI水中並渦旋15分鐘。然後將所得產物在IPA-乾冰中冷凍並且然後凍乾。得到白色粉末,將其稱重(淨重:11.45g;理論產量:11.77g;產率:97.36%)並藉由1H-NMR在THF-d8中證實為2-乙醯氧基-4-甲氧基-4’-甲基二苯甲酮(AcO-MeO-Me-Bzp)(化合物II)。 In a round bottom (rb) flask equipped with a stir bar and purged with dry nitrogen (dN 2 ), take 80 g of anhydrous tetrahydrofuran (THF, from Aldrich), 10 g (41.29 mmol/1.0 equivalent) of 2 -Hydroxy-4-methoxy-4'-methylbenzophenone (HO-MeO-Me-Bzp) (from Alfa Aesar) (Compound I) and 0.25g of N, N -Dimethylaminopyridine (DMAP) (5 mol% relative to [wrt] compound I from Alfa Aesar). Rinse the DMAP vial with about 5 mL of dry THF and then add it to the reaction flask. The mixture was stirred at room temperature (RT) to dissolve within 15 minutes. Then, 26 g (6 equivalents) of triethylamine (TEA, from Aldrich) was added via a syringe. The solution was stirred at room temperature for 15 minutes. Then, 13.17 g (3.1 equivalent) of acetic anhydride (Ac2O) was slowly added to the reaction mixture within 5 minutes. 15 mL of anhydrous THF was added to the flask. The reaction solution was stirred overnight at room temperature under nitrogen (N 2 ) and then concentrated under reduced pressure to remove about 80% of volatiles. THF was added to prepare a total solution mass having a concentration of about 30 wt% relative to the starting benzophenone. The solution was stirred at room temperature for 5 minutes. The product was precipitated by slowly adding 150 g of a 1:1 ice:water mixture (5 times the reaction solution by weight (wt)) under stirring. The flask was placed in an ice water bath and stirred for 3 hours. After 3 hours, the pH of the solution phase was measured to be 3.86 (pH meter), and the mixture was filtered through Whatman #4 (25 μm) filter paper under a vacuum of 940 mbar. The precipitate was washed with about 1500 g of ice-cold water until the washing liquid was clear and colorless, and the conductivity of the filtrate was <10 μS/cm and the pH was neutral. The precipitate was collected and suspended in 100 mL cold DI water and vortexed for 15 minutes. The resulting product was then frozen in IPA-dry ice and then lyophilized. A white powder was obtained, which was weighed (net weight: 11.45g; theoretical yield: 11.77g; yield: 97.36%) and confirmed by 1H-NMR in THF-d8 to be 2-acetoxy-4-methoxy -4'-methylbenzophenone (AcO-MeO-Me-Bzp) (Compound II).

步驟2-2-乙醯氧基-4-甲氧基-4’-溴甲基-二苯甲酮的合成 Step 2 Synthesis of 2-acetoxy-4-methoxy-4’-bromomethyl-benzophenone

乙腈、N-溴代琥珀醯亞胺(NBS)和AIBN購自西格瑪奧德里奇(Sigma Aldrich)並使用如從前一步驟獲得的乙酸酯保護的二苯甲酮衍生物(II)。在配備有冷凝器、N2吹掃裝置、熱電偶、油-起泡器空氣阱和攪拌棒的500mL三頸燒瓶中加入在步驟1中獲得的8.85g(0.031mol/1.0當量)的AcO-MeO-Me-Bzp(II)並在N2下攪拌30分鐘。將冷凝器設定為9℃並向反應燒瓶中加入220mL無水乙腈。將混合物在室溫下攪拌。一旦冷凝器已經達到約9℃,用乾燥N2輕輕吹掃反應燒瓶30分鐘並將冷凝器設定為4℃。在冷凝器已經達到4℃或30分鐘的N2吹掃(以較晚者為准)後,將反應混合物在400rpm的攪拌下和溫和的正N2流下迅速升高至回流。反應溶液在約80-82℃下回流。然後稱量出6.11g(1.1當量)的N-溴代琥珀醯亞胺(NBS)(來自西格瑪奧德里奇)和0.52g(0.1當量)的偶氮-二-異丁腈(來自西格瑪奧德里奇)並在正N2流下加入到反應燒瓶中。反應繼續,在回流下持續2小時, 伴隨溫和的正氮氣流。在兩小時後,反應藉由在非常溫和的乾燥N2流下冷卻至室溫來停止。將冷卻的反應溶液通過棉塞過濾。然後將溶液在減壓下濃縮至約50wt%。產物藉由加入約200g的1:1冰-水混合物(約3倍的反應溶液重量)從反應溶液中沈澱。 Acetonitrile, N-bromosuccinimide (NBS) and AIBN were purchased from Sigma Aldrich and used the acetate protected benzophenone derivative (II) as obtained from the previous step. In a 500mL three-necked flask equipped with a condenser, N 2 purging device, thermocouple, oil-bubble air trap and a stir bar, was added 8.85g (0.031mol/1.0 equivalent) of AcO- obtained in step 1. MeO-Me-Bzp (II) and stirred under N 2 30 minutes. Set the condenser to 9°C and add 220 mL of anhydrous acetonitrile to the reaction flask. The mixture was stirred at room temperature. Once the condenser had reached about 9°C, the reaction flask was gently purged with dry N 2 for 30 minutes and the condenser was set to 4°C. After the condenser has reached 4°C or 30 minutes of N 2 purge (whichever is later), the reaction mixture is rapidly raised to reflux under 400 rpm stirring and a gentle positive N 2 flow. The reaction solution is refluxed at about 80-82°C. Then weigh out 6.11g (1.1 equivalent) of N-bromosuccinimide (NBS) (from Sigma-Aldrich) and 0.52g (0.1 equivalent) of azo-bis-isobutyronitrile (from Sigma-Aldrich) Odd) and added to the reaction flask under positive N 2 flow. The reaction continued for 2 hours under reflux with a gentle flow of positive nitrogen. After two hours, the reaction was stopped by cooling to room temperature under a very gentle stream of dry N 2. The cooled reaction solution was filtered through a cotton plug. The solution was then concentrated to about 50% by weight under reduced pressure. The product was precipitated from the reaction solution by adding about 200 g of a 1:1 ice-water mixture (about 3 times the weight of the reaction solution).

將混合物在冰浴中攪拌3小時。三小時後,沈澱物通過Whatman #4(25um)濾紙在950毫巴壓力下過濾。將沈澱物用200mL冷DI水(約5倍的用於pptn的冰水體積)洗滌5次直到濾液的電導率小於10μS/cm和中性pH。將固體樣品與100mL冷DI水混合並且然後將混合物在乾冰/IPA浴中冷凍並且然後凍乾。得到粉末狀灰白色固體(淨重:10.986g;理論產量:11.307g;%產率:97.17%)並藉由NMR確認為產物III,2-乙醯氧基-4-甲氧基-4’-溴甲基-二苯甲酮(AcO-MeO-BrCH2-Bzp)。產物III的%純度由NMR估算為85mol%,其中約7%可能是未反應的起始材料和約8%的其他未識別的雜質。 The mixture was stirred in an ice bath for 3 hours. After three hours, the precipitate was filtered through Whatman #4 (25um) filter paper at a pressure of 950 mbar. The precipitate was washed 5 times with 200 mL of cold DI water (about 5 times the volume of ice water for pptn) until the conductivity of the filtrate was less than 10 μS/cm and neutral pH. The solid sample was mixed with 100 mL of cold DI water and then the mixture was frozen in a dry ice/IPA bath and then lyophilized. A powdery off-white solid (net weight: 10.986 g; theoretical yield: 11.307 g;% yield: 97.17%) was obtained and confirmed by NMR as the product III, 2-acetoxy-4-methoxy-4'-bromo Methyl-benzophenone (AcO-MeO-BrCH 2 -Bzp). The% purity of product III was estimated by NMR to be 85 mol%, of which about 7% may be unreacted starting material and about 8% of other unidentified impurities.

步驟3-2-乙醯氧基-4-甲氧基-4’-(丙烯醯胺基-N,N-二甲基丙基胺基甲基)-二苯甲酮的合成 Step 3 Synthesis of 2-acetoxy-4-methoxy-4'-(acrylamido-N,N-dimethylpropylaminomethyl)-benzophenone

在具有攪拌棒的稱重的20mL琥珀玻璃小瓶中,取1.5g(0.004mol/l當量)的來自步驟2的產物(III),AcO-MeO-BrCH2-Bzp。向其中加入8mL乙酸乙酯,在室溫(RT)下攪拌10分鐘。在室溫下在攪拌下向所得溶液中加入1.94g(0.0123mol/3當量)的N,N-二甲基胺基丙基丙烯醯胺(NN-DMAPrAAm)。緩慢形成沈澱物並將該反應在室溫下攪拌過夜。向反應混合物中加入1mL己烷並將反應混合物在室溫下攪拌1小時。棄去澄清的上清液。將殘餘物溶於0.50mL乙腈中並攪拌30分鐘以溶解。使用過量的1:1乙酸乙酯:己烷混合物沈澱溶液中的產物。該過程重複4次。向所得的固 體殘餘物中加入5mL DI水並使混合物溶解。基於估算的最終產物重量,加入MEHQ以使濃度為約150mg/Kg(ppm)。在減壓下除去來自混濁溶液的殘餘有機物以得到具有中性pH的澄清溶液。將溶液冷凍並凍乾過夜。淨重:1.4829g;理論產量:2.05g;%產率:72.19%。該塊狀樣品係易潮解的並用乾燥空氣吹掃並儲存在琥珀燒瓶中的乾燥器中。獲得產物IV並由NMR估算具有>90%的純度。 In a weighed 20 mL amber glass vial with a stir bar, take 1.5 g (0.004 mol/l equivalent) of the product (III) from step 2, AcO-MeO-BrCH 2 -Bzp. 8 mL of ethyl acetate was added thereto, and the mixture was stirred at room temperature (RT) for 10 minutes. 1.94 g (0.0123 mol/3 equivalents) of N,N-dimethylaminopropyl acrylamide (NN-DMAPrAAm) was added to the resulting solution under stirring at room temperature. A precipitate formed slowly and the reaction was stirred at room temperature overnight. 1 mL of hexane was added to the reaction mixture and the reaction mixture was stirred at room temperature for 1 hour. Discard the clear supernatant. The residue was dissolved in 0.50 mL of acetonitrile and stirred for 30 minutes to dissolve. An excess of 1:1 ethyl acetate:hexane mixture was used to precipitate the product in solution. This process is repeated 4 times. To the resulting solid residue was added 5 mL of DI water and the mixture was dissolved. Based on the estimated final product weight, MEHQ was added so that the concentration was about 150 mg/Kg (ppm). The residual organics from the turbid solution were removed under reduced pressure to obtain a clear solution with a neutral pH. The solution was frozen and lyophilized overnight. Net weight: 1.4829g; theoretical yield: 2.05g;% yield: 72.19%. The bulk sample is deliquescent and purged with dry air and stored in a desiccator in an amber flask. The product IV was obtained and estimated by NMR to have a purity of >90%.

步驟4-2-羥基-4-甲氧基-4’-(丙烯醯胺基-N,N-二甲基丙基胺基甲基)-二苯甲酮的合成 Step 4 Synthesis of 2-hydroxy-4-methoxy-4'-(acrylamido-N,N-dimethylpropylaminomethyl)-benzophenone

製備5.0mL在1000mg/L下的在DI水中的乙酸酯保護的UV阻隔劑(IV)溶液。將該溶液用pH 7緩衝液(在DI水:正丙醇中12.5mM磷酸鹽)稀釋至20mg/L。收集該溶液的UV-Vis光譜(圖1,曲線1)。 Prepare 5.0 mL of acetate-protected UV blocker (IV) solution in DI water at 1000 mg/L. The solution was diluted to 20 mg/L with pH 7 buffer (12.5 mM phosphate in DI water: n-propanol). The UV-Vis spectrum of the solution was collected (Figure 1, curve 1).

將固體碳酸鉀(K2CO3)加入到該1000mg/L溶液中以具有1w/v%的K2CO3濃度。將該溶液混合以溶解K2CO3並使該溶液在室溫下靜置過夜以獲得所希望的產物(UV吸收性乙烯基單體,即方案中的化合物V)。將所得溶液用pH 7緩衝液(在DI水:正丙醇中12.5mM磷酸鹽)稀釋至對於UV吸收性乙烯基單體具有20mg/L的濃度。收集該UV吸收性乙烯基單體的這種溶液的UV-Vis光譜並示於圖1(曲線2)中。 Solid potassium carbonate (K 2 CO 3 ) was added to the 1000 mg/L solution to have a K 2 CO 3 concentration of 1 w/v%. The solution was mixed to dissolve K 2 CO 3 and allowed to stand overnight at room temperature to obtain the desired product (UV-absorbing vinyl monomer, that is, compound V in the scheme). The resulting solution was diluted with a pH 7 buffer (12.5 mM phosphate in DI water: n-propanol) to have a concentration of 20 mg/L for the UV-absorbing vinyl monomer. The UV-Vis spectrum of this solution of the UV-absorbing vinyl monomer was collected and shown in Figure 1 (curve 2).

實例3Example 3

將在實例2中製備的UV吸收性乙烯基單體直接加入水性鏡片配製物中,該水性鏡片配製物在WO2002071106的實例8-8d(藉由引用以其全文結合在此)中描述,處於0、0.7和1.5wt%的濃度並且各自具有1.0wt%的2,4,6-三甲基苯甲醯基-二苯基氧化膦的鋰鹽(Li-TPO)(來自TCI-美國,

Figure 106105690-A0202-12-0056-162
)作為光引發劑。那三種配製物藉由光流變學研究(在30mW/cm2下的405nm LED光源)被測定為分別具有約21秒、約23秒、或約21秒的固化時間。 The UV-absorbing vinyl monomer prepared in Example 2 was directly added to the aqueous lens formulation described in Example 8-8d of WO2002071106 (incorporated in its entirety by reference), at 0 , 0.7 and 1.5wt% and each having 1.0wt% of 2,4,6-trimethylbenzyl-diphenylphosphine oxide lithium salt (Li-TPO) (from TCI-USA,
Figure 106105690-A0202-12-0056-162
) As a photoinitiator. Those three formulations were determined to have a curing time of about 21 seconds, about 23 seconds, or about 21 seconds by optical rheology studies ( 405 nm LED light source at 30 mW/cm 2 ).

根據在WO2002071106的實例8中描述的自動鏡片製造方法從那些水性配製物製造鏡片,除了模具中的鏡片配製物用405nm LED以30mW/cm2的強度照射約25秒外。將所得鏡片包裝在含有鹽水61的泡罩包裝中、密封並在121℃下高壓滅菌45分鐘。測定高壓滅菌的鏡片的%T(百分比透射率)。當UV吸收性乙烯基單體的濃度係0(即,對照鏡片)時,對照鏡片具有約96.30%的%T-UVA和約84.61%的%T-UVB。當UV吸收性乙烯基單體的濃度係按重量計0.70%時,所得鏡片具有約23.6%的%T-UVA和約3.79%的%T-UVB。當UV吸收性乙烯基單體的濃度係按重量計1.50%時,所得鏡片具有約8.80%的%T-UVA和約0.13%的%T-UVB。 Those from the aqueous formulations of manufacturing a lens, in addition to a lens mold with a formulation at an intensity of 405nm LED is irradiated 30mW / cm 2 for about 25 seconds in an automatic lens manufacturing method of an outer described in WO2002071106 in Example 8. The resulting lens was packaged in a blister pack containing saline 61, sealed, and autoclaved at 121°C for 45 minutes. Determine the %T (percent transmittance) of the autoclaved lens. When the concentration of the UV-absorbing vinyl monomer is 0 (ie, the control lens), the control lens has a %T-UVA of about 96.30% and a %T-UVB of about 84.61%. When the concentration of the UV-absorbing vinyl monomer is 0.70% by weight, the resulting lens has a %T-UVA of about 23.6% and a %T-UVB of about 3.79%. When the concentration of the UV-absorbing vinyl monomer is 1.50% by weight, the resulting lens has a %T-UVA of about 8.80% and a %T-UVB of about 0.13%.

圖2和3示出了在高壓滅菌之後具有0.7wt%和1.5wt%的UV吸收性乙烯基單體的鏡片連同在高壓滅菌後的對照鏡片(0wt%的UV吸收性乙烯基單體)的%T。 Figures 2 and 3 show the lens with 0.7wt% and 1.5wt% UV-absorbing vinyl monomer after autoclaving and the control lens (0wt% UV-absorbing vinyl monomer) after autoclaving %T.

實例4Example 4

這個實例示出了如何根據以下方案製備本發明的較佳的UV吸收性乙烯基單體。 This example shows how to prepare the preferred UV-absorbing vinyl monomer of the present invention according to the following scheme.

Figure 106105690-A0202-12-0057-163
Figure 106105690-A0202-12-0057-163

步驟1-2-(2-乙醯氧基-5-甲基苯基)苯并三唑(AcO-Me-Bzt)的合成Step 1-2-(2-Acetoxy-5-methylphenyl)benzotriazole (AcO-Me-Bzt) synthesis

在配備有磁力攪拌棒並用N2吹掃的稱重的2L圓底燒瓶中加入340g無水THF。將燒瓶在攪拌的同時用N2吹掃一分鐘並且然後加蓋。將40g(177.4mmol,1.0當量)2-(2-羥基-5-甲基苯基)苯并三唑(Me-Bzt-OH,來自TCI-美國)稱量並加入燒瓶中。將反應燒瓶用N2快速吹掃並且然後加蓋並攪拌以使固體溶解。向該溶液中加入1.09g(8.87mmol)的4-二甲基胺基吡啶(4-DMAP)(相對於苯并三唑為5mol%)。將燒瓶用N2快速吹掃、加蓋並使反應混合物攪拌以使固體溶解。將108.96g(6當量)的三乙胺(Et3N)稱量出並在攪拌下緩慢加入到反應燒瓶中。將54.58g(3當量)的Ac2O稱量出並然後緩慢加入到反應溶液中。將20g的THF加入到反應中。將燒瓶用N2吹掃、蓋緊並將反應溶液在N2下攪拌過夜。 Into a weighed 2L round bottom flask equipped with a magnetic stir bar and purged with N 2 was added 340 g of anhydrous THF. The flask was purged with N 2 while stirring for one minute and then capped. 40 g (177.4 mmol, 1.0 equivalent) of 2-(2-hydroxy-5-methylphenyl)benzotriazole (Me-Bzt-OH, from TCI-USA) was weighed and added to the flask. The reaction flask was quickly purged with N 2 and then capped and stirred to dissolve the solids. To this solution, 1.09 g (8.87 mmol) of 4-dimethylaminopyridine (4-DMAP) (5 mol% with respect to benzotriazole) was added. The flask was purged with N 2 quickly, the reaction mixture was capped and stirred to dissolve the solids. 108.96 g (6 equivalents) of triethylamine (Et 3 N) were weighed out and slowly added to the reaction flask under stirring. 54.58 g (3 equivalents) of Ac 2 O was weighed out and then slowly added to the reaction solution. 20 g of THF was added to the reaction. The flask was purged with N 2, and the reaction solution was capped under N 2 with stirring overnight.

將反應溶液在減壓下濃縮,以除去約65-70%的揮發物或直到觀察到沈澱,以較早者為准。如果看到沈澱,則加入正好足夠的THF以正好溶解沈澱物。將溶液在室溫下攪拌30分鐘。在攪拌下藉由加入250g冰和250g DI水的混合物沈澱產物。所得混合物具有4.75的pH。將燒瓶放置在冰浴中並攪拌3小時。將混合物通過Whatman #4(25um)濾紙在950毫巴的真空下 過濾。將沈澱物用1Kg冰水洗滌五次直到洗滌液係澄清無色的並且濾液的電導率係<10uS/cm。將沈澱物收集並與500mL冷DI水混合。將混合物冷凍並且然後凍乾以得到白色粉末(47.22g),其結構藉由NMR證實為AcO-Me-Bzt。淨重:47.22g;理論產量:47.29g;產率:99.85%;純度:>90%。 The reaction solution is concentrated under reduced pressure to remove about 65-70% of volatiles or until precipitation is observed, whichever is earlier. If precipitation is seen, add just enough THF to just dissolve the precipitate. The solution was stirred at room temperature for 30 minutes. The product was precipitated by adding a mixture of 250 g ice and 250 g DI water under stirring. The resulting mixture has a pH of 4.75. The flask was placed in an ice bath and stirred for 3 hours. Pass the mixture through Whatman #4 (25um) filter paper under a vacuum of 950 mbar filter. Wash the precipitate with 1Kg ice water five times until the washing liquid is clear and colorless and the conductivity of the filtrate is <10uS/cm. The precipitate was collected and mixed with 500 mL of cold DI water. The mixture was frozen and then lyophilized to obtain a white powder (47.22 g), the structure of which was confirmed to be AcO-Me-Bzt by NMR. Net weight: 47.22g; Theoretical yield: 47.29g; Yield: 99.85%; Purity: >90%.

步驟2-2-(2-乙醯氧基-5-溴甲基苯基)苯并三唑(AcO-BrCHStep 2-2-(2-Acetoxy-5-bromomethylphenyl)benzotriazole (AcO-BrCH 22 -Bzt)的合成-Bzt) synthesis

在配備有冷凝器、N2吹掃裝置、熱電偶和油-起泡器空氣阱的1L三頸燒瓶中加入20g(0.074mmol/1.0當量)的來自步驟2的AcO-Me-Bzt(II)。將這種固體在N2下攪拌至少45分鐘。向其中加入480mL的無水乙腈並將混合物在室溫下在N2下攪拌以產生溶液。將冷凝器設定為9℃並且將該反應溶液用乾燥的N2輕輕鼓泡30分鐘。在冷凝器已經達到4℃或30分鐘的N2吹掃(以較晚者為准)後,將反應混合物迅速升高至回流,在輕微正N2流下在400rpm下攪拌。反應溶液在約81-82℃下回流。將14.71g(1.1當量)的NBS和1.25g(0.1當量)的AIBN在正N2流下加入到反應燒瓶中並使反應在輕微正N2流下在回流下繼續。在2h 15m後,反應藉由使在N2下冷卻至室溫來停止。將反應溶液通過棉塞過濾到1L圓底燒瓶中。然後將溶液在減壓下濃縮以產生固體物質。向樣品中加入75mL的在THF中的6.67% ACN以溶解固體。製備約250g的按重量計1:1冰水(約2.5倍的總溶液體積)。將產物藉由在攪拌下緩慢加入冰-水混合物沈澱。然後將燒瓶放置在冰浴中並攪拌3小時。將沈澱物通過Whatman #4(25um)濾紙在輕度真空下過濾。將沈澱物用500mL冷DI水洗滌5次。(約10倍的用於沈澱的冰水體積)直到濾液的電導率小於10μS/cm和中性pH。將獲得的固體樣品轉移至1L圓底燒瓶中並 混合100mL冷DI水。然後將混合物冷凍並且然後凍乾以得到固體產物(淨重:26.08g;理論產量:25.83g;%產率:>100%;純度:75%,其中10%可能是未反應的起始材料和15%未識別的材料)。 Add 20g (0.074mmol/1.0 equivalent) of AcO-Me-Bzt(II) from step 2 to a 1L three-necked flask equipped with condenser, N 2 purge device, thermocouple and oil-bubble air trap . This solid was stirred under N 2 for at least 45 minutes. 480 mL of anhydrous acetonitrile was added thereto and the mixture was stirred at room temperature under N 2 to produce a solution. The condenser was set to 9°C and the reaction solution was gently bubbled with dry N 2 for 30 minutes. After the condenser has reached 4°C or 30 minutes of N 2 purge (whichever is later), the reaction mixture is quickly raised to reflux and stirred at 400 rpm under a slight positive N 2 flow. The reaction solution is refluxed at about 81-82°C. To 14.71g (1.1 equiv.) Of NBS and 1.25g (0.1 eq) of AIBN was added under a stream of N 2 in the positive to the reaction flask and the reaction was slightly positive N 2 flow was continued at reflux. After 2h 15m, the lower the reaction by N 2 was cooled to room temperature at stop. The reaction solution was filtered through a cotton plug into a 1L round bottom flask. The solution was then concentrated under reduced pressure to produce a solid material. 75 mL of 6.67% ACN in THF was added to the sample to dissolve the solids. Prepare about 250 g of 1:1 ice water by weight (about 2.5 times the total solution volume). The product was precipitated by slowly adding the ice-water mixture with stirring. The flask was then placed in an ice bath and stirred for 3 hours. The precipitate was filtered through Whatman #4 (25um) filter paper under mild vacuum. The precipitate was washed 5 times with 500 mL of cold DI water. (About 10 times the volume of ice water used for precipitation) until the conductivity of the filtrate is less than 10 μS/cm and neutral pH. The obtained solid sample was transferred to a 1 L round bottom flask and mixed with 100 mL of cold DI water. The mixture was then frozen and then lyophilized to obtain a solid product (net weight: 26.08g; theoretical yield: 25.83g;% yield: >100%; purity: 75%, of which 10% may be unreacted starting material and 15 % Unidentified material).

步驟3-化合物IV的合成Step 3-Synthesis of compound IV

在具有攪拌棒的稱重的琥珀1L燒瓶中,取22g(0.058mol/l當量)的產物(III)(AcO-BrCH2-Bzt),假定基於NMR為92%純度。向其中加入350mL乙酸乙酯(EtAc)以溶解。將溶液在室溫下攪拌一小時。在此期間,在50mL滴液漏斗中測量出27.592g/0.176mol/3當量的NN-DMAPrAAm。在室溫下在攪拌下在15分鐘內將NN-DMAPrAAm緩慢加入反應溶液中。沈澱物緩慢地開始形成並將反應在室溫下攪拌過夜,覆蓋在箔中。停止攪拌並使沈澱物沈降。從反應溶液中傾析上清液以得到70.4g的固體。向其中加入70mL乙腈並將混合物在室溫下在箔覆蓋的燒瓶中渦旋一小時以溶解。將所得溶液在減壓下濃縮以除去80%的揮發物。在攪拌下向溶液中緩慢加入120mL的16.7%的EtAc中的己烷,以得到兩相混合物。傾析澄清的上清液以得到約30g的黏性半固體。向該黏性殘餘物中加入60mL乙腈並渦旋15分鐘以溶解殘餘物,並且然後在減壓下濃縮以除去90%-95%的揮發物。得到澄清的黏性液體。使用滴液漏斗在攪拌下向其中加入120mL的16.67%己烷在乙酸乙酯中的溶液。觀察到兩相,下部黏性糊狀固體和上部渾濁上清液相。將混合物在室溫下輕輕攪拌15分鐘並且然後使其靜置45分鐘。傾析澄清無色的上清液以產生約32g的黏性半固體。將該過程再重複兩次以產生黏性半固體殘餘物。在減壓下除去粗殘餘物中的揮發物以得到約25g的固體物質。將MEHQ,3.7mg,溶於乙腈中並加入到殘餘物中(基於估算的產物重量約150mg/Kg(ppm)MEHQ)中。將約50mL乙腈加入到 殘餘物中並將混合物渦旋以在15分鐘內溶解。將溶液在琥珀燒瓶中在減壓下濃縮以盡可能多地除去揮發物,以得到21.21g的固體物質。向殘餘物中加入200g DI水並將混合物攪拌10分鐘。將樣品在黑暗中通過Whatman#5(2.5um)濾紙進行重力過濾,以得到具有中性pH的澄清溶液。將該澄清溶液冷凍並凍乾以得到灰白色固體。總產量18g,%產率:77%。 In a weighed amber 1 L flask with a stir bar, take 22 g (0.058 mol/l equivalent) of product (III) (AcO-BrCH 2 -Bzt), assuming 92% purity based on NMR. 350 mL of ethyl acetate (EtAc) was added thereto to dissolve. The solution was stirred at room temperature for one hour. During this period, 27.592g/0.176mol/3 equivalent of NN-DMAPrAAm was measured in a 50mL dropping funnel. NN-DMAPrAAm was slowly added to the reaction solution within 15 minutes under stirring at room temperature. A precipitate slowly started to form and the reaction was stirred overnight at room temperature, covered in foil. Stop stirring and allow the precipitate to settle. The supernatant liquid was decanted from the reaction solution to obtain 70.4 g of solid. 70 mL of acetonitrile was added and the mixture was vortexed in a foil-covered flask at room temperature for one hour to dissolve. The resulting solution was concentrated under reduced pressure to remove 80% of volatiles. Under stirring, 120 mL of 16.7% hexane in EtAc was slowly added to the solution to obtain a two-phase mixture. The clear supernatant was decanted to obtain about 30 g of viscous semi-solid. To the viscous residue was added 60 mL of acetonitrile and vortexed for 15 minutes to dissolve the residue, and then concentrated under reduced pressure to remove 90%-95% of volatiles. Obtain a clear viscous liquid. Using a dropping funnel, 120 mL of a solution of 16.67% hexane in ethyl acetate was added thereto with stirring. Two phases were observed, a viscous paste-like solid in the lower part and a turbid supernatant liquid phase in the upper part. The mixture was gently stirred at room temperature for 15 minutes and then allowed to stand for 45 minutes. The clear, colorless supernatant was decanted to produce about 32 g of viscous semi-solid. This process was repeated two more times to produce a viscous semi-solid residue. The volatiles in the crude residue were removed under reduced pressure to obtain about 25 g of solid matter. MEHQ, 3.7 mg, was dissolved in acetonitrile and added to the residue (approximately 150 mg/Kg (ppm) MEHQ based on estimated product weight). About 50 mL of acetonitrile was added to the residue and the mixture was vortexed to dissolve within 15 minutes. The solution was concentrated under reduced pressure in an amber flask to remove as much volatiles as possible to obtain 21.21 g of solid matter. To the residue was added 200 g of DI water and the mixture was stirred for 10 minutes. The sample was gravity filtered through Whatman#5 (2.5um) filter paper in the dark to obtain a clear solution with neutral pH. The clear solution was frozen and lyophilized to obtain an off-white solid. The total output is 18g,% yield: 77%.

步驟4-化合物V的合成(具有苯并三唑部分的UV吸收性乙烯基單體)Step 4-Synthesis of compound V (UV-absorbing vinyl monomer with benzotriazole moiety)

製備5.0mL在1000mg/L的濃度下的在DI水中的產物IV溶液。將該水性溶液用pH 7緩衝液(在DI水:正丙醇中12.5mM磷酸鹽)稀釋至20mg/L。收集該溶液的UV-Vis光譜(圖4,曲線1)。 Prepare 5.0 mL of product IV solution in DI water at a concentration of 1000 mg/L. The aqueous solution was diluted to 20 mg/L with pH 7 buffer (12.5 mM phosphate in DI water: n-propanol). The UV-Vis spectrum of the solution was collected (Figure 4, curve 1).

將固體碳酸鉀(K2CO3)加入到該1000mg/L溶液中以具有1w/v%的K2CO3濃度。將溶液混合以溶解K2CO3並使溶液在室溫下靜置過夜以獲得所希望的產物-UV吸收性乙烯基單體(即,方案中的化合物V)。將所得溶液用pH 7緩衝液(在DI水:正丙醇中的12.5mM磷酸鹽)稀釋至20mg/L的UV吸收性乙烯基單體。收集該UV吸收性乙烯基單體的這種溶液的UV-Vis光譜並示於圖4(曲線2)中。 Solid potassium carbonate (K 2 CO 3 ) was added to the 1000 mg/L solution to have a K 2 CO 3 concentration of 1 w/v%. The solution was mixed to dissolve the K 2 CO 3 and the solution was allowed to stand overnight at room temperature to obtain the desired product—UV-absorbing vinyl monomer (ie, compound V in the scheme). The resulting solution was diluted with pH 7 buffer (12.5 mM phosphate in DI water: n-propanol) to 20 mg/L of UV-absorbing vinyl monomer. The UV-Vis spectrum of this solution of the UV-absorbing vinyl monomer was collected and shown in Figure 4 (curve 2).

實例5Example 5

將在實例4中製備的UV吸收性乙烯基單體直接加入水性鏡片配製物中,該水性鏡片配製物在WO2002071106的實例8-8d(藉由引用以其全文結合在此)中描述,處於0、0.91wt%和1.4wt%的濃度並且各自具有1.0wt%的Li-TPO作為光引發劑。那三種配製物藉由光流變學研究(在30mW/cm2下的405nm LED光源)被測定為分別具有約25秒、約60秒、或約82秒的固化時間。 The UV-absorbing vinyl monomer prepared in Example 4 was directly added to the aqueous lens formulation described in Example 8-8d of WO2002071106 (incorporated in its entirety by reference), at 0 , 0.91wt% and 1.4wt%, and each has 1.0wt% Li-TPO as a photoinitiator. Those three formulations were determined to have a curing time of about 25 seconds, about 60 seconds, or about 82 seconds by optical rheology studies ( 405 nm LED light source at 30 mW/cm 2 ).

根據在WO2002071106的實例8中描述的自動鏡片製造方法從那些水性配製物製造鏡片,除了模具中的鏡片配製物用405nm LED以30mW/cm2的強度照射約25秒外。將所得鏡片包裝在含有鹽水61的泡罩包裝中、密封並在121℃下高壓滅菌45分鐘。測定高壓滅菌的鏡片的%T。當UV吸收性乙烯基單體的濃度係0(即,對照鏡片)時,對照鏡片具有約95.57%的%T-UVA和約81.64%的%T-UVB。當UV吸收性乙烯基單體的濃度係按重量計0.91%時,所得鏡片具有約7.39%的%T-UVA和約2.74%的%T-UVB。當UV吸收性乙烯基單體的濃度係按重量計1.40%時,所得鏡片具有約3.45%的%T-UVA和約0.59%的%T-UVB。 Those from the aqueous formulations of manufacturing a lens, in addition to a lens mold with a formulation at an intensity of 405nm LED is irradiated 30mW / cm 2 for about 25 seconds in an automatic lens manufacturing method of an outer described in WO2002071106 in Example 8. The resulting lens was packaged in a blister pack containing saline 61, sealed, and autoclaved at 121°C for 45 minutes. Determine the %T of autoclaved lenses. When the concentration of the UV-absorbing vinyl monomer is 0 (ie, the control lens), the control lens has a %T-UVA of about 95.57% and a %T-UVB of about 81.64%. When the concentration of the UV-absorbing vinyl monomer is 0.91% by weight, the resulting lens has a %T-UVA of about 7.39% and a %T-UVB of about 2.74%. When the concentration of the UV-absorbing vinyl monomer is 1.40% by weight, the resulting lens has a %T-UVA of about 3.45% and a %T-UVB of about 0.59%.

圖5和6示出了在高壓滅菌之後具有0.91wt%和1.4wt%的UV吸收性乙烯基單體的鏡片連同在高壓滅菌後的對照鏡片(不含UV吸收性乙烯基單體)的%T。 Figures 5 and 6 show the% of lenses with 0.91wt% and 1.4wt% of UV-absorbing vinyl monomers after autoclaving and the control lens (without UV-absorbing vinyl monomers) after autoclaving T.

Figure 106105690-A0202-11-0002-1
Figure 106105690-A0202-11-0002-1

Claims (25)

一種具有式(I)至(VII)中任一個的UV吸收性乙烯基單體
Figure 106105690-A0305-02-0064-1
Figure 106105690-A0305-02-0064-2
Figure 106105690-A0305-02-0064-3
Figure 106105690-A0305-02-0064-4
Figure 106105690-A0305-02-0064-5
Figure 106105690-A0305-02-0064-6
Figure 106105690-A0305-02-0064-7
其中:Ro係H或CH3;R1、R2和R2’彼此獨立的是H、CH3、CCl3、CF3、Cl、Br、OH、OCH3、或NR’R”,其中R’和R”彼此獨立的是H或C1-C4烷基; R1’彼此獨立的是H、CH3、CCl3、CF3、Cl、Br、OH、OCH3、SO3H、SO3Na、或NR’R”,其中R’和R”彼此獨立的是H或C1-C4烷基;R3和R4彼此獨立的是H或第一親水基團,該第一親水基團係 *-CH2-(OC2H4)n1-OCH3、*-CH2-(OC2H4)n1-OH、
Figure 106105690-A0305-02-0065-27
Figure 106105690-A0305-02-0065-23
Figure 106105690-A0305-02-0065-24
Figure 106105690-A0305-02-0065-25
、或
Figure 106105690-A0305-02-0065-20
,條件係R3和R4中的至少一個係該第一親水基團; R5係H、*-COOH、*-CONH-C2H4-(OC2H4)n1-OCH3、或*-CONH-C2H4-(OC2H4)n1-OH;R6和R7之一係H或第二親水基團,該第二親水基團係 *-CH2-(OC2H4)n1-OCH3、*-CH2-(OC2H4)n1-OH、
Figure 106105690-A0305-02-0065-28
Figure 106105690-A0305-02-0065-29
Figure 106105690-A0305-02-0065-30
、或
Figure 106105690-A0305-02-0065-32
,而R6和R7中 的另一個係
Figure 106105690-A0305-02-0065-35
Figure 106105690-A0305-02-0065-34
Figure 106105690-A0305-02-0065-33
; R8係CH3、C2H5
Figure 106105690-A0305-02-0065-36
Figure 106105690-A0305-02-0065-38
、或
Figure 106105690-A0305-02-0065-40
; R9係SO3Na、
Figure 106105690-A0305-02-0065-43
Figure 106105690-A0305-02-0065-42
Figure 106105690-A0305-02-0065-41
Figure 106105690-A0305-02-0065-48
、或
Figure 106105690-A0305-02-0065-50
; R9’係H、SO3Na、
Figure 106105690-A0305-02-0065-44
Figure 106105690-A0305-02-0065-45
Figure 106105690-A0305-02-0066-51
Figure 106105690-A0305-02-0066-52
、或
Figure 106105690-A0305-02-0066-54
; R10係甲基或乙基; L1係
Figure 106105690-A0305-02-0066-55
Figure 106105690-A0305-02-0066-56
Figure 106105690-A0305-02-0066-57
Figure 106105690-A0305-02-0066-58
Figure 106105690-A0305-02-0066-59
、 或
Figure 106105690-A0305-02-0066-61
的直接鍵或鍵聯; L2係*-CH2-*、*-C2H4-*、*-C3H6-*、*-C3H6-S-C2H4-*、*-C3H6-S-C3H6-*、 或
Figure 106105690-A0305-02-0066-62
的鍵聯; X1係O或NRo;並且Y1、Y2和Y3彼此獨立的是C2-C4伸烷基二價基團;Q1、Q2和Q3彼此獨立的是(甲基)丙烯醯胺基或(甲基)丙烯醯氧基;m1係零或1,條件係如果m1係零,那麼Q2係(甲基)丙烯醯胺基;並且n1係2至20的整數。
A UV-absorbing vinyl monomer having any one of formula (I) to (VII)
Figure 106105690-A0305-02-0064-1
Figure 106105690-A0305-02-0064-2
Figure 106105690-A0305-02-0064-3
Figure 106105690-A0305-02-0064-4
Figure 106105690-A0305-02-0064-5
Figure 106105690-A0305-02-0064-6
Figure 106105690-A0305-02-0064-7
Wherein: R o is H or CH 3 ; R 1 , R 2 and R 2 'are independent of each other are H, CH 3 , CCl 3 , CF 3 , Cl, Br, OH, OCH 3 , or NR'R", where R'and R" independently of each other are H or C 1 -C 4 alkyl; R 1 'independently of each other are H, CH 3 , CCl 3 , CF 3 , Cl, Br, OH, OCH 3 , SO 3 H, SO 3 Na, or NR'R", where R'and R" are independent of each other are H or C 1 -C 4 alkyl; R 3 and R 4 are independent of each other are H or the first hydrophilic group, the first Hydrophilic groups *-CH 2 -(OC 2 H 4 ) n1 -OCH 3 、*-CH 2 -(OC 2 H 4 ) n1 -OH,
Figure 106105690-A0305-02-0065-27
,
Figure 106105690-A0305-02-0065-23
,
Figure 106105690-A0305-02-0065-24
,
Figure 106105690-A0305-02-0065-25
,or
Figure 106105690-A0305-02-0065-20
, The condition is that at least one of R 3 and R 4 is the first hydrophilic group; R 5 is H, *-COOH, *-CONH-C 2 H 4 -(OC 2 H 4 ) n1 -OCH 3 , or * -CONH-C 2 H 4 -(OC 2 H 4 ) n1 -OH; one of R 6 and R 7 is H or a second hydrophilic group, and the second hydrophilic group is *-CH 2 -(OC 2 H 4 ) n1 -OCH 3 、*-CH 2 -(OC 2 H 4 ) n1 -OH,
Figure 106105690-A0305-02-0065-28
,
Figure 106105690-A0305-02-0065-29
,
Figure 106105690-A0305-02-0065-30
,or
Figure 106105690-A0305-02-0065-32
, And the other line of R 6 and R 7
Figure 106105690-A0305-02-0065-35
,
Figure 106105690-A0305-02-0065-34
or
Figure 106105690-A0305-02-0065-33
; R 8 is CH 3 , C 2 H 5 ,
Figure 106105690-A0305-02-0065-36
,
Figure 106105690-A0305-02-0065-38
,or
Figure 106105690-A0305-02-0065-40
; R 9 is SO 3 Na,
Figure 106105690-A0305-02-0065-43
,
Figure 106105690-A0305-02-0065-42
,
Figure 106105690-A0305-02-0065-41
,
Figure 106105690-A0305-02-0065-48
,or
Figure 106105690-A0305-02-0065-50
; R 9 'is H, SO 3 Na,
Figure 106105690-A0305-02-0065-44
,
Figure 106105690-A0305-02-0065-45
,
Figure 106105690-A0305-02-0066-51
,
Figure 106105690-A0305-02-0066-52
,or
Figure 106105690-A0305-02-0066-54
; R 10 is methyl or ethyl; L1 is
Figure 106105690-A0305-02-0066-55
,
Figure 106105690-A0305-02-0066-56
,
Figure 106105690-A0305-02-0066-57
,
Figure 106105690-A0305-02-0066-58
,
Figure 106105690-A0305-02-0066-59
, Or
Figure 106105690-A0305-02-0066-61
Direct bond or linkage; L2 series *-CH 2 -*, *-C 2 H 4 -*, *-C 3 H 6 -*, *-C 3 H 6 -SC 2 H 4 -*, *- C 3 H 6 -SC 3 H 6 -*, or
Figure 106105690-A0305-02-0066-62
X1 is O or NR o ; and Y 1 , Y 2 and Y 3 are independently C 2 -C 4 alkylene divalent groups; Q1, Q2 and Q3 are independently of each other (methyl) Acrylamido group or (meth)acrylamido group; m1 is zero or 1, provided that if m1 is zero, then Q 2 is a (meth)acrylamido group; and n1 is an integer from 2 to 20.
如申請專利範圍第1項所述之UV吸收性乙烯基單體,係具有式(I)之乙烯基單體。 The UV-absorbing vinyl monomer described in item 1 of the scope of the patent application is a vinyl monomer of formula (I). 如申請專利範圍第2項所述之UV吸收性乙烯基單體,係選自具有下式中任一個的乙烯基單體:
Figure 106105690-A0305-02-0066-8
Figure 106105690-A0305-02-0067-9
Figure 106105690-A0305-02-0067-63
,以及
Figure 106105690-A0305-02-0067-64
其中:Q1係(甲基)丙烯醯胺基或(甲基)丙烯醯氧基;Y1係伸乙基或伸丙基二價基團;R1和R2彼此獨立的是H、CH3、CCl3、CF3、Cl、Br、OH、OCH3、或NR’R”,其中R’和R”彼此獨立的是H、甲基或乙基。
The UV-absorbing vinyl monomer described in item 2 of the scope of patent application is selected from vinyl monomers having any of the following formulas:
Figure 106105690-A0305-02-0066-8
Figure 106105690-A0305-02-0067-9
Figure 106105690-A0305-02-0067-63
,as well as
Figure 106105690-A0305-02-0067-64
Among them: Q 1 is a (meth)acrylamido or (meth)acrylamido group; Y 1 is an ethylene or propylene divalent group; R 1 and R 2 are independently H, CH 3 , CCl 3 , CF 3 , Cl, Br, OH, OCH 3 , or NR'R", where R'and R" are independently H, methyl or ethyl.
如申請專利範圍第1項所述之UV吸收性乙烯基單體,係具有式(II)之乙烯基單體。 The UV-absorbing vinyl monomer described in item 1 of the scope of the patent application is a vinyl monomer of formula (II). 如申請專利範圍第4項所述之UV吸收性乙烯基單體,係選自具有下式中任一個的乙烯基單體:
Figure 106105690-A0305-02-0067-10
Figure 106105690-A0305-02-0068-11
Figure 106105690-A0305-02-0068-65
Figure 106105690-A0305-02-0068-66
,以及
Figure 106105690-A0305-02-0068-67
其中:Q1係(甲基)丙烯醯胺基或(甲基)丙烯醯氧基;Y1係伸乙基或伸丙基二價基團;R1和R2彼此獨立的是CH3、CCl3、CF3、Cl、Br、NR’R”、OH、或OCH3;R’和R”彼此獨立的是H、甲基或乙基;R3和R4彼此獨立的是*-CH2-(OC2H4)n1-OCH3、*-CH2-(OC2H4)n1-OH、
Figure 106105690-A0305-02-0068-12
Figure 106105690-A0305-02-0068-68
、或
Figure 106105690-A0305-02-0068-70
;R10係甲基或乙基。
The UV-absorbing vinyl monomer described in item 4 of the scope of patent application is selected from vinyl monomers having any of the following formulas:
Figure 106105690-A0305-02-0067-10
Figure 106105690-A0305-02-0068-11
Figure 106105690-A0305-02-0068-65
,
Figure 106105690-A0305-02-0068-66
,as well as
Figure 106105690-A0305-02-0068-67
Among them: Q 1 is a (meth)acrylamido or (meth)acryloxy; Y 1 is an ethylene or propylene divalent group; R 1 and R 2 are independently CH 3 , CCl 3 , CF 3 , Cl, Br, NR'R”, OH, or OCH 3 ; R'and R” independently of each other are H, methyl or ethyl; R 3 and R 4 independently of each other are *-CH 2 -(OC 2 H 4 ) n1 -OCH 3 、*-CH 2 -(OC 2 H 4 ) n1 -OH,
Figure 106105690-A0305-02-0068-12
Figure 106105690-A0305-02-0068-68
,or
Figure 106105690-A0305-02-0068-70
; R 10 is methyl or ethyl.
如申請專利範圍第1項所述之UV吸收性乙烯基單體,係具有式(III)之乙烯基單體。 The UV-absorbing vinyl monomer described in item 1 of the scope of the patent application is a vinyl monomer of formula (III). 如申請專利範圍第6項所述之UV吸收性乙烯基單體,係選自具有下式中任一個的乙烯基單體:
Figure 106105690-A0305-02-0069-13
Figure 106105690-A0305-02-0070-14
其中:Q1係(甲基)丙烯醯胺基或(甲基)丙烯醯氧基;Y1係伸乙基或伸丙基二價基團;R1和R2彼此獨立的是CH3、CCl3、CF3、Cl、Br、NR’R”、OH、或OCH3;其中R’和R”彼此獨立的是H或C1-C4烷基;R8 係CH3、C2H5
Figure 106105690-A0305-02-0070-71
Figure 106105690-A0305-02-0070-72
、或
Figure 106105690-A0305-02-0070-74
;R10 係甲基或乙基。
The UV-absorbing vinyl monomer described in item 6 of the scope of patent application is selected from vinyl monomers having any of the following formulas:
Figure 106105690-A0305-02-0069-13
Figure 106105690-A0305-02-0070-14
Among them: Q 1 is a (meth)acrylamido or (meth)acryloxy; Y 1 is an ethylene or propylene divalent group; R 1 and R 2 are independently CH 3 , CCl 3 , CF 3 , Cl, Br, NR'R", OH, or OCH 3 ; wherein R'and R" are independently H or C 1 -C 4 alkyl; R 8 is CH 3 , C 2 H 5 .
Figure 106105690-A0305-02-0070-71
,
Figure 106105690-A0305-02-0070-72
,or
Figure 106105690-A0305-02-0070-74
; R 10 is methyl or ethyl.
如申請專利範圍第1項所述之UV吸收性乙烯基單體,係具有式(IV)或(V)之乙烯基單體。 The UV-absorbing vinyl monomer described in item 1 of the scope of patent application is a vinyl monomer having formula (IV) or (V). 如申請專利範圍第8項所述之UV吸收性乙烯基單體,係選自具有下式中任一個的乙烯基單體:
Figure 106105690-A0305-02-0071-15
其中R1’係H、CH3、CCl3、CF3、Cl、Br、NR’R”,其中R’和R”彼此獨立的是H或C1-C4烷基;Q2係(甲基)丙烯醯胺基或(甲基)丙烯醯氧基;Y2係伸乙基或伸丙基二價基團。
The UV-absorbing vinyl monomer described in item 8 of the scope of patent application is selected from vinyl monomers having any of the following formulas:
Figure 106105690-A0305-02-0071-15
Wherein R 1 'is H, CH 3 , CCl 3 , CF 3 , Cl, Br, NR'R", where R'and R" are independently H or C 1 -C 4 alkyl; Q 2 is (form Group) acrylamido group or (meth)acryloyloxy group; Y 2 is an ethylene or propylene divalent group.
如申請專利範圍第1項所述之UV吸收性乙烯基單體,係具有式(VI)或(VII)之乙烯基單體。 The UV-absorbing vinyl monomer described in item 1 of the scope of patent application is a vinyl monomer having formula (VI) or (VII). 如申請專利範圍第10項所述之UV吸收性乙烯基單體,係選自具有下式中任一個的乙烯基單體:
Figure 106105690-A0305-02-0072-16
其中R1’係H、CH3、CCl3、CF3、Cl、Br、OH、或OCH3、NR’R”, 其中R’和R”彼此獨立的是H或C1-C4烷基,R8係CH3、C2H5
Figure 106105690-A0305-02-0072-78
Figure 106105690-A0305-02-0072-75
、或
Figure 106105690-A0305-02-0072-77
;R10係甲基或乙基;Q3係(甲基) 丙烯醯胺基或(甲基)丙烯醯氧基;Y3係伸乙基或伸丙基二價基團。
The UV-absorbing vinyl monomer described in item 10 of the scope of the patent application is selected from vinyl monomers having any of the following formulas:
Figure 106105690-A0305-02-0072-16
Wherein R 1 'is H, CH 3 , CCl 3 , CF 3 , Cl, Br, OH, or OCH 3 , NR'R", where R'and R" are independently H or C 1 -C 4 alkyl , R 8 is CH 3 , C 2 H 5 ,
Figure 106105690-A0305-02-0072-78
,
Figure 106105690-A0305-02-0072-75
,or
Figure 106105690-A0305-02-0072-77
; R 10 is a methyl or ethyl group; Q 3 is a (meth)acrylamido or (meth)acryloxy; Y 3 is an ethylene or propylene divalent group.
一種水凝膠接觸鏡片,包含交聯的聚合物材料,該交聯的聚合物材料包含如申請專利範圍第1至11項中任一項所述之UV吸收性乙烯基單體的重複單元,其中該水凝膠接觸鏡片具有:在280與315奈米之間的約10%或更小的UVB透射率(指定為UVB%T);在315與380奈米之間的約30%或更小的UVA透射率(指定為UVA%T);在380nm與440nm之間的約60%或更小的紫光透射率(指定為紫光%T);以及當完全水合時按重量計從約15%至約80%的水含量(在室溫,約22℃至28℃下)。 A hydrogel contact lens, comprising a cross-linked polymer material, the cross-linked polymer material comprising the repeating unit of the UV-absorbing vinyl monomer as described in any one of items 1 to 11 in the scope of the patent application, Wherein the hydrogel contact lens has: a UVB transmittance of about 10% or less between 280 and 315 nanometers (designated as UVB%T); about 30% or more between 315 and 380 nanometers Small UVA transmittance (designated as UVA%T); between 380nm and 440nm about 60% or less violet light transmittance (designated as purple%T); and from about 15% by weight when fully hydrated To about 80% water content (at room temperature, about 22°C to 28°C). 如申請專利範圍第12項所述之水凝膠接觸鏡片,其中該水凝膠接觸鏡片係矽酮水凝膠接觸鏡片,其中該交聯的聚合物材料包含至少一種親水性乙烯基單體的重複單元和至少一種含矽氧烷的乙烯基單體和/或大分子單體的重複單元。 The hydrogel contact lens according to claim 12, wherein the hydrogel contact lens is a silicone hydrogel contact lens, wherein the cross-linked polymer material contains at least one hydrophilic vinyl monomer Repeating units and at least one repeating unit of siloxane-containing vinyl monomer and/or macromonomer. 如申請專利範圍第12項所述之水凝膠接觸鏡片,其中該交聯的聚合物材料包含可光化交聯的聚乙烯醇預聚物的重複單元。 The hydrogel contact lens according to claim 12, wherein the cross-linked polymer material comprises repeating units of actinically cross-linkable polyvinyl alcohol prepolymer. 如申請專利範圍14項所述之水凝膠接觸鏡片,其中該可光化交聯的聚乙 烯醇預聚物包含乙烯醇(即,
Figure 106105690-A0305-02-0073-80
)的重複單元和具有式(VIII)之 重複單元
Figure 106105690-A0305-02-0073-17
其中:R11係氫或C1-C6烷基; R12
Figure 106105690-A0305-02-0073-81
Figure 106105690-A0305-02-0073-82
乙烯式不飽和基團 其中q1和q2彼此獨立的是零或一,並且R16和R17彼此獨立的是C2-C8伸烷基二價基團,R18係C2-C8烯基;R13可以是氫或C1-C6烷基;並且R14係C1-C6伸烷基二價基團。
The hydrogel contact lens described in the 14th item of the patent application, wherein the actinically crosslinkable polyvinyl alcohol prepolymer contains vinyl alcohol (ie,
Figure 106105690-A0305-02-0073-80
) And the repeating unit of formula (VIII)
Figure 106105690-A0305-02-0073-17
Among them: R 11 is hydrogen or C 1 -C 6 alkyl; R 12 is
Figure 106105690-A0305-02-0073-81
or
Figure 106105690-A0305-02-0073-82
An ethylenically unsaturated group where q1 and q2 are independent of each other are zero or one, and R 16 and R 17 are independent of each other are a C 2 -C 8 alkylene divalent group, and R 18 is a C 2 -C 8 alkene R 13 may be hydrogen or a C 1 -C 6 alkyl group; and R 14 is a C 1 -C 6 alkylene divalent group.
一種用於生產UV吸收性接觸鏡片之方法,該方法包括以下步驟:(1)獲得包含以下各項的鏡片配製物(a)按重量計從約0.1%至約4%的如申請專利範圍第1至11項中任一項所述之UV吸收性乙烯基單體,(b)按重量計從約0.1%至約2.0%的至少一種自由基引發劑,以及(c)至少一種選自下組的可聚合組分,該組由以下各項組成:親水性乙烯基單體、水溶性不含矽酮的預聚物、含矽酮的預聚物、非 矽酮疏水性乙烯基單體、含矽氧烷的乙烯基單體、含矽氧烷的乙烯基大分子單體、乙烯基交聯劑、以及其組合;(2)將該鏡片配製物引入到用於製造軟性接觸鏡片的模具中,其中該模具具有第一半模和第二半模,該第一半模具有限定接觸鏡片的前表面的第一模製表面,該第二半模具有限定該接觸鏡片的後表面的第二模製表面,其中所述第一和第二半模被配置為接納彼此,使得在所述第一與第二模製表面之間形成型腔;並且(3)熱固化或光化固化在該模具中的該鏡片配製物以形成該UV吸收性接觸鏡片,其中該形成的UV吸收性接觸鏡片的特徵在於具有在280與315奈米之間的約10%或更小的UVB%T和在315與380奈米之間的約30%或更小的UVA%T以及在380nm與440nm之間的約60%或更小的紫光%T。 A method for producing UV-absorbing contact lenses, the method comprising the following steps: (1) obtaining a lens formulation containing the following items (a) from about 0.1% to about 4% by weight as claimed in the scope of the patent application The UV-absorbing vinyl monomer described in any one of items 1 to 11, (b) from about 0.1% to about 2.0% by weight of at least one free radical initiator, and (c) at least one selected from Group of polymerizable components, the group consists of the following: hydrophilic vinyl monomers, water-soluble prepolymers without silicone, prepolymers containing silicone, non- Silicone hydrophobic vinyl monomers, silicone-containing vinyl monomers, silicone-containing vinyl macromonomers, vinyl crosslinking agents, and combinations thereof; (2) introducing the lens formulation Into a mold for manufacturing a soft contact lens, wherein the mold has a first mold half and a second mold half, the first mold half has a first molding surface that defines the front surface of the contact lens, and the second mold half has A second molding surface defining the back surface of the contact lens, wherein the first and second mold halves are configured to receive each other such that a cavity is formed between the first and second molding surfaces; and ( 3) Thermally or actinically cure the lens formulation in the mold to form the UV-absorbing contact lens, wherein the formed UV-absorbing contact lens is characterized by having a thickness of about 10 between 280 and 315 nm. % Or less UVB%T and about 30% or less UVA%T between 315 and 380nm and about 60% or less violet %T between 380nm and 440nm. 如申請專利範圍第16項所述之方法,其中該自由基引發劑係熱引發劑,其中用熱的方法進行該固化步驟。 The method described in item 16 of the scope of patent application, wherein the free radical initiator is a thermal initiator, and the curing step is performed by a thermal method. 如申請專利範圍第16項所述之方法,其中該自由基引發劑係光引發劑,其中該固化步驟係藉由用具有在從380nm至500nm範圍內的波長的光照射而進行的。 The method described in claim 16, wherein the free radical initiator is a photoinitiator, and wherein the curing step is performed by irradiating with light having a wavelength in the range from 380 nm to 500 nm. 如申請專利範圍第17項所述之方法,其中該鏡片配製物包含至少一種親水性乙烯基單體、至少一種含矽氧烷的乙烯基單體、至少一種含矽氧烷的乙烯基大分子單體。 The method according to claim 17, wherein the lens formulation comprises at least one hydrophilic vinyl monomer, at least one silicone-containing vinyl monomer, and at least one silicone-containing vinyl macromolecule monomer. 如申請專利範圍第18項所述之方法,其中該鏡片配製物包含至少一種親水性乙烯基單體、至少一種含矽氧烷的乙烯基單體、至少一種含矽氧烷 的乙烯基大分子單體。 The method according to claim 18, wherein the lens formulation comprises at least one hydrophilic vinyl monomer, at least one silicone-containing vinyl monomer, and at least one silicone-containing vinyl monomer Of vinyl macromonomers. 如申請專利範圍第17項所述之方法,其中該鏡片配製物係包含至少一種可光化交聯的聚乙烯醇預聚物的水基鏡片配製物,其中該可光化交聯的 聚乙烯醇預聚物包含乙烯醇(即,
Figure 106105690-A0305-02-0075-83
)的重複單元和具有式 (VIII)之重複單元
Figure 106105690-A0305-02-0075-18
其中:R11係氫或C1-C6烷基; R12
Figure 106105690-A0305-02-0075-84
Figure 106105690-A0305-02-0075-85
乙烯式不飽和基團 其中q1和q2彼此獨立的是零或一,並且R16和R17彼此獨立的是C2-C8伸烷基二價基團,R18係C2-C8烯基;R13可以是氫或C1-C6烷基;並且R14係C1-C6伸烷基二價基團。
The method according to claim 17, wherein the lens formulation is a water-based lens formulation comprising at least one actinically crosslinkable polyvinyl alcohol prepolymer, wherein the actinically crosslinkable polyethylene The alcohol prepolymer contains vinyl alcohol (ie,
Figure 106105690-A0305-02-0075-83
) And the repeating unit of formula (VIII)
Figure 106105690-A0305-02-0075-18
Among them: R 11 is hydrogen or C 1 -C 6 alkyl; R 12 is
Figure 106105690-A0305-02-0075-84
or
Figure 106105690-A0305-02-0075-85
An ethylenically unsaturated group where q1 and q2 are independent of each other are zero or one, and R 16 and R 17 are independent of each other are a C 2 -C 8 alkylene divalent group, and R 18 is a C 2 -C 8 alkene R 13 may be hydrogen or a C 1 -C 6 alkyl group; and R 14 is a C 1 -C 6 alkylene divalent group.
如申請專利範圍第18項所述之方法,其中該鏡片配製物係包含至少一種可光化交聯的聚乙烯醇預聚物的水基鏡片配製物,其中該可光化交聯的 聚乙烯醇預聚物包含乙烯醇(即,
Figure 106105690-A0305-02-0075-86
)的重複單元和具有式 (VIII)之重複單元
Figure 106105690-A0305-02-0076-19
其中:R11係氫或C1-C6烷基; R12
Figure 106105690-A0305-02-0076-87
Figure 106105690-A0305-02-0076-88
乙烯式不飽和基團 其中q1和q2彼此獨立的是零或一,並且R16和R17彼此獨立的是C2-C8伸烷基二價基團,R18係C2-C8烯基;R13可以是氫或C1-C6烷基;並且R14係C1-C6伸烷基二價基團。
The method described in item 18 of the patent application, wherein the lens formulation is a water-based lens formulation comprising at least one actinically crosslinkable polyvinyl alcohol prepolymer, wherein the actinically crosslinkable polyethylene The alcohol prepolymer contains vinyl alcohol (ie,
Figure 106105690-A0305-02-0075-86
) And the repeating unit of formula (VIII)
Figure 106105690-A0305-02-0076-19
Among them: R 11 is hydrogen or C 1 -C 6 alkyl; R 12 is
Figure 106105690-A0305-02-0076-87
or
Figure 106105690-A0305-02-0076-88
An ethylenically unsaturated group where q1 and q2 are independent of each other are zero or one, and R 16 and R 17 are independent of each other are a C 2 -C 8 alkylene divalent group, and R 18 is a C 2 -C 8 alkene R 13 may be hydrogen or a C 1 -C 6 alkyl group; and R 14 is a C 1 -C 6 alkylene divalent group.
如申請專利範圍第22項所述之方法,其中該光引發劑係苯甲醯基氧化膦。 The method described in item 22 of the scope of patent application, wherein the photoinitiator is benzyl phosphine oxide. 如申請專利範圍第22項所述之方法,其中該光引發劑係基於鍺的諾裡什I型光引發劑。 The method described in item 22 of the scope of patent application, wherein the photoinitiator is a Norish type I photoinitiator based on germanium. 如申請專利範圍第18項所述之方法,其中該光引發劑係基於鍺的諾裡什I型光引發劑。 The method described in item 18 of the scope of patent application, wherein the photoinitiator is a Norish type I photoinitiator based on germanium.
TW106105690A 2016-02-22 2017-02-21 Uv-absorbing vinylic monomers and uses thereof TWI718257B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662298137P 2016-02-22 2016-02-22
US62/298,137 2016-02-22

Publications (2)

Publication Number Publication Date
TW201736332A TW201736332A (en) 2017-10-16
TWI718257B true TWI718257B (en) 2021-02-11

Family

ID=58264574

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106105690A TWI718257B (en) 2016-02-22 2017-02-21 Uv-absorbing vinylic monomers and uses thereof

Country Status (6)

Country Link
US (2) US10254567B2 (en)
EP (1) EP3419966B1 (en)
JP (1) JP6546352B2 (en)
CA (2) CA3010331C (en)
TW (1) TWI718257B (en)
WO (1) WO2017145024A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10906258B2 (en) 2017-08-29 2021-02-02 Alcon Inc. Cast-molding process for producing contact lenses
US11111327B2 (en) 2018-01-22 2021-09-07 Alcon Inc. Cast-molding process for producing UV-absorbing contact lenses
US11543683B2 (en) 2019-08-30 2023-01-03 Johnson & Johnson Vision Care, Inc. Multifocal contact lens displaying improved vision attributes
US11993037B1 (en) 2018-03-02 2024-05-28 Johnson & Johnson Vision Care, Inc. Contact lens displaying improved vision attributes
US10935695B2 (en) 2018-03-02 2021-03-02 Johnson & Johnson Vision Care, Inc. Polymerizable absorbers of UV and high energy visible light
EP3816716A4 (en) * 2018-06-26 2022-03-09 Seed Co., Ltd. Anionic drug-containing ophthalmic device
EP3894909A4 (en) * 2018-12-10 2023-04-05 Seed Co., Ltd. Uv absorbing ocular lens
US11958824B2 (en) 2019-06-28 2024-04-16 Johnson & Johnson Vision Care, Inc. Photostable mimics of macular pigment
EP4304842A1 (en) * 2021-03-08 2024-01-17 Alcon Inc. Method for making photofunctional contact lenses
US20230364832A1 (en) 2022-04-28 2023-11-16 Alcon Inc. Method for making uv and hevl-absorbing ophthalmic lenses
TW202411352A (en) 2022-05-23 2024-03-16 瑞士商愛爾康公司 Uv/hevl-filtering contact lenses
CN115232510B (en) * 2022-08-04 2023-07-04 广东诚展科技股份有限公司 Liquid photosensitive LDI inner layer ink and preparation method thereof
WO2024038390A1 (en) 2022-08-17 2024-02-22 Alcon Inc. A contact lens with a hydrogel coating thereon
DE102022128813A1 (en) * 2022-10-31 2024-05-02 Universität Siegen, Körperschaft des öffentlichen Rechts Anti-adhesive polymer coatings for short-term implants

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937349A (en) * 1987-10-29 1990-06-26 Ciba-Geigy Corporation Process for the preparation of 3-[2'H-benzotriazol-(2')-yl]-4-hydroxy-benzenesulfonic acids and the salts thereof
TW200642836A (en) * 2005-03-04 2006-12-16 Bausch & Lomb Radiation-absorbing materials, ophthalmic compositions containing same, and method of treating ophthalmic devices
TW200934458A (en) * 2008-02-04 2009-08-16 Everlight Chem Ind Corp Polymerizable water-soluble or alcohol-soluble UV-light absorbent
TW201209079A (en) * 2010-07-30 2012-03-01 Novartis Ag Method for making UV-absorbing ophthalmic lenses
TW201242942A (en) * 2011-04-28 2012-11-01 Largan Medical Co Ltd Composition of contact lens for UV resistant

Family Cites Families (180)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE282493C (en) *
DE292066C (en) *
US4343927A (en) 1976-11-08 1982-08-10 Chang Sing Hsiung Hydrophilic, soft and oxygen permeable copolymer compositions
US4182822A (en) 1976-11-08 1980-01-08 Chang Sing Hsiung Hydrophilic, soft and oxygen permeable copolymer composition
US4390676A (en) 1976-11-15 1983-06-28 Schering Corporation Ultraviolet absorbing lenses
US4136250A (en) 1977-07-20 1979-01-23 Ciba-Geigy Corporation Polysiloxane hydrogels
US4153641A (en) 1977-07-25 1979-05-08 Bausch & Lomb Incorporated Polysiloxane composition and contact lens
US4189546A (en) 1977-07-25 1980-02-19 Bausch & Lomb Incorporated Polysiloxane shaped article for use in biomedical applications
CA1164710A (en) * 1978-05-09 1984-04-03 Edward J. Reardon, Jr. Phototropic photosensitive compositions containing fluoran colorformer
US4261875A (en) 1979-01-31 1981-04-14 American Optical Corporation Contact lenses containing hydrophilic silicone polymers
US4276402A (en) 1979-09-13 1981-06-30 Bausch & Lomb Incorporated Polysiloxane/acrylic acid/polcyclic esters of methacrylic acid polymer contact lens
US4254248A (en) 1979-09-13 1981-03-03 Bausch & Lomb Incorporated Contact lens made from polymers of polysiloxane and polycyclic esters of acrylic acid or methacrylic acid
US4259467A (en) 1979-12-10 1981-03-31 Bausch & Lomb Incorporated Hydrophilic contact lens made from polysiloxanes containing hydrophilic sidechains
US4260725A (en) 1979-12-10 1981-04-07 Bausch & Lomb Incorporated Hydrophilic contact lens made from polysiloxanes which are thermally bonded to polymerizable groups and which contain hydrophilic sidechains
US4341889A (en) 1981-02-26 1982-07-27 Bausch & Lomb Incorporated Polysiloxane composition and biomedical devices
US4327203A (en) 1981-02-26 1982-04-27 Bausch & Lomb Incorporated Polysiloxane with cycloalkyl modifier composition and biomedical devices
US4355147A (en) 1981-02-26 1982-10-19 Bausch & Lomb Incorporated Polysiloxane with polycyclic modifier composition and biomedical devices
US4444711A (en) 1981-12-21 1984-04-24 Husky Injection Molding Systems Ltd. Method of operating a two-shot injection-molding machine
US4661575A (en) 1982-01-25 1987-04-28 Hercules Incorporated Dicyclopentadiene polymer product
US4460534A (en) 1982-09-07 1984-07-17 International Business Machines Corporation Two-shot injection molding
US4486577A (en) 1982-10-12 1984-12-04 Ciba-Geigy Corporation Strong, silicone containing polymers with high oxygen permeability
US4543398A (en) 1983-04-28 1985-09-24 Minnesota Mining And Manufacturing Company Ophthalmic devices fabricated from urethane acrylates of polysiloxane alcohols
US4528311A (en) 1983-07-11 1985-07-09 Iolab Corporation Ultraviolet absorbing polymers comprising 2-hydroxy-5-acrylyloxyphenyl-2H-benzotriazoles
NZ208751A (en) * 1983-07-11 1987-04-30 Iolab Corp 2-hydroxy-5-acrylyloxyalkylphenyl-2h-benzotriazole derivatives and polymers and copolymers thereof and use as uv absorbing additives in polymer compositions
US4605712A (en) 1984-09-24 1986-08-12 Ciba-Geigy Corporation Unsaturated polysiloxanes and polymers thereof
DE3439483A1 (en) 1984-10-27 1986-05-07 Röhm GmbH, 6100 Darmstadt RADICALLY POLYMERIZABLE UV ABSORBER, METHOD FOR PRODUCING IT AND ITS POLYMERS
US4833218A (en) 1984-12-18 1989-05-23 Dow Corning Corporation Hydrophilic silicone-organic copolymer elastomers containing bioactine agent
CA1318529C (en) 1985-05-08 1993-06-01 Harry I. Zeltzer Contact lens for correction of color blindness
US4719248A (en) * 1985-08-08 1988-01-12 Bausch & Lomb Incorporated Ultraviolet blocking agents for contact lenses
US4684538A (en) 1986-02-21 1987-08-04 Loctite Corporation Polysiloxane urethane compounds and adhesive compositions, and method of making and using the same
JPS62230759A (en) 1986-04-01 1987-10-09 Nippon Shokubai Kagaku Kogyo Co Ltd Novel acryl or methacrylamide derivative
DE3708308A1 (en) 1986-04-10 1987-10-22 Bayer Ag CONTACT OPTICAL ITEMS
US5190565A (en) 1986-07-28 1993-03-02 Allied-Signal Inc. Sulfonated 2-(2'-hydroxyaryl)-2H-benzotriazoles and/or sulfonated aromatic formaldehyde condensates and their use to improve stain resistance and dye lightfasteness
AU612117B2 (en) 1986-07-28 1991-07-04 Allied Corporation Sulfonate benzotriazoles and their use in polyamide
US4716234A (en) 1986-12-01 1987-12-29 Iolab Corporation Ultraviolet absorbing polymers comprising 2-(2'-hydroxy-5'-acryloyloxyalkoxyphenyl)-2H-benzotriazole
US4803254A (en) 1987-03-11 1989-02-07 Iolab Corporation Vinylsilylalkoxy arylbenzotriazole compounds and UV absorbing compositions made therefrom
US4837289A (en) 1987-04-30 1989-06-06 Ciba-Geigy Corporation UV- and heat curable terminal polyvinyl functional macromers and polymers thereof
JPH0824694B2 (en) 1988-02-09 1996-03-13 ホーヤ株式会社 Contact lenses for correcting blue eyes
US5070170A (en) 1988-02-26 1991-12-03 Ciba-Geigy Corporation Wettable, rigid gas permeable, substantially non-swellable contact lens containing block copolymer polysiloxane-polyoxyalkylene backbone units, and use thereof
US4954587A (en) 1988-07-05 1990-09-04 Ciba-Geigy Corporation Dimethylacrylamide-copolymer hydrogels with high oxygen permeability
JPH0651795B2 (en) 1988-09-16 1994-07-06 信越化学工業株式会社 Methacryl functional dimethyl polysiloxane
DE3837884A1 (en) 1988-11-08 1990-05-10 Mutzhas Maximilian F LIGHT FILTER FOR IMPROVING VISION
US4954586A (en) 1989-01-17 1990-09-04 Menicon Co., Ltd Soft ocular lens material
US5034461A (en) 1989-06-07 1991-07-23 Bausch & Lomb Incorporated Novel prepolymers useful in biomedical devices
EP0415880B1 (en) 1989-08-25 1995-04-05 Ciba-Geigy Ag Light stabilised inks
US5079319A (en) 1989-10-25 1992-01-07 Ciba-Geigy Corporation Reactive silicone and/or fluorine containing hydrophilic prepolymers and polymers thereof
US5010141A (en) 1989-10-25 1991-04-23 Ciba-Geigy Corporation Reactive silicone and/or fluorine containing hydrophilic prepolymers and polymers thereof
WO1993005085A1 (en) 1991-09-12 1993-03-18 Bausch & Lomb Incorporated Wettable silicone hydrogel compositions and methods
ES2090710T3 (en) 1991-11-05 1996-10-16 Bausch & Lomb HUMECTABLE SILICONE HYDROGEL COMPOSITIONS AND METHODS FOR ITS MANUFACTURE.
US5358995A (en) 1992-05-15 1994-10-25 Bausch & Lomb Incorporated Surface wettable silicone hydrogels
JPH05317692A (en) * 1992-05-25 1993-12-03 Dai Ichi Kogyo Seiyaku Co Ltd Coating film material of microcapsule, microcapsule using the same and its production
JP3195662B2 (en) 1992-08-24 2001-08-06 株式会社メニコン Ophthalmic lens materials
JP2774233B2 (en) 1992-08-26 1998-07-09 株式会社メニコン Ophthalmic lens materials
JPH0688066A (en) * 1992-09-09 1994-03-29 Toray Ind Inc Ultraviolet absorber and ultraviolet-absorbing composition containing the same
US5487885A (en) 1992-12-21 1996-01-30 Biophysica, Inc. Sunblocking polymers and their formulation
JP3251676B2 (en) * 1992-12-28 2002-01-28 興和株式会社 Hydrophilic UV absorber
ATE160343T1 (en) 1993-04-22 1997-12-15 Jessen Wesley Corp UV-ABSORBING BENZOTRIAZOLES CONTAINING A STYRENE GROUP
TW328535B (en) 1993-07-02 1998-03-21 Novartis Ag Functional photoinitiators and their manufacture
US6800225B1 (en) 1994-07-14 2004-10-05 Novartis Ag Process and device for the manufacture of mouldings and mouldings manufactured in accordance with that process
TW272976B (en) 1993-08-06 1996-03-21 Ciba Geigy Ag
US5470932A (en) 1993-10-18 1995-11-28 Alcon Laboratories, Inc. Polymerizable yellow dyes and their use in opthalmic lenses
US5712356A (en) 1993-11-26 1998-01-27 Ciba Vision Corporation Cross-linkable copolymers and hydrogels
JPH0757857B2 (en) 1993-11-29 1995-06-21 株式会社日本触媒 Urethane resin coating composition
US5894002A (en) 1993-12-13 1999-04-13 Ciba Vision Corporation Process and apparatus for the manufacture of a contact lens
US5625427A (en) 1993-12-15 1997-04-29 Corning Incorporated Ophthalmic lens
US5843346A (en) 1994-06-30 1998-12-01 Polymer Technology Corporation Method of cast molding contact lenses
US5592245A (en) 1994-08-10 1997-01-07 Moore; J. Paul Apparatus for enhancing visual perception of selected objects in recreational and sporting activities
US5760100B1 (en) 1994-09-06 2000-11-14 Ciba Vision Corp Extended wear ophthalmic lens
US5617154A (en) 1994-10-28 1997-04-01 Flexlens Light filtering contact lens
US5665840A (en) 1994-11-18 1997-09-09 Novartis Corporation Polymeric networks from water-soluble prepolymers
TW349967B (en) 1995-02-03 1999-01-11 Novartis Ag Process for producing contact lenses and a cross-linkable polyvinylalcohol used therefor
EP0807270B1 (en) 1995-02-03 1999-03-31 Novartis AG Crosslinked polymers containing ester or amide groups
US5838419A (en) 1996-02-22 1998-11-17 Holland; Stephen Method and apparatus for treating refractive eye abnormalities
ES2160335T3 (en) 1996-10-21 2001-11-01 Novartis Ag RETICULABLE POLYMERS.
GB9700376D0 (en) 1997-01-09 1997-02-26 Ciba Geigy Ag Production of keto acids
TW425403B (en) 1997-02-04 2001-03-11 Novartis Ag Branched polyurethane (meth)acrylate prepolymers, opthal-mic mouldings derived therefrom and processes for their manufacture
ATE216501T1 (en) 1997-02-21 2002-05-15 Novartis Erfind Verwalt Gmbh OPTHALMIC MOLDING COMPOUND
US5975695A (en) 1997-09-10 1999-11-02 Intercast Europe S.P.A. Optical element for use in eye-protecting devices
US6479587B1 (en) 1997-09-16 2002-11-12 Novartis Ag Crosslinkable polyurea polymers
TW429327B (en) 1997-10-21 2001-04-11 Novartis Ag Single mould alignment
US5962548A (en) 1998-03-02 1999-10-05 Johnson & Johnson Vision Products, Inc. Silicone hydrogel polymers
US6039913A (en) 1998-08-27 2000-03-21 Novartis Ag Process for the manufacture of an ophthalmic molding
EP1002807A1 (en) 1998-11-20 2000-05-24 Novartis AG Functionalized resin derived from polyallylamine
US6132044A (en) 1998-11-20 2000-10-17 Luxottica Leasing S.P.A Filter for a special purpose lens and method of making filter
US5981675A (en) 1998-12-07 1999-11-09 Bausch & Lomb Incorporated Silicone-containing macromonomers and low water materials
FR2789673B1 (en) 1999-02-12 2001-05-04 Corning Sa COLORLESS MINERAL GLASSES WITH A STEEP OPTICAL ABSORPTION FRONT BETWEEN 370 AND 425 NM; PRODUCTS IN THE SAID GLASSES
CN1162472C (en) 1999-07-27 2004-08-18 博士伦公司 Contact lens material
US6432137B1 (en) 1999-09-08 2002-08-13 Medennium, Inc. High refractive index silicone for use in intraocular lenses
JP2001139640A (en) * 1999-11-12 2001-05-22 Mitsubishi Chemicals Corp Uv-absorbing copolymer
US6305801B1 (en) 1999-12-02 2001-10-23 Peakvision, Llc Contact lens with filtering for outdoor sporting and recreational activities
US7521519B1 (en) 2000-03-14 2009-04-21 Novartis Ag Organic compounds
AU2001260143A1 (en) 2000-03-24 2001-10-03 Novartis Ag Crosslinkable or polymerizable prepolymers
US8500274B2 (en) 2000-11-03 2013-08-06 High Performance Optics, Inc. Dual-filter ophthalmic lens to reduce risk of macular degeneration
US8403478B2 (en) 2001-11-02 2013-03-26 High Performance Optics, Inc. Ophthalmic lens to preserve macular integrity
JP2002226521A (en) * 2001-02-02 2002-08-14 Otsuka Chem Co Ltd Ultraviolet absorbing copolymer
TWI261057B (en) 2001-03-07 2006-09-01 Novartis Ag Process for the manufacture of moldings
US6641261B2 (en) 2001-10-06 2003-11-04 Stryker Corporation Lens for vision enhancement
US7255435B2 (en) 2001-12-11 2007-08-14 Pratt Steven G Blue blocking tens
US6955430B2 (en) 2001-12-11 2005-10-18 Pratt Steven G Blue blocking lens
US6811727B2 (en) 2002-01-09 2004-11-02 Corning Incorporated Ophthalmic filter materials
AU2003258609A1 (en) 2002-08-14 2004-03-03 Novartis Ag Radiation-curable prepolymers
CA2497261C (en) 2002-08-28 2012-07-31 Robert Casper A device for the prevention of melatonin suppression by light at night
US7748845B2 (en) 2002-08-28 2010-07-06 Robert Casper Method and device for preventing alterations in circadian rhythm
BR0316607B1 (en) 2002-12-12 2014-12-23 Ciba Sc Holding Ag Amino-substituted hydroxyphenyl benzophenone derivatives, their use, and cosmetic preparation.
US7387759B2 (en) 2002-12-17 2008-06-17 Novartis Ag System and method for curing polymeric moldings having a masking collar
US7384590B2 (en) 2002-12-17 2008-06-10 Novartis Ag System and method for curing polymeric moldings
US7276544B2 (en) 2003-09-08 2007-10-02 Bausch & Lomb Incorporated Process for manufacturing intraocular lenses with blue light absorption characteristics
US7977430B2 (en) 2003-11-25 2011-07-12 Novartis Ag Crosslinkable polyurea prepolymers
EP1740999A1 (en) 2004-04-30 2007-01-10 Advanced Medical Optics, Inc. Ophthalmic devices having a highly selective violet light transmissive filter and related methods
JP4401875B2 (en) * 2004-06-24 2010-01-20 株式会社資生堂 Oil-in-water emulsion composition
US8030369B2 (en) * 2004-10-13 2011-10-04 Novartis Ag Contact lenses with improved wearing comfort
WO2007055707A2 (en) 2004-12-01 2007-05-18 William Marsh Rice University Multi-step purification of single-wall carbon nanotubes
ES2247946B2 (en) 2005-04-19 2006-10-01 Universidad Complutense De Madrid THERAPEUTIC CONTACT LENS FOR PSEUDO-AFAQUIC EYES AND / OR IN NEURODEGENERATION PROCESS.
US20060252850A1 (en) 2005-05-04 2006-11-09 Bausch & Lomb Incorporated Radiation-absorbing polymeric materials and ophthalmic devices comprising same
US7857848B2 (en) 2005-05-05 2010-12-28 Key Medical Technologies, Inc. Infinite refractive index gradient (IRIG) polymers for ocular implant and contact lens applications
US7842367B2 (en) 2005-05-05 2010-11-30 Key Medical Technologies, Inc. Ultra violet, violet, and blue light filtering polymers for ophthalmic applications
US7771470B2 (en) 2005-05-05 2010-08-10 Key Medical Technologies, Inc. Ophthalmic apparatuses and methods
US20070092831A1 (en) 2005-10-24 2007-04-26 Bausch & Lomb Incorporated Radiation-absorbing polymeric materials and ophthalmic devices comprising same
US20070092830A1 (en) 2005-10-24 2007-04-26 Bausch & Lomb Incorporated Polymeric radiation-absorbing materials and ophthalmic devices comprising same
US7703917B2 (en) 2006-01-10 2010-04-27 Universidad Complutense De Madrid Therapeutic prophylactic ophthalmologic lens for pseudoaphakic eyes and/or eyes suffering neurodegeneration
US7520608B2 (en) 2006-03-20 2009-04-21 High Performance Optics, Inc. Color balanced ophthalmic system with selective light inhibition
US20070216861A1 (en) 2006-03-20 2007-09-20 Andrew Ishak Ophthalmic system combining ophthalmic components with blue light wavelength blocking and color-balancing functionalities
US9377569B2 (en) 2006-03-20 2016-06-28 High Performance Optics, Inc. Photochromic ophthalmic systems that selectively filter specific blue light wavelengths
US8882267B2 (en) 2006-03-20 2014-11-11 High Performance Optics, Inc. High energy visible light filter systems with yellowness index values
US7556376B2 (en) 2006-08-23 2009-07-07 High Performance Optics, Inc. System and method for selective light inhibition
US8360574B2 (en) 2006-03-20 2013-01-29 High Performance Optics, Inc. High performance selective light wavelength filtering providing improved contrast sensitivity
US20120075577A1 (en) 2006-03-20 2012-03-29 Ishak Andrew W High performance selective light wavelength filtering providing improved contrast sensitivity
US8113651B2 (en) 2006-03-20 2012-02-14 High Performance Optics, Inc. High performance corneal inlay
US7364291B2 (en) 2006-06-29 2008-04-29 Johnson & Johnson Vision Care, Inc. Contact lenses with light blocking rings
AU2007272558B2 (en) 2006-07-12 2010-12-09 Novartis Ag Actinically crosslinkable copolymers for manufacturing contact lenses
AU2007294454B2 (en) 2006-09-06 2012-09-13 Carl Zeiss Vision Australia Holdings Limited Ultraviolet light absorbing optical elements and compositions and methods for manufacture
EP1905415B1 (en) 2006-09-27 2009-07-01 Ivoclar Vivadent AG Polymerisable compositions comprising acyl-germanium as initiators
FR2908899B1 (en) 2006-11-17 2009-02-06 Essilor Int MULTI-SHAPED OPHTHALMIC LENSES FOR NIGHT VISION
FR2908897B1 (en) 2006-11-17 2009-03-06 Essilor Int COLORFUL COLOR OPHTHALMIC LENSES.
AR064286A1 (en) 2006-12-13 2009-03-25 Quiceno Gomez Alexandra Lorena PRODUCTION OF OPHTHALMIC DEVICES BASED ON POLYMERIZATION BY PHOTOINDUCIDED SCALE GROWTH
CA2671740C (en) 2006-12-13 2015-08-11 Novartis Ag Actinically curable silicone hydrogel copolymers and uses thereof
WO2008116131A2 (en) 2007-03-22 2008-09-25 Novartis Ag Prepolymers with dangling polysiloxane-containing polymer chains
CN101641615B (en) 2007-03-22 2012-06-06 诺瓦提斯公司 Silicone-containing prepolymers with dangling hydrophilic polymeric chains
US7825257B1 (en) 2007-10-23 2010-11-02 Bausch & Lomb Incorporated Synthesis of benzotriazole monomer
US7884228B1 (en) 2008-05-06 2011-02-08 Alcon, Inc. UV-absorbers for ophthalmic lens materials
US7803359B1 (en) 2008-05-06 2010-09-28 Alcon, Inc. UV-absorbers for ophthalmic lens materials
TWI453199B (en) 2008-11-04 2014-09-21 Alcon Inc Uv/visible light absorbers for ophthalmic lens materials
JP5575881B2 (en) 2009-05-22 2014-08-20 ノバルティス アーゲー Actinically crosslinkable siloxane-containing copolymer
US8642712B2 (en) 2009-05-22 2014-02-04 Novartis Ag Actinically-crosslinkable siloxane-containing copolymers
TWI487690B (en) 2009-07-06 2015-06-11 Alcon Inc Visible light absorbers for ophthalmic lens materials
TWI464151B (en) 2009-07-06 2014-12-11 Alcon Inc Uv/visible light absorbers for ophthalmic lens materials
US7915323B2 (en) 2009-07-09 2011-03-29 Bausch & Lamb Incorporated Mono ethylenically unsaturated polycarbosiloxane monomers
CA2767171C (en) 2009-07-09 2014-04-29 Bausch & Lomb Incorporated Mono ethylenically unsaturated polymerizable group containing polycarbosiloxane monomers
EP2480927A4 (en) * 2009-09-15 2018-01-17 Novartis AG Prepolymers suitable for making ultra-violet absorbing contact lenses
EP2523943B1 (en) 2010-01-15 2014-11-19 DSM IP Assets B.V. Process to make uv radiation absorbing 2-phenyl-1,2,3-benzotriazoles
TWI473629B (en) 2010-01-18 2015-02-21 Alcon Inc Visible light absorbers for ophthalmic lens materials
US8877103B2 (en) 2010-04-13 2014-11-04 Johnson & Johnson Vision Care, Inc. Process for manufacture of a thermochromic contact lens material
US9690115B2 (en) 2010-04-13 2017-06-27 Johnson & Johnson Vision Care, Inc. Contact lenses displaying reduced indoor glare
CN103026267B (en) 2010-04-29 2015-04-29 诺华公司 Intraocular lenses with combinations of UV absorbers and blue light chromophores
US20120023896A1 (en) * 2010-07-30 2012-02-02 Hamilton Sundstrand Corporation Auxiliary power unit fire enclosure drain
US8835525B2 (en) 2010-10-06 2014-09-16 Novartis Ag Chain-extended polysiloxane crosslinkers with dangling hydrophilic polymer chains
JP5784131B2 (en) 2010-10-06 2015-09-24 ノバルティス アーゲー Polymerizable chain-extended polysiloxane with pendant hydrophilic groups
CA2808462C (en) 2010-10-06 2016-01-12 Novartis Ag Water-processable silicone-containing prepolymers and uses thereof
EP3929546A1 (en) 2011-03-03 2021-12-29 Enchroma, Inc. Multi-band color vision filters and method by lp-optimization
US10391179B2 (en) 2011-03-21 2019-08-27 Momentive Performance Materials Inc. Organomodified carbosiloxane monomers containing compositions and uses thereof
US8772367B2 (en) 2011-03-21 2014-07-08 Momentive Performance Materials Inc. Siloxane monomers containing hydrolysis resistance carbosiloxane linkage, process for their preparation and thin films containing the same for contact lens application
TW201311621A (en) 2011-08-15 2013-03-16 Novartis Ag UV-absorbers for ophthalmic lens materials
EP2602654B1 (en) 2011-12-08 2023-04-19 Essilor International Ophthalmic filter
US8585938B1 (en) 2012-03-30 2013-11-19 Novartis Ag UV-absorbers for ophthalmic lens materials
NZ701889A (en) 2012-05-16 2016-08-26 Essilor Int Ophthalmic lens
MX341789B (en) * 2012-05-25 2016-09-02 Bausch & Lomb Fully polymerized uv blocking silicone hydrogel lens.
WO2013188825A1 (en) 2012-06-15 2013-12-19 The Regents Of The University Of California Optical filters and methods for reducing glare from glare-producing light
US9255180B2 (en) 2012-06-28 2016-02-09 Johnson & Johnson Consumer Inc. Ultraviolet radiation absorbing polyethers
AU2013280569B2 (en) 2012-06-28 2017-11-16 Johnson & Johnson Consumer Inc. Sunscreen compositions containing an ultraviolet radiation-absorbing polymer
US20150192800A1 (en) 2012-07-10 2015-07-09 Photokinetics, Inc. Optimization of light filters and illuminants and products derived therefrom
PL2875091T3 (en) 2012-07-23 2017-04-28 Bausch & Lomb Incorporated Light absorbing compounds for optical polymers
EP2885355A1 (en) * 2012-08-16 2015-06-24 Basf Se Stable uv absorber composition
CA2889891C (en) * 2012-12-14 2017-10-24 Novartis Ag Amphiphilic siloxane-containing vinylic monomers and uses thereof
WO2014133111A1 (en) 2013-02-27 2014-09-04 三井化学株式会社 Optical material, composition for use therein, and use thereof
EP2963456B1 (en) 2013-02-27 2020-05-27 Mitsui Chemicals, Inc. Optical material and use thereof
CN105793738A (en) 2013-12-13 2016-07-20 三井化学株式会社 Polymerizable composition for optical materials, optical material and method for producing same
WO2015088015A1 (en) 2013-12-13 2015-06-18 三井化学株式会社 Polymerizable composition for optical materials
JP6329005B2 (en) * 2014-06-05 2018-05-23 株式会社メニコン Ophthalmic lens
CA2982707C (en) * 2015-06-02 2019-11-12 Novartis Ag Visible-light photoinitiators and uses thereof
US10268053B2 (en) * 2016-02-22 2019-04-23 Novartis Ag UV/visible-absorbing vinylic monomers and uses thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937349A (en) * 1987-10-29 1990-06-26 Ciba-Geigy Corporation Process for the preparation of 3-[2'H-benzotriazol-(2')-yl]-4-hydroxy-benzenesulfonic acids and the salts thereof
TW200642836A (en) * 2005-03-04 2006-12-16 Bausch & Lomb Radiation-absorbing materials, ophthalmic compositions containing same, and method of treating ophthalmic devices
TW200934458A (en) * 2008-02-04 2009-08-16 Everlight Chem Ind Corp Polymerizable water-soluble or alcohol-soluble UV-light absorbent
TW201209079A (en) * 2010-07-30 2012-03-01 Novartis Ag Method for making UV-absorbing ophthalmic lenses
TW201242942A (en) * 2011-04-28 2012-11-01 Largan Medical Co Ltd Composition of contact lens for UV resistant

Also Published As

Publication number Publication date
CA3116257A1 (en) 2017-08-31
EP3419966B1 (en) 2020-03-25
CA3010331A1 (en) 2017-08-31
US20190179170A1 (en) 2019-06-13
EP3419966A1 (en) 2019-01-02
CA3010331C (en) 2021-06-22
CA3116257C (en) 2024-01-16
US20170242275A1 (en) 2017-08-24
US10254567B2 (en) 2019-04-09
TW201736332A (en) 2017-10-16
WO2017145024A1 (en) 2017-08-31
JP6546352B2 (en) 2019-07-17
US10823983B2 (en) 2020-11-03
JP2019504169A (en) 2019-02-14

Similar Documents

Publication Publication Date Title
TWI718257B (en) Uv-absorbing vinylic monomers and uses thereof
EP3303415B1 (en) Visible-light photoinitiators and uses thereof
EP3645532B1 (en) Hydroxyphenyl phenanthrolines as polymerizable blockers of high energy light for preparing ophthalmic devices, such as e.g. contact lenses
EP3383854B1 (en) Water-soluble uv-absorbing compounds and uses thereof
EP3990431A1 (en) Polymerizable fused tricyclic compounds as absorbers of uv and visible light
JP7413281B2 (en) Polymerizable absorber for UV and high energy visible light
CN112334444B (en) Polymerizable absorbers for UV and high energy visible light
US10752720B2 (en) Polymerizable blockers of high energy light
CN115769106A (en) Transition metal complexes as visible light absorbers
KR20220054543A (en) Multifocal contact lenses exhibiting improved vision properties
AU2021399237A1 (en) Photostable mimics of macular pigment
US20230176251A1 (en) Ophthalmic lenses and their manufacture by in-mold modification
US20230105465A1 (en) Anthraquinone-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses
KR20220115858A (en) Contact lenses containing photosensitive chromophores and packages therefor
US20230278300A1 (en) Ophthalmic lenses and their manufacture by in-mold modification
US20230117655A1 (en) Polymerizable fused tricyclic compounds as absorbers of uv and visible light
CN118055850A (en) Ophthalmic lens and its manufacture by in-mold modification
WO2022130089A1 (en) Photostable mimics of macular pigment
WO2023119021A1 (en) Contact lenses containing light absorbing regions and methods for their preparation